{"FP": [{"generated": ["alternative herbal medicine"], "gold": [], "text": "We describe here the unexpected onset of heavy toxicity including rhabdomyolysis after the fourth course of trabectedin in a patient with retroperitoneal liposarcoma who at the same time was taking an alternative herbal medicine suspected of triggering this adverse event."}, {"generated": ["EGb 761\u00ae"], "gold": [], "text": "In spite of chemotherapy, the lesion progressed rapidly reaching 16 \u00d7 10 cm and extending into the pre-aortic seat of the retro-peritoneum space."}, {"generated": ["trabectedin"], "gold": [], "text": "Due to the absence of co-morbidity, the patient had not received any other drugs during treatment with trabectedin."}, {"generated": ["chokeberry"], "gold": [], "text": "Moreover, as the patient took a commercial preparation of chokeberry juice which did not provide information on the amounts of its compounds, it cannot be excluded that other interactions might have occurred such as the inhibition of transport mechanisms, the activation of the death receptor and other unknown mechanisms."}, {"generated": ["medicinal cannabis"], "gold": ["cannabis"], "text": "This case report highlights the complexity associated with medicinal cannabis and the health risks associated with its use."}, {"generated": ["carbidopa-levodopa"], "gold": [], "text": "The clinical pharmacist recommended dose increases of carbidopa-levodopa to help control his tremors still present early in the morning (Figure 1)."}, {"generated": ["CB1Rs"], "gold": [], "text": "When CB1Rs on presynaptic neurons are activated, inhibitory neurotransmitter levels are reduced and dopamine levels increase [5,24,25]."}, {"generated": ["PGX results"], "gold": [], "text": "Interestingly, the patient\u2019s PGx results (Table 1) reported a genotype for COMT Met/Met, therefore higher levels of dopamine in his synapses would be expected."}, {"generated": ["morphine"], "gold": [], "text": "Given this patient\u2019s genetic results, guidelines, and current pain status, the clinical pharmacist suggested morphine as an alternative, as it does not utilize CYP2D6 for metabolism [34]."}, {"generated": ["CAM"], "gold": [], "text": "In China, 93.4% of cancer patients reported having used CAM in 2009-2010 [4]."}, {"generated": ["HDIs"], "gold": [], "text": "To date an increasing number of studies in evaluating HDIs have been reported [11]."}, {"generated": ["HDIs"], "gold": [], "text": "In the following, we reviewed pharmacogenomics studies, mainly from clinic study, on some important herb products that have been reported to have HDIs."}, {"generated": ["traditional hypoglycemic herbs"], "gold": [], "text": "Therefore, rs1142345 was associated with the clinical effect of traditional hypoglycemic herbs."}, {"generated": ["PM", "EMs"], "gold": [], "text": "AUC: concentration-time curve; EMs: extensive metabolizer; PM: poor metabolizer."}, {"generated": ["PM", "EMs"], "gold": [], "text": "AUC: concentration-time curve; EMs: extensive metabolizer; PM: poor metabolizer."}, {"generated": ["cytochrome P450"], "gold": [], "text": "The cytochrome P450 (CYP450) family of enzymes especially plays an important role in the biotransformation of about 70% of xenobiotics and other endogenous substances [14]."}, {"generated": ["herbal medicinal remedies"], "gold": [], "text": "With the tremendous surge in the acceptance of and public interest in herbal medicinal remedies, researchers are adopting the guidelines and opinions proposed for DDI studies to study HDI."}, {"generated": ["TDI"], "gold": [], "text": "The TDI effects of these herbals is felt when patients chronically use them because sufficient intermediary metabolites may be generated and this can be deleterious to consumers concomitantly taking conventional medications, as stated earlier."}, {"generated": ["water"], "gold": [], "text": "Extraction was performed using water to mimic the indigenous mode of extraction."}, {"generated": ["NADP Phytofingerprinting"], "gold": [], "text": "Briefly, serial dilutions of the extracts were added to a mixture of regeneration system, NADP Phytofingerprinting was performed on the extracts using a Waters Acquity UPLC system (Waters Corporation, Milford, MA, USA) with an Acquity BEH C18 column (2.1 mm \u00d7 100 mm, 1.7 \u00b5m particle size) incorporating a binary pump, vacuum degasser, autosampler, column oven, and Micromass Xevo tandem quadrupole mass spectrometric detector (QTOF xevo G2; Waters micromass, Manchester, UK) equipped with ESI probe."}, {"generated": ["DDI models"], "gold": [], "text": "Currently, there is no specific pharmacological tool to predict HDI since almost all in vitro-in vivo-extrapolation (IVIVE) Drug-Drug Interaction (DDI) models deal with one inhibitor-drug and one victim-drug."}, {"generated": ["OATs", "SLC22 family members"], "gold": [], "text": "Currently, there are 29 putative SLC22 family members, 18 of which are believed to be OATs."}, {"generated": ["OATs", "SLC22 family members"], "gold": [], "text": "Currently, there are 29 putative SLC22 family members, 18 of which are believed to be OATs."}, {"generated": ["Oat3", "Oat1"], "gold": [], "text": "Further, unique substrates that interact with Oat1, but not with Oat3 (and vice-versa) have been identified [7]."}, {"generated": ["Oat3", "Oat1"], "gold": [], "text": "Further, unique substrates that interact with Oat1, but not with Oat3 (and vice-versa) have been identified [7]."}, {"generated": ["Danshen"], "gold": ["Danshen components"], "text": "For the most part these latter two transporter families and the OATs have fairly distinct substrate interactions; however, the possibility that they also may contribute to the overall clinical pharmacokinetic profile of Danshen components in vivo needs to be considered until investigated directly."}, {"generated": ["alternative medicines"], "gold": [], "text": "Furthermore, 31% of diabetic patients have been reported to take alternative medicines, most in conjunction with conventional medicines (Ryan et al., 2001)."}, {"generated": ["EGb 761\u00ae"], "gold": [], "text": "Four of these metabolites (6\u03b1, 6\u03b2, 7\u03b1 and 7\u03b2 positions) have been identified in urine, which represented 1, 20, 6 and 14% of urinary recovered dose 96\u2009h after dose, respectively (Oida et al., 1985)."}, {"generated": ["CYP2C9*3", "CYP2C9*2"], "gold": [], "text": "Detection of the CYP2C9*2 and CYP2C9*3 alleles were carried out using a polymerase chain reaction based restriction fragment length polymorphism (polymerase chain reaction-RFLP) analysis."}, {"generated": ["CYP2C9*3", "CYP2C9*2"], "gold": [], "text": "Detection of the CYP2C9*2 and CYP2C9*3 alleles were carried out using a polymerase chain reaction based restriction fragment length polymorphism (polymerase chain reaction-RFLP) analysis."}, {"generated": ["HotMasterMix"], "gold": [], "text": "Briefly, PCR was performed in a final reaction volume of 50\u2009\u03bcl, which included 20\u2009\u03bcl 2.5 \u00d7 HotMasterMix (Eppendorf, Westbury, NY, USA), approximately 250\u2009ng of human genomic DNA and the primer pairs (0.25\u2009\u03bcM)."}, {"generated": ["Sang-Ju-Yin"], "gold": [], "text": "(2003)."}, {"generated": ["tolbutamide", "glipizide"], "gold": [], "text": "By contrast, for carriers of the CYP2C9*3 allele, the CL/Fs of glipizide (Kidd et al., 1999) and tolbutamide (Kirchheiner et al., 2002a) were significantly different from wild-type subjects, with ratios of 0.18 and 0.58, respectively."}, {"generated": ["tolbutamide", "glipizide"], "gold": [], "text": "By contrast, for carriers of the CYP2C9*3 allele, the CL/Fs of glipizide (Kidd et al., 1999) and tolbutamide (Kirchheiner et al., 2002a) were significantly different from wild-type subjects, with ratios of 0.18 and 0.58, respectively."}, {"generated": ["EBV", "CMV"], "gold": [], "text": "Serological titers for acute cytomegalovirus (CMV) and Epstein Barr virus (EBV) were negative."}, {"generated": ["EBV", "CMV"], "gold": [], "text": "Serological titers for acute cytomegalovirus (CMV) and Epstein Barr virus (EBV) were negative."}, {"generated": ["smooth muscle antibody", "ANA"], "gold": [], "text": "Antinuclear antibody (ANA) was 1 : 40 and smooth muscle antibody was modestly elevated at 1 : 80."}, {"generated": ["smooth muscle antibody", "ANA"], "gold": [], "text": "Antinuclear antibody (ANA) was 1 : 40 and smooth muscle antibody was modestly elevated at 1 : 80."}, {"generated": ["herbal supplement"], "gold": [], "text": "This case culminated in liver failure despite discontinuation of the herbal supplement [4]."}, {"generated": ["hapten"], "gold": [], "text": "The immune mechanism is precipitated by a drug or a metabolite acting as a hapten covalently binding to host cellular protein, converting into an immunogen [24] and thereby eliciting an autoimmune response."}, {"generated": ["Naranjo"], "gold": [], "text": "Naranjo [8] Causality Scale for Adverse Drug Reactions."}, {"generated": ["Levofloxacin"], "gold": [], "text": "Levofloxacin (LVFX) is used to treat numerous bacterial infections belonging to the third-generation fluoroquinolone antibiotic family [8]."}, {"generated": ["LVFX"], "gold": [], "text": "Based on our findings, the developed method is acceptable and accurate for analyzing LVFX in complex matrices."}, {"generated": ["calibration curve"], "gold": [], "text": "The diluted samples were analyzed using a calibration curve to derive their integrities, which were within the acceptable limit of \u00b115%."}, {"generated": ["pharmacokinetic level"], "gold": [], "text": "At present, our current studies at the pharmacokinetic level may not be able to explain this problem strongly."}, {"generated": ["KY\u00ae"], "gold": [], "text": "KY[2017]073)."}, {"generated": ["diabetes"], "gold": [], "text": "People with diabetes receiving this combination should be closely monitored to evaluate possible signs of reduced efficacy."}, {"generated": ["KF"], "gold": ["the extract and constituents of KF"], "text": "Furthermore, the extract and constituents of KF have been shown to possess anticancer, antioxidant, anti-osteoporosis, and anti-inflammatory properties (Nadia et al., 2012; Fathilah et al., 2013)."}, {"generated": ["Penicillin-streptomycin", "Sodium Pyruvate", "Dulbecco\u2019s Modified Eagle Medium", "HEPES", "Trypsin EDTA", "Minimal Essential Medium", "Hanks balanced salt solution"], "gold": [], "text": "Dulbecco\u2019s Modified Eagle Medium (DMEM), Minimal Essential Medium (MEM), Hanks balanced salt solution (HBSS), HEPES, Trypsin EDTA, Penicillin-streptomycin, and Sodium Pyruvate were from GIBCO BRL (Invitrogen Corp., Grand Island, NY, USA)."}, {"generated": ["Penicillin-streptomycin", "Sodium Pyruvate", "Dulbecco\u2019s Modified Eagle Medium", "HEPES", "Trypsin EDTA", "Minimal Essential Medium", "Hanks balanced salt solution"], "gold": [], "text": "Dulbecco\u2019s Modified Eagle Medium (DMEM), Minimal Essential Medium (MEM), Hanks balanced salt solution (HBSS), HEPES, Trypsin EDTA, Penicillin-streptomycin, and Sodium Pyruvate were from GIBCO BRL (Invitrogen Corp., Grand Island, NY, USA)."}, {"generated": ["Penicillin-streptomycin", "Sodium Pyruvate", "Dulbecco\u2019s Modified Eagle Medium", "HEPES", "Trypsin EDTA", "Minimal Essential Medium", "Hanks balanced salt solution"], "gold": [], "text": "Dulbecco\u2019s Modified Eagle Medium (DMEM), Minimal Essential Medium (MEM), Hanks balanced salt solution (HBSS), HEPES, Trypsin EDTA, Penicillin-streptomycin, and Sodium Pyruvate were from GIBCO BRL (Invitrogen Corp., Grand Island, NY, USA)."}, {"generated": ["Penicillin-streptomycin", "Sodium Pyruvate", "Dulbecco\u2019s Modified Eagle Medium", "HEPES", "Trypsin EDTA", "Minimal Essential Medium", "Hanks balanced salt solution"], "gold": [], "text": "Dulbecco\u2019s Modified Eagle Medium (DMEM), Minimal Essential Medium (MEM), Hanks balanced salt solution (HBSS), HEPES, Trypsin EDTA, Penicillin-streptomycin, and Sodium Pyruvate were from GIBCO BRL (Invitrogen Corp., Grand Island, NY, USA)."}, {"generated": ["Penicillin-streptomycin", "Sodium Pyruvate", "Dulbecco\u2019s Modified Eagle Medium", "HEPES", "Trypsin EDTA", "Minimal Essential Medium", "Hanks balanced salt solution"], "gold": [], "text": "Dulbecco\u2019s Modified Eagle Medium (DMEM), Minimal Essential Medium (MEM), Hanks balanced salt solution (HBSS), HEPES, Trypsin EDTA, Penicillin-streptomycin, and Sodium Pyruvate were from GIBCO BRL (Invitrogen Corp., Grand Island, NY, USA)."}, {"generated": ["Penicillin-streptomycin", "Sodium Pyruvate", "Dulbecco\u2019s Modified Eagle Medium", "HEPES", "Trypsin EDTA", "Minimal Essential Medium", "Hanks balanced salt solution"], "gold": [], "text": "Dulbecco\u2019s Modified Eagle Medium (DMEM), Minimal Essential Medium (MEM), Hanks balanced salt solution (HBSS), HEPES, Trypsin EDTA, Penicillin-streptomycin, and Sodium Pyruvate were from GIBCO BRL (Invitrogen Corp., Grand Island, NY, USA)."}, {"generated": ["Penicillin-streptomycin", "Sodium Pyruvate", "Dulbecco\u2019s Modified Eagle Medium", "HEPES", "Trypsin EDTA", "Minimal Essential Medium", "Hanks balanced salt solution"], "gold": [], "text": "Dulbecco\u2019s Modified Eagle Medium (DMEM), Minimal Essential Medium (MEM), Hanks balanced salt solution (HBSS), HEPES, Trypsin EDTA, Penicillin-streptomycin, and Sodium Pyruvate were from GIBCO BRL (Invitrogen Corp., Grand Island, NY, USA)."}, {"generated": ["digoxin"], "gold": ["non-essential amino acids"], "text": "Radio labeled digoxin [ Parental and transfected MDCK-II cells were grown in DMEM supplemented with 10% FBS, 1% non-essential amino acids, 1%  The assay for reversible inhibition was conducted in a total volume of 200 \u03bcL in 96-well microplates."}, {"generated": ["L. pumila"], "gold": ["the extract of L. pumila and the constituents", "calcein-AM"], "text": "IC Next, we determined the inhibition of P-gp by the extract of L. pumila and the constituents by using the two widely used probes calcein-AM and digoxin (Rautio et al., 2006)."}, {"generated": ["Cytochrome P450 enzymes", "CYP2C9", "CYP3A4", "CYP2C8"], "gold": [], "text": "Cytochrome P450 enzymes, CYP2C8, CYP2C9, and CYP3A4, are important in the metabolism of hypoglycemic drugs, such as thiazolidinediones (TZDs) and sulfonylureas, and hypocholesterolemic drugs, such as atorvastatin."}, {"generated": ["Cytochrome P450 enzymes", "CYP2C9", "CYP3A4", "CYP2C8"], "gold": [], "text": "Cytochrome P450 enzymes, CYP2C8, CYP2C9, and CYP3A4, are important in the metabolism of hypoglycemic drugs, such as thiazolidinediones (TZDs) and sulfonylureas, and hypocholesterolemic drugs, such as atorvastatin."}, {"generated": ["Cytochrome P450 enzymes", "CYP2C9", "CYP3A4", "CYP2C8"], "gold": [], "text": "Cytochrome P450 enzymes, CYP2C8, CYP2C9, and CYP3A4, are important in the metabolism of hypoglycemic drugs, such as thiazolidinediones (TZDs) and sulfonylureas, and hypocholesterolemic drugs, such as atorvastatin."}, {"generated": ["Cytochrome P450 enzymes", "CYP2C9", "CYP3A4", "CYP2C8"], "gold": [], "text": "Cytochrome P450 enzymes, CYP2C8, CYP2C9, and CYP3A4, are important in the metabolism of hypoglycemic drugs, such as thiazolidinediones (TZDs) and sulfonylureas, and hypocholesterolemic drugs, such as atorvastatin."}, {"generated": ["CYP2C9", "CYP3A4", "CYP2C8"], "gold": [], "text": "Qualitative screening of extracts and compounds was used to identify potential inhibitory effects on CYP2C8, CYP2C9 and CYP3A4."}, {"generated": ["CYP2C9", "CYP3A4", "CYP2C8"], "gold": [], "text": "Qualitative screening of extracts and compounds was used to identify potential inhibitory effects on CYP2C8, CYP2C9 and CYP3A4."}, {"generated": ["CYP2C9", "CYP3A4", "CYP2C8"], "gold": [], "text": "Qualitative screening of extracts and compounds was used to identify potential inhibitory effects on CYP2C8, CYP2C9 and CYP3A4."}, {"generated": ["DMSO", "acetonitrile", "methanol"], "gold": [], "text": "The organic solvents such as methanol, acetonitrile and DMSO showed no inhibitory effects on the respective enzymes (Supplementary Materials, Figure S1a\u2013c)."}, {"generated": ["DMSO", "acetonitrile", "methanol"], "gold": [], "text": "The organic solvents such as methanol, acetonitrile and DMSO showed no inhibitory effects on the respective enzymes (Supplementary Materials, Figure S1a\u2013c)."}, {"generated": ["DMSO", "acetonitrile", "methanol"], "gold": [], "text": "The organic solvents such as methanol, acetonitrile and DMSO showed no inhibitory effects on the respective enzymes (Supplementary Materials, Figure S1a\u2013c)."}, {"generated": ["CYP2C9", "CYP3A4", "CYP2C8"], "gold": [], "text": "GRT and FRE inhibited the reaction rate of CYP2C8, CYP2C9, and CYP3A4 as measured over 30 min (Figure 2a\u2013c)."}, {"generated": ["CYP2C9", "CYP3A4", "CYP2C8"], "gold": [], "text": "GRT and FRE inhibited the reaction rate of CYP2C8, CYP2C9, and CYP3A4 as measured over 30 min (Figure 2a\u2013c)."}, {"generated": ["CYP2C9", "CYP3A4", "CYP2C8"], "gold": [], "text": "GRT and FRE inhibited the reaction rate of CYP2C8, CYP2C9, and CYP3A4 as measured over 30 min (Figure 2a\u2013c)."}, {"generated": ["distilled water"], "gold": [], "text": "Stock solutions (10 mg/mL) were prepared by diluting the extracts and compounds in distilled water."}, {"generated": ["sulfaphenazole", "quercetin", "ketoconazole"], "gold": ["quercetin"], "text": "quercetin (positive CYP2C8 inhibitor), sulfaphenazole (positive CYP2C9 inhibitor), and ketoconazole (positive CYP3A4 inhibitor)."}, {"generated": ["sulfaphenazole", "quercetin", "ketoconazole"], "gold": ["quercetin"], "text": "quercetin (positive CYP2C8 inhibitor), sulfaphenazole (positive CYP2C9 inhibitor), and ketoconazole (positive CYP3A4 inhibitor)."}, {"generated": ["EGb 761\u00ae"], "gold": [], "text": "2)."}, {"generated": ["docetaxel"], "gold": [], "text": "The following pharmacokinetic parameters of docetaxel were calculated: area under the plasma concentration\u2013time curve from time zero to infinity (AUC0\u2013\u221e), elimination half-life (t1/2) and maximum plasma concentration (Cmax)."}, {"generated": ["docetaxel"], "gold": [], "text": "The individual differences in docetaxel AUC0\u2013\u221e are depicted in Figure 3."}, {"generated": ["zosuquidar", "R101933"], "gold": [], "text": "For example, the potent P-gp inhibitors R101933 [27, 28] and zosuquidar [29] did not significantly alter plasma levels of docetaxel in cancer patients."}, {"generated": ["zosuquidar", "R101933"], "gold": [], "text": "For example, the potent P-gp inhibitors R101933 [27, 28] and zosuquidar [29] did not significantly alter plasma levels of docetaxel in cancer patients."}, {"generated": ["EGb 761\u00ae"], "gold": [], "text": "Considering the risk of tumour progression, randomization was not in the interest of patients with advanced cancer."}, {"generated": ["CYP3A4"], "gold": [], "text": "Thus, the risk of CYP3A4-mediated interactions may be product dependent."}, {"generated": ["ethyl acetate", "ethyl gallate"], "gold": [], "text": "Briefly, 1 mL of ethyl acetate was added to 100 \u00b5L plasma and ascorbic acid-EDTA solution 10:1 (v/v) mixture with 10 \u00b5L ethyl gallate (1 \u00b5g/mL) as internal standard and vortexed for 15 minutes and centrifuged at 4,500 rpm for 20 minutes."}, {"generated": ["ethyl acetate", "ethyl gallate"], "gold": [], "text": "Briefly, 1 mL of ethyl acetate was added to 100 \u00b5L plasma and ascorbic acid-EDTA solution 10:1 (v/v) mixture with 10 \u00b5L ethyl gallate (1 \u00b5g/mL) as internal standard and vortexed for 15 minutes and centrifuged at 4,500 rpm for 20 minutes."}, {"generated": ["IS"], "gold": ["EGC", "EC", "ECG"], "text": "The monitored M/Z values of the parent and product ions under the positive electrospray mode of ECG, EGC, EC, and internal standard (IS) injected into MS through the Atlantis T3 (4.6\u00d750 mm \u00d73 \u00b5m) C18 (Waters) column were 443.10 \u2192 123.00, 307.20 \u2192 151.00, 291.20 \u2192 139.00, and 199.00 \u2192 127.03, respectively."}, {"generated": ["Mrp2 substrate drug"], "gold": ["RGE"], "text": "Next, we investigated the effects of RGE on the biliary excretion of Mrp2 substrate drug in rats."}, {"generated": ["Bsep", "P-gp"], "gold": [], "text": "Nuclear receptors, such as farnesoid X receptor (FXR, also known as bile acid receptor) and pregnane X receptor (PXR), are known as major regulators of the expression of Bsep and P-gp, respectively [35]."}, {"generated": ["Bsep", "P-gp"], "gold": [], "text": "Nuclear receptors, such as farnesoid X receptor (FXR, also known as bile acid receptor) and pregnane X receptor (PXR), are known as major regulators of the expression of Bsep and P-gp, respectively [35]."}, {"generated": ["liver"], "gold": [], "text": "Briefly, total protein was obtained by homogenizing 100 mg of liver samples with equal volume of a tissue lysis buffer."}, {"generated": ["M.-K.C."], "gold": [], "text": "Conceptualization, M.-K.C."}, {"generated": ["AC", "DST"], "gold": ["DST"], "text": "However, it is unknown whether there is an interaction between AC and DST."}, {"generated": ["EGb 761\u00ae"], "gold": [], "text": "; 3.5\u2009\u03bcm) at room temperature."}, {"generated": ["EGb 761\u00ae"], "gold": [], "text": "After centrifuging at 3500\u2009rpm for 10\u2009min, the supernatant was obtained and frozen at \u221240\u2009\u00b0C until analysis."}, {"generated": ["AC"], "gold": [], "text": "The maximum plasma concentration (C Rat liver microsomes were used to determine the metabolic rate of AC."}, {"generated": ["t Experimental"], "gold": [], "text": "The half-life (t Experimental values are expressed as mean\u2009\u00b1\u2009SD."}, {"generated": ["acetonitrile"], "gold": [], "text": "The highest recovery was obtained using acetonitrile as a protein precipitant."}, {"generated": ["AC"], "gold": [], "text": "Linearity for AC was obtained over the concentration range of 1\u2013500\u2009ng/mL."}, {"generated": ["EGb 761\u00ae"], "gold": [], "text": "Its effective plasma drug concentration is close to the toxic concentration, and large individual differences in the effects of the drug have been observed."}, {"generated": ["Western drugs"], "gold": [], "text": "Most of these reports and studies are on combinations with Western drugs."}, {"generated": ["digoxin"], "gold": [], "text": "Endogenous digoxin substances are present in neonates and patients with renal dysfunction, and these substances may lead to elevated or false-positive digoxin plasma concentration monitoring results."}, {"generated": ["digoxin"], "gold": [], "text": "Based on our analysis of the literature, the mechanism of interaction between TCM formulations and digoxin is as follows: A."}, {"generated": ["digoxin"], "gold": [], "text": "Experiments in mice have shown that the AUC of digoxin is increased by gavage and intravenous injection."}, {"generated": ["food"], "gold": [], "text": "When the bias of medicine is greater than that of food, it will inevitably affect the balance of qi, blood, yin and yang of the human body (Jia et al., 2021)."}, {"generated": ["digoxin"], "gold": [], "text": "Although a lot of experience has been accumulated in the clinical application of digoxin over the years, limited research has been conducted on its possible interactions with TCM formulations."}, {"generated": ["digoxin"], "gold": [], "text": "Therefore, the interactions between TCM formulations and digoxin are difficult to elucidate, and they are easily ignored by physicians."}, {"generated": ["cytochrome P450"], "gold": [], "text": "The most important class of enzymes involved in human drug metabolism is cytochrome P450 (P450), which occurs as a superfamily of related monooxygenase forms responsible for oxidative metabolism of xenobiotics and endogenous compounds (Nebert et al., 2013)."}, {"generated": ["Metabolic drug interactions"], "gold": [], "text": "Metabolic drug interactions normally occur between two or more drugs such that the addition of the perpetrator drug alters the systemic levels of the victim drug (Lin and Lu, 1998; Bohnert et al., 2016)."}, {"generated": ["C. asiatica"], "gold": ["C. asiatica Plant"], "text": "C. asiatica Plant Material and Preparation of CAW-R61J."}, {"generated": ["CAW-R61F", "CAW-R61H"], "gold": ["dried CA for CAW-R61F", "dried CA for CAW-R61H"], "text": "Aliquots of the two filtrates were shipped to Oregon Health & Science University (OHSU, Portland, OR), where they were frozen and lyophilized, yielding 21.4% from dried CA for CAW-R61F (extraction lot 1) and 23.9% from dried CA for CAW-R61H (extraction lot 2)."}, {"generated": ["CAW-R61F", "CAW-R61H"], "gold": ["dried CA for CAW-R61F", "dried CA for CAW-R61H"], "text": "Aliquots of the two filtrates were shipped to Oregon Health & Science University (OHSU, Portland, OR), where they were frozen and lyophilized, yielding 21.4% from dried CA for CAW-R61F (extraction lot 1) and 23.9% from dried CA for CAW-R61H (extraction lot 2)."}, {"generated": ["DMSO"], "gold": ["CAW-R61J"], "text": "DMSO was added to the CAW-R61J dosing solutions to 0.1% (v/v) such that all treatment conditions contained 0.1% DMSO."}, {"generated": ["Hill model"], "gold": [], "text": "To determine the IC50 values, the concentration-response (percentage control value) curves were fitted to a four-parameter sigmoid (Hill) model, according to eq."}, {"generated": ["logEC50"], "gold": [], "text": "2 above (substituting logEC50 for logIC50)."}, {"generated": ["Prism 8.0.2"], "gold": [], "text": "All curve fitting was carried out using Prism 8.0.2 (GraphPad Software, San Diego, CA)."}, {"generated": ["dmd.120.090860f1"], "gold": [], "text": "Object name is dmd.120.090860f1.jpg Fig."}, {"generated": ["EGb 761\u00ae"], "gold": [], "text": "; data not shown)."}, {"generated": ["CYP2B6", "CYP2C9", "CYP1A2"], "gold": [], "text": "The strongest reversible inhibition was against CYP2C9 (IC50 330 \u00b5g/ml), and the least inhibition was against CYP1A2 and CYP2B6 (IC50 > 1000 \u00b5g/ml)."}, {"generated": ["CYP2B6", "CYP2C9", "CYP1A2"], "gold": [], "text": "The strongest reversible inhibition was against CYP2C9 (IC50 330 \u00b5g/ml), and the least inhibition was against CYP1A2 and CYP2B6 (IC50 > 1000 \u00b5g/ml)."}, {"generated": ["CYP2B6", "CYP2C9", "CYP1A2"], "gold": [], "text": "The strongest reversible inhibition was against CYP2C9 (IC50 330 \u00b5g/ml), and the least inhibition was against CYP1A2 and CYP2B6 (IC50 > 1000 \u00b5g/ml)."}, {"generated": ["dmd.120.090860f3"], "gold": [], "text": "Object name is dmd.120.090860f3.jpg Fig."}, {"generated": ["triplicate determinations"], "gold": [], "text": "of triplicate determinations."}, {"generated": ["CAW-R61J"], "gold": ["the centelloid content of CAW-R61J"], "text": "Based on the centelloid content of CAW-R61J, we expect similar plasma concentrations for these compounds in our clinical studies using this extract."}, {"generated": ["CA derivatives"], "gold": ["CA"], "text": "It will also be important to examine possible interactions of CA derivatives with phase II drug-metabolizing enzymes."}, {"generated": ["combination drugs"], "gold": [], "text": "Therefore, the tolerability and safety of combination drugs were evaluated in the context of their DDI potential."}, {"generated": ["fimasartan"], "gold": [], "text": "Based on these clinical outcomes, fimasartan can be recommended for patients with hypertension and chronic kidney disease [4,14]."}, {"generated": ["Fimasartan-amide", "Hydrochlorothiazide", "Fimasartan", "Amlodipine"], "gold": [], "text": "Fimasartan, fimasartan-amide, amlodipine, and hydrochlorothiazide levels in each sample were determined using an Agilent 6470 Triple Quadrupole LC-MS/MS system (Agilent, Wilmington, DE, USA)."}, {"generated": ["Fimasartan-amide", "Hydrochlorothiazide", "Fimasartan", "Amlodipine"], "gold": [], "text": "Fimasartan, fimasartan-amide, amlodipine, and hydrochlorothiazide levels in each sample were determined using an Agilent 6470 Triple Quadrupole LC-MS/MS system (Agilent, Wilmington, DE, USA)."}, {"generated": ["Fimasartan-amide", "Hydrochlorothiazide", "Fimasartan", "Amlodipine"], "gold": [], "text": "Fimasartan, fimasartan-amide, amlodipine, and hydrochlorothiazide levels in each sample were determined using an Agilent 6470 Triple Quadrupole LC-MS/MS system (Agilent, Wilmington, DE, USA)."}, {"generated": ["Fimasartan-amide", "Hydrochlorothiazide", "Fimasartan", "Amlodipine"], "gold": [], "text": "Fimasartan, fimasartan-amide, amlodipine, and hydrochlorothiazide levels in each sample were determined using an Agilent 6470 Triple Quadrupole LC-MS/MS system (Agilent, Wilmington, DE, USA)."}, {"generated": ["QC"], "gold": [], "text": "Three concentrations of quality control (QC) samples were prepared at low, medium, and high concentrations in the range of the standard calibration curves."}, {"generated": ["berberine"], "gold": [], "text": "Then, 150 \u03bcL acetonitrile containing 1 ng/mL berberine (IS) was added to the reconstituted standard curves."}, {"generated": ["QC samples"], "gold": [], "text": "Post-preparative stability was evaluated by comparing the extracted QC samples maintained in the autosampler at 6 \u00b0C for 24 h (compared with the untreated QC samples)."}, {"generated": ["amlodipine", "hydrochlorothiazide", "fimasartan"], "gold": [], "text": "Each rat in the combination group received a mixture of fimasartan (3 mg/kg), amlodipine (5 mg/kg), and hydrochlorothiazide (5 mg/kg) dissolved in saline containing 10% DMSO."}, {"generated": ["amlodipine", "hydrochlorothiazide", "fimasartan"], "gold": [], "text": "Each rat in the combination group received a mixture of fimasartan (3 mg/kg), amlodipine (5 mg/kg), and hydrochlorothiazide (5 mg/kg) dissolved in saline containing 10% DMSO."}, {"generated": ["amlodipine", "hydrochlorothiazide", "fimasartan"], "gold": [], "text": "Each rat in the combination group received a mixture of fimasartan (3 mg/kg), amlodipine (5 mg/kg), and hydrochlorothiazide (5 mg/kg) dissolved in saline containing 10% DMSO."}, {"generated": ["saline"], "gold": [], "text": "The jejunal segments were then isolated and rinsed using pre-warmed saline."}, {"generated": ["berberine"], "gold": [], "text": "For amlodipine analysis, 50 \u03bcL aliquots were mixed with 150 \u03bcL acetonitrile containing 1 ng/mL berberine (IS)."}, {"generated": ["product ion"], "gold": [], "text": "The ionization mode and mass transition from Q1 to Q3 were selected based on the product ion scan results of authentic standards and previously published reports (Figure 1)."}, {"generated": ["fimasartan-amide", "amlodipine", "hydrochlorothiazide", "fimasartan"], "gold": [], "text": "Figure 2 shows the chromatograms of the blank matrix and those of fimasartan, fimasartan-amide, amlodipine, and hydrochlorothiazide spiked at the LLOQ or rat plasma samples 1 h after oral administration of fimasartan, amlodipine, and hydrochlorothiazide."}, {"generated": ["fimasartan-amide", "amlodipine", "hydrochlorothiazide", "fimasartan"], "gold": [], "text": "Figure 2 shows the chromatograms of the blank matrix and those of fimasartan, fimasartan-amide, amlodipine, and hydrochlorothiazide spiked at the LLOQ or rat plasma samples 1 h after oral administration of fimasartan, amlodipine, and hydrochlorothiazide."}, {"generated": ["fimasartan-amide", "amlodipine", "hydrochlorothiazide", "fimasartan"], "gold": [], "text": "Figure 2 shows the chromatograms of the blank matrix and those of fimasartan, fimasartan-amide, amlodipine, and hydrochlorothiazide spiked at the LLOQ or rat plasma samples 1 h after oral administration of fimasartan, amlodipine, and hydrochlorothiazide."}, {"generated": ["fimasartan-amide", "amlodipine", "hydrochlorothiazide", "fimasartan"], "gold": [], "text": "Figure 2 shows the chromatograms of the blank matrix and those of fimasartan, fimasartan-amide, amlodipine, and hydrochlorothiazide spiked at the LLOQ or rat plasma samples 1 h after oral administration of fimasartan, amlodipine, and hydrochlorothiazide."}, {"generated": ["fimasartan"], "gold": [], "text": "These results suggest that fimasartan is an attractive candidate for the treatment of hypertension and suggest the increasing use of fimasartan monotherapy and combination therapy."}, {"generated": ["amlodipine", "hydrochlorothiazide", "fimasartan"], "gold": [], "text": "We also used the same MRM condition as previously published reports [39,40] and the product ion mass spectra from fimasartan, amlodipine, and hydrochlorothiazide showed different mass fragmentation patterns (Figure 1)."}, {"generated": ["amlodipine", "hydrochlorothiazide", "fimasartan"], "gold": [], "text": "We also used the same MRM condition as previously published reports [39,40] and the product ion mass spectra from fimasartan, amlodipine, and hydrochlorothiazide showed different mass fragmentation patterns (Figure 1)."}, {"generated": ["amlodipine", "hydrochlorothiazide", "fimasartan"], "gold": [], "text": "We also used the same MRM condition as previously published reports [39,40] and the product ion mass spectra from fimasartan, amlodipine, and hydrochlorothiazide showed different mass fragmentation patterns (Figure 1)."}, {"generated": ["M.P."], "gold": [], "text": "and M.P."}, {"generated": ["HAART"], "gold": [], "text": "However, there are several challenges associated with the chronic nature of HAART administration."}, {"generated": ["ART"], "gold": [], "text": "However, attention has now shifted from reduction in mortality to improvement of the quality of life for people taking ART [1,2]."}, {"generated": ["NVP", "EFV"], "gold": [], "text": "EFV and NVP have been associated with a number of side effects including liver damage, nausea, vomiting, fever, diarrhoea, dyslipidemia and headache [10]."}, {"generated": ["NVP", "EFV"], "gold": [], "text": "EFV and NVP have been associated with a number of side effects including liver damage, nausea, vomiting, fever, diarrhoea, dyslipidemia and headache [10]."}, {"generated": ["medicinal plants"], "gold": [], "text": "There is substantial evidence supporting the potential of medicinal plants in combating diseases, especially in developing countries [12,13,14,15]."}, {"generated": ["CYP2B6"], "gold": [], "text": "Genetic polymorphism in CYP2B6 have been implicated in variations in the activity of the enzyme in metabolizing xenobiotics [26]."}, {"generated": ["washout period"], "gold": [], "text": "Each participant received three treatments with a 7 \u00b1 1-day washout period in-between."}, {"generated": ["AAP"], "gold": [], "text": "To mimic the recommended dose based on the status of patients, AAP dose is suggested from 1000 mg to the maximum dose of 1000 mg \u00d7 4 times (8 tablets) per day for treatment of the common cold [22,23]."}, {"generated": ["GGT", "AAP"], "gold": ["GGT"], "text": "Therefore, two simulation scenarios were used to evaluate the magnitude of any interaction, (AAP 1000 mg once daily + GGT 7680 mg once daily) and (AAP 1000 mg \u00d7 4 times daily + GGT 7680 mg once daily) in a week."}, {"generated": ["AAP"], "gold": ["GGT"], "text": "AAP at 1000 once a day or 1000 mg \u00d7 4 times a day was administered in the presence or absence of GGT (7680 mg) daily."}, {"generated": ["Y.C.P."], "gold": [], "text": "and Y.C.P."}, {"generated": ["AAP"], "gold": [], "text": "Non-compartmental analysis (NCA) result of pharmacokinetic (PK) parameters of AAP."}, {"generated": ["herbal supplement"], "gold": [], "text": "[1\u20133,8,9] Still other surveys indicate that herbal supplement usage is prevalent among patients taking prescription medications,[10\u201312] with many individuals greater than 65 years of age."}, {"generated": ["probe drug"], "gold": [], "text": "Adherence to these restrictions was further emphasized five days before each probe drug administration."}, {"generated": ["EGb 761\u00ae", "CYP"], "gold": [], "text": "Table I  Pre- and Postsupplementation Phenotypic Ratios (means, 95% confidence intervals) Phenotypic Ratio (CYP)\tSupplement\tPresupplementation (mean and 95% CI)\tPostsupplementation."}, {"generated": ["EGb 761\u00ae", "CYP"], "gold": [], "text": "Table I  Pre- and Postsupplementation Phenotypic Ratios (means, 95% confidence intervals) Phenotypic Ratio (CYP)\tSupplement\tPresupplementation (mean and 95% CI)\tPostsupplementation."}, {"generated": ["young individuals"], "gold": [], "text": "This finding also corroborates the results of an earlier study in young individuals."}, {"generated": ["anticoagulant therapy"], "gold": [], "text": "[11,12] Such an interaction is particularly relevant to elderly patients on anticoagulant therapy."}, {"generated": ["ginkgo"], "gold": ["ginkgolides"], "text": "This interaction appears attributable to the inhibition of platelet activating factor by various ginkgolides."}, {"generated": ["botanical supplements"], "gold": [], "text": "Therefore, botanical supplements, when taken concomitantly with conventional medications, can give rise to serious herb-drug interactions."}, {"generated": ["quinine", "3-hydroxyquinine"], "gold": [], "text": "Blood samples were collected and analyzed for plasma quinine and its metabolite, (3-hydroxyquinine) using a validated HPLC method."}, {"generated": ["quinine", "3-hydroxyquinine"], "gold": [], "text": "Blood samples were collected and analyzed for plasma quinine and its metabolite, (3-hydroxyquinine) using a validated HPLC method."}, {"generated": ["quinine sulphate"], "gold": [], "text": "In the first phase, after an overnight fast, each subject in the respective groups received a single oral dose of 600 mg quinine sulphate tablets (Maderich Ltd, Surrey, England)."}, {"generated": ["quinine", "3-hydroxyquinine"], "gold": [], "text": "The limit of quantitation was 0.37\u00b5g/ml and 0.5\u00b5g/ml for quinine and for 3-hydroxyquinine respectively."}, {"generated": ["quinine", "3-hydroxyquinine"], "gold": [], "text": "The limit of quantitation was 0.37\u00b5g/ml and 0.5\u00b5g/ml for quinine and for 3-hydroxyquinine respectively."}, {"generated": ["quinine"], "gold": [], "text": "The AUC0\u2013\u221e of quinine was slightly reduced by about 9 %."}, {"generated": ["dizziness"], "gold": [], "text": "Precisely, only 3 participants complained of very light dizziness."}, {"generated": ["Sophora frutescens"], "gold": ["S. frutescens"], "text": "In Stage 2 77 additional participants were randomized to either 1,200 mg S. frutescens or placebo."}, {"generated": ["TCAM"], "gold": [], "text": "More than 50% of adults in KwaZulu-Natal attending public sector facilities for ART initiation disclose using TCAM [10], and similar levels of TCAM use by HIV positive individuals may occur worldwide [11]."}, {"generated": ["MOS-HIV"], "gold": [], "text": "With respect to the MOS-HIV, failure differences were found between placebo and 1200 mg, favouring the 1200mg group."}, {"generated": ["electrocardiogram"], "gold": [], "text": "On serial electrocardiograms the PR interval, QRS duration and corrected QT interval (QTc) were similar in both arms (S2 Table)."}, {"generated": ["anticough syrups", "Iranian borage (E. amoenum)"], "gold": ["Iranian borage (E. amoenum)"], "text": "[2526] Iranian borage (E. amoenum) as unformulated and anticough syrups as formulated herbal products were the most used ones in our study population, while common cold and respiratory problems were determined to be the main indications for this trend."}, {"generated": ["TEM"], "gold": [], "text": "The patient had a Karnofsky performance status scale of 90% after resection without neurological deficiencies and was referred to our department for further treatment with radiotherapy and temozolomide (TEM)."}, {"generated": ["fluorethylenthyrosin"], "gold": [], "text": "Unfortunately, a [18 F]-fluorethylenthyrosin positron emission tomography positive residual tumor was detected 2 months after the end of radiotherapy."}, {"generated": ["herbal formulas"], "gold": [], "text": "Therefore, we think that a comprehensive management of our patients should also include education about the risk of interactions with herbal formulas."}, {"generated": ["normal saline"], "gold": [], "text": "Briefly, whole blood (0.5\u2009mL) was diluted twofold with freshly prepared normal saline and incubated at 37\u2009\u00b0C for at least 6\u2009min."}, {"generated": ["International normalized ratio"], "gold": [], "text": "International normalized ratio  International normalized ratio was measured at each blood sampling time before and after warfarin dosing using a BFT II analyser."}, {"generated": ["human plasma"], "gold": [], "text": "Percentage factor activity for each sample was obtained from a standard curve constructed using different dilutions of standard human plasma of known factor activity and clotting time."}, {"generated": ["S-warfarin"], "gold": [], "text": "In brief, a two-compartment pharmacokinetic model was used to describe S-warfarin concentration\u2013time data and an indirect pharmacodynamic model described the relationship between percentage of prothrombin complex activity (PCA; which was derived from the INR data in this study) and S-warfarin concentration."}, {"generated": ["EGb 761", "garlic", "S-warfarin", "R-warfarin"], "gold": ["cranberry", "garlic"], "text": "Table 2  Pharmacokinetic parameters of S-warfarin and R-warfarin  \tMean (95% CI)\tGeometric mean ratio (90% CI)  \tWarfarin only\tWarfarin and cranberry\tWarfarin and garlic\tWarfarin and cranberry/warfarin only\tWarfarin and garlic/warfarin only S-warfarin \u2003tmax (h)\t1.4 (1.1\u20131.6)\t1.9 (1.1\u20132.7)\t1.3 (1.1\u20131.6)\tNA\tNA \u2003Cmax (\u03bcg\u2009mL\u22121)\t1.8 (1.7\u20131.9)\t1.7 (1.5\u20132.0)\t1.9 (1.5\u20132.2)\t0.94 (0.67\u20131.29)\t1.06 (0.77\u20131.47) \u2003t1/2 (h)\t38.6 (35.7\u201341.5)\t34.9 (31.0\u201338.8)\t41.2 (35.1\u201347.3)\t0.94 (0.79\u20131.12)\t0.99 (0.83\u20131.18) \u2003AUC (\u03bcg\u2009mL\u22121\u2009h)\t60.3 (54.5\u201366.1)\t63.0 (57.3\u201368.8)\t65.5 (55.3\u201375.6)\t1.04 (0.94\u20131.67)\t1.06 (0.95\u20131.19) \u2003CL/F (mL\u2009h\u22121)\t213 (193\u2013232)\t204 (183\u2013224)\t202 (175\u2013229)\t0.89 (0.80\u20130.99)\t1.05 (0.94\u20131.17) \u2003Fraction unbound (fu)\t0.010 (0.007\u20130.013)\t0.010 (0.007\u20130.014)\t0.011 (0.008\u20130.014)\t1.00 (0.75\u20131.25)\t1.12 (0.39\u20131.84)  \t \t \t \t \t  R-warfarin \u2003tmax (h)\t1.4 (1.1\u20131.6)\t1.9 (1.1\u20132.7)\t1.8 (0.7\u20132.9)\tNA\tNA \u2003Cmax (\u03bcg\u2009mL\u22121)\t1.8 (1.7\u20132.0)\t1.7 (1.5\u20131.9)\t1.9 (1.5\u20132.2)\t0.90 (0.67\u20131.21)\t1.02 (0.8\u20131.4) \u2003t1/2 (h)\t55.6 (46.2\u201365.0)\t47.7 (41.5\u201353.9)\t52.6 (47.4\u201357.9)\t0.93 (0.80\u20131.08)\t0.98 (0.84\u20131.14) \u2003AUC (\u03bcg\u2009mL\u22121\u2009h)\t108.7 (90.0\u2013127.3)\t105.8 (91.7\u2013119.9)\t105.0 (96.3\u2013113.7)\t1.0 (0.9\u20131.1)\t0.99 (0.87\u20131.13) \u2003CL/F (mL\u2009h\u22121)\t123 (106\u2013140)\t124 (109\u2013139)\t121 (112\u2013131)\t0.87 (0.75\u20130.99)\t0.96 (0.84\u20131.11) \u2003Fraction unbound (fu)\t0.006 (0.004\u20130.007)\t0.005 (0.004\u20130.007)\t0.006 (0.004\u20130.007)\t0.95 (0.72\u20131.18)\t1.04 (0.80\u20131.29) Open in a separate window Abbreviations: AUC, area under the plasma concentration\u2013time curve; CI, confidence interval; CL, clearance; CL/F, apparent clearance; Cmax, maximum concentration; F, bioavailability; NA, not applicable; tmax, time to Cmax."}, {"generated": ["EGb 761", "garlic", "S-warfarin", "R-warfarin"], "gold": ["cranberry", "garlic"], "text": "Table 2  Pharmacokinetic parameters of S-warfarin and R-warfarin  \tMean (95% CI)\tGeometric mean ratio (90% CI)  \tWarfarin only\tWarfarin and cranberry\tWarfarin and garlic\tWarfarin and cranberry/warfarin only\tWarfarin and garlic/warfarin only S-warfarin \u2003tmax (h)\t1.4 (1.1\u20131.6)\t1.9 (1.1\u20132.7)\t1.3 (1.1\u20131.6)\tNA\tNA \u2003Cmax (\u03bcg\u2009mL\u22121)\t1.8 (1.7\u20131.9)\t1.7 (1.5\u20132.0)\t1.9 (1.5\u20132.2)\t0.94 (0.67\u20131.29)\t1.06 (0.77\u20131.47) \u2003t1/2 (h)\t38.6 (35.7\u201341.5)\t34.9 (31.0\u201338.8)\t41.2 (35.1\u201347.3)\t0.94 (0.79\u20131.12)\t0.99 (0.83\u20131.18) \u2003AUC (\u03bcg\u2009mL\u22121\u2009h)\t60.3 (54.5\u201366.1)\t63.0 (57.3\u201368.8)\t65.5 (55.3\u201375.6)\t1.04 (0.94\u20131.67)\t1.06 (0.95\u20131.19) \u2003CL/F (mL\u2009h\u22121)\t213 (193\u2013232)\t204 (183\u2013224)\t202 (175\u2013229)\t0.89 (0.80\u20130.99)\t1.05 (0.94\u20131.17) \u2003Fraction unbound (fu)\t0.010 (0.007\u20130.013)\t0.010 (0.007\u20130.014)\t0.011 (0.008\u20130.014)\t1.00 (0.75\u20131.25)\t1.12 (0.39\u20131.84)  \t \t \t \t \t  R-warfarin \u2003tmax (h)\t1.4 (1.1\u20131.6)\t1.9 (1.1\u20132.7)\t1.8 (0.7\u20132.9)\tNA\tNA \u2003Cmax (\u03bcg\u2009mL\u22121)\t1.8 (1.7\u20132.0)\t1.7 (1.5\u20131.9)\t1.9 (1.5\u20132.2)\t0.90 (0.67\u20131.21)\t1.02 (0.8\u20131.4) \u2003t1/2 (h)\t55.6 (46.2\u201365.0)\t47.7 (41.5\u201353.9)\t52.6 (47.4\u201357.9)\t0.93 (0.80\u20131.08)\t0.98 (0.84\u20131.14) \u2003AUC (\u03bcg\u2009mL\u22121\u2009h)\t108.7 (90.0\u2013127.3)\t105.8 (91.7\u2013119.9)\t105.0 (96.3\u2013113.7)\t1.0 (0.9\u20131.1)\t0.99 (0.87\u20131.13) \u2003CL/F (mL\u2009h\u22121)\t123 (106\u2013140)\t124 (109\u2013139)\t121 (112\u2013131)\t0.87 (0.75\u20130.99)\t0.96 (0.84\u20131.11) \u2003Fraction unbound (fu)\t0.006 (0.004\u20130.007)\t0.005 (0.004\u20130.007)\t0.006 (0.004\u20130.007)\t0.95 (0.72\u20131.18)\t1.04 (0.80\u20131.29) Open in a separate window Abbreviations: AUC, area under the plasma concentration\u2013time curve; CI, confidence interval; CL, clearance; CL/F, apparent clearance; Cmax, maximum concentration; F, bioavailability; NA, not applicable; tmax, time to Cmax."}, {"generated": ["EGb 761", "garlic", "S-warfarin", "R-warfarin"], "gold": ["cranberry", "garlic"], "text": "Table 2  Pharmacokinetic parameters of S-warfarin and R-warfarin  \tMean (95% CI)\tGeometric mean ratio (90% CI)  \tWarfarin only\tWarfarin and cranberry\tWarfarin and garlic\tWarfarin and cranberry/warfarin only\tWarfarin and garlic/warfarin only S-warfarin \u2003tmax (h)\t1.4 (1.1\u20131.6)\t1.9 (1.1\u20132.7)\t1.3 (1.1\u20131.6)\tNA\tNA \u2003Cmax (\u03bcg\u2009mL\u22121)\t1.8 (1.7\u20131.9)\t1.7 (1.5\u20132.0)\t1.9 (1.5\u20132.2)\t0.94 (0.67\u20131.29)\t1.06 (0.77\u20131.47) \u2003t1/2 (h)\t38.6 (35.7\u201341.5)\t34.9 (31.0\u201338.8)\t41.2 (35.1\u201347.3)\t0.94 (0.79\u20131.12)\t0.99 (0.83\u20131.18) \u2003AUC (\u03bcg\u2009mL\u22121\u2009h)\t60.3 (54.5\u201366.1)\t63.0 (57.3\u201368.8)\t65.5 (55.3\u201375.6)\t1.04 (0.94\u20131.67)\t1.06 (0.95\u20131.19) \u2003CL/F (mL\u2009h\u22121)\t213 (193\u2013232)\t204 (183\u2013224)\t202 (175\u2013229)\t0.89 (0.80\u20130.99)\t1.05 (0.94\u20131.17) \u2003Fraction unbound (fu)\t0.010 (0.007\u20130.013)\t0.010 (0.007\u20130.014)\t0.011 (0.008\u20130.014)\t1.00 (0.75\u20131.25)\t1.12 (0.39\u20131.84)  \t \t \t \t \t  R-warfarin \u2003tmax (h)\t1.4 (1.1\u20131.6)\t1.9 (1.1\u20132.7)\t1.8 (0.7\u20132.9)\tNA\tNA \u2003Cmax (\u03bcg\u2009mL\u22121)\t1.8 (1.7\u20132.0)\t1.7 (1.5\u20131.9)\t1.9 (1.5\u20132.2)\t0.90 (0.67\u20131.21)\t1.02 (0.8\u20131.4) \u2003t1/2 (h)\t55.6 (46.2\u201365.0)\t47.7 (41.5\u201353.9)\t52.6 (47.4\u201357.9)\t0.93 (0.80\u20131.08)\t0.98 (0.84\u20131.14) \u2003AUC (\u03bcg\u2009mL\u22121\u2009h)\t108.7 (90.0\u2013127.3)\t105.8 (91.7\u2013119.9)\t105.0 (96.3\u2013113.7)\t1.0 (0.9\u20131.1)\t0.99 (0.87\u20131.13) \u2003CL/F (mL\u2009h\u22121)\t123 (106\u2013140)\t124 (109\u2013139)\t121 (112\u2013131)\t0.87 (0.75\u20130.99)\t0.96 (0.84\u20131.11) \u2003Fraction unbound (fu)\t0.006 (0.004\u20130.007)\t0.005 (0.004\u20130.007)\t0.006 (0.004\u20130.007)\t0.95 (0.72\u20131.18)\t1.04 (0.80\u20131.29) Open in a separate window Abbreviations: AUC, area under the plasma concentration\u2013time curve; CI, confidence interval; CL, clearance; CL/F, apparent clearance; Cmax, maximum concentration; F, bioavailability; NA, not applicable; tmax, time to Cmax."}, {"generated": ["warfarin"], "gold": [], "text": "Pharmacokinetic\u2013pharmacodynamic modelling  The population PKPD parameter estimates for warfarin are presented in the Table 3."}, {"generated": ["cranberry juice"], "gold": ["cranberry"], "text": "(2007) also investigated the effect of pretreatment with cranberry juice for 5 days on warfarin pharmacokinetics and found no clinically significant change in the AUC of S-warfarin."}, {"generated": ["Atrial fibrillation"], "gold": [], "text": "(2006b) included 7 patients with atrial fibrillation, whereas Ansell et al."}, {"generated": ["cranberry juice"], "gold": ["cranberry"], "text": "(2007) concluded that there were no pharmacodynamic interactions between warfarin and cranberry juice, but they employed a low dose of warfarin (10\u2009mg), which made this end point difficult to assess."}, {"generated": ["warfarin"], "gold": [], "text": "Current address: Drug Metabolism and Pharmacokinetics, Covance Laboratories Inc., Madison, WI, USA Patients commonly take complementary medicines in conjunction with warfarin yet evidence supporting the safety or the risk of a herb\u2013drug interaction is lacking."}, {"generated": ["caffeine", "1-hydroxymidazolam", "hydroxychlorzoxazone", "debrisoquine", "midazolam", "paraxanthine", "chlorzoxazone"], "gold": [], "text": "Before and after the test period, the activities of CYP 3A4/5 (1-hydroxymidazolam/midazolam serum ratio), CYP 1A2 (paraxanthine/caffeine serum ratio), CYP 2E1 (hydroxychlorzoxazone/chlorzoxazone serum ratio), and CYP 2D6 (debrisoquine urinary recovery ratio) were determined."}, {"generated": ["caffeine", "1-hydroxymidazolam", "hydroxychlorzoxazone", "debrisoquine", "midazolam", "paraxanthine", "chlorzoxazone"], "gold": [], "text": "Before and after the test period, the activities of CYP 3A4/5 (1-hydroxymidazolam/midazolam serum ratio), CYP 1A2 (paraxanthine/caffeine serum ratio), CYP 2E1 (hydroxychlorzoxazone/chlorzoxazone serum ratio), and CYP 2D6 (debrisoquine urinary recovery ratio) were determined."}, {"generated": ["caffeine", "1-hydroxymidazolam", "hydroxychlorzoxazone", "debrisoquine", "midazolam", "paraxanthine", "chlorzoxazone"], "gold": [], "text": "Before and after the test period, the activities of CYP 3A4/5 (1-hydroxymidazolam/midazolam serum ratio), CYP 1A2 (paraxanthine/caffeine serum ratio), CYP 2E1 (hydroxychlorzoxazone/chlorzoxazone serum ratio), and CYP 2D6 (debrisoquine urinary recovery ratio) were determined."}, {"generated": ["caffeine", "1-hydroxymidazolam", "hydroxychlorzoxazone", "debrisoquine", "midazolam", "paraxanthine", "chlorzoxazone"], "gold": [], "text": "Before and after the test period, the activities of CYP 3A4/5 (1-hydroxymidazolam/midazolam serum ratio), CYP 1A2 (paraxanthine/caffeine serum ratio), CYP 2E1 (hydroxychlorzoxazone/chlorzoxazone serum ratio), and CYP 2D6 (debrisoquine urinary recovery ratio) were determined."}, {"generated": ["caffeine", "1-hydroxymidazolam", "hydroxychlorzoxazone", "debrisoquine", "midazolam", "paraxanthine", "chlorzoxazone"], "gold": [], "text": "Before and after the test period, the activities of CYP 3A4/5 (1-hydroxymidazolam/midazolam serum ratio), CYP 1A2 (paraxanthine/caffeine serum ratio), CYP 2E1 (hydroxychlorzoxazone/chlorzoxazone serum ratio), and CYP 2D6 (debrisoquine urinary recovery ratio) were determined."}, {"generated": ["caffeine", "1-hydroxymidazolam", "hydroxychlorzoxazone", "debrisoquine", "midazolam", "paraxanthine", "chlorzoxazone"], "gold": [], "text": "Before and after the test period, the activities of CYP 3A4/5 (1-hydroxymidazolam/midazolam serum ratio), CYP 1A2 (paraxanthine/caffeine serum ratio), CYP 2E1 (hydroxychlorzoxazone/chlorzoxazone serum ratio), and CYP 2D6 (debrisoquine urinary recovery ratio) were determined."}, {"generated": ["caffeine", "1-hydroxymidazolam", "hydroxychlorzoxazone", "debrisoquine", "midazolam", "paraxanthine", "chlorzoxazone"], "gold": [], "text": "Before and after the test period, the activities of CYP 3A4/5 (1-hydroxymidazolam/midazolam serum ratio), CYP 1A2 (paraxanthine/caffeine serum ratio), CYP 2E1 (hydroxychlorzoxazone/chlorzoxazone serum ratio), and CYP 2D6 (debrisoquine urinary recovery ratio) were determined."}, {"generated": ["EGb 761\u00ae", "valsartan"], "gold": [], "text": "The results were not presented in detail but indicated that the two drugs act independently from each other."}, {"generated": ["EGb 761\u00ae", "valsartan"], "gold": [], "text": "The results were not presented in detail but indicated that the two drugs act independently from each other."}, {"generated": ["MedIQ"], "gold": [], "text": "In a data base for interactions of medicinal drugs (MedIQ), the rating \u201cweak interaction\u201d is given for CYP-isoenzymes, P-gp, and UGT, based on in vitro data."}, {"generated": ["clarithromycin", "rifampin"], "gold": [], "text": "Subjects also received rifampin (600 mg) and clarithromycin (1000 mg) for 7 days as positive controls for CYP3A induction and inhibition, respectively."}, {"generated": ["clarithromycin", "rifampin"], "gold": [], "text": "Subjects also received rifampin (600 mg) and clarithromycin (1000 mg) for 7 days as positive controls for CYP3A induction and inhibition, respectively."}, {"generated": ["Venlafaxine"], "gold": [], "text": "Venlafaxine is a serotonin-norepinephrine reuptake inhibitor used as an antidepressant."}, {"generated": ["venlafaxine"], "gold": [], "text": "After venlafaxine discontinuation, there was rapid improvement, with regression of the radiological abnormalities and normalization of the LVEF."}, {"generated": ["DIP"], "gold": [], "text": "Although DIP can occur from hours to months after the beginning of treatment, Another typical feature of DIP is its reversibility after drug discontinuation."}, {"generated": ["venlafaxine"], "gold": [], "text": "The present case details the occurrence of cardiopulmonary toxicity, which was probably associated with venlafaxine."}, {"generated": ["LBA", "detec\u00e7\u00e3o de doen\u00e7as autoimunes", "cateterismo card\u00edaco direito", "bi\u00f3psia mioc\u00e1rdica"], "gold": [], "text": "Uma investiga\u00e7\u00e3o ampla foi realizada, incluindo LBA, estudos de imagem, detec\u00e7\u00e3o de doen\u00e7as autoimunes, cateterismo card\u00edaco direito e bi\u00f3psia mioc\u00e1rdica."}, {"generated": ["LBA", "detec\u00e7\u00e3o de doen\u00e7as autoimunes", "cateterismo card\u00edaco direito", "bi\u00f3psia mioc\u00e1rdica"], "gold": [], "text": "Uma investiga\u00e7\u00e3o ampla foi realizada, incluindo LBA, estudos de imagem, detec\u00e7\u00e3o de doen\u00e7as autoimunes, cateterismo card\u00edaco direito e bi\u00f3psia mioc\u00e1rdica."}, {"generated": ["LBA", "detec\u00e7\u00e3o de doen\u00e7as autoimunes", "cateterismo card\u00edaco direito", "bi\u00f3psia mioc\u00e1rdica"], "gold": [], "text": "Uma investiga\u00e7\u00e3o ampla foi realizada, incluindo LBA, estudos de imagem, detec\u00e7\u00e3o de doen\u00e7as autoimunes, cateterismo card\u00edaco direito e bi\u00f3psia mioc\u00e1rdica."}, {"generated": ["LBA", "detec\u00e7\u00e3o de doen\u00e7as autoimunes", "cateterismo card\u00edaco direito", "bi\u00f3psia mioc\u00e1rdica"], "gold": [], "text": "Uma investiga\u00e7\u00e3o ampla foi realizada, incluindo LBA, estudos de imagem, detec\u00e7\u00e3o de doen\u00e7as autoimunes, cateterismo card\u00edaco direito e bi\u00f3psia mioc\u00e1rdica."}, {"generated": ["venlafaxina"], "gold": [], "text": "A administra\u00e7\u00e3o circunstancial de inibidores da isoenzima CYP2D6 e a presen\u00e7a de um fen\u00f3tipo de metaboliza\u00e7\u00e3o lenta de CYP2D6 podem ter resultado na acumula\u00e7\u00e3o t\u00f3xica da venlafaxina e na manifesta\u00e7\u00e3o cl\u00ednica subsequente."}, {"generated": ["complemento"], "gold": [], "text": "Os par\u00e2metros renais e hep\u00e1ticos, as prote\u00ednas do complemento e o sedimento urin\u00e1rio estavam todos normais."}, {"generated": ["herb extract complex", "red ginseng"], "gold": ["herb extract complex (RHC)", "red ginseng"], "text": "This study aims to confirm the safety of red ginseng and herb extract complex (RHC), which are used to relieve menopausal symptoms."}, {"generated": ["UGT"], "gold": [], "text": "Therefore, evaluation of inhibition of compounds towards UGT isoforms was always carried out using recombinant UGTs and nonspecific substrates [19,20,21]."}, {"generated": ["Lineweaver-Burk", "Dixon"], "gold": [], "text": "When the intersection is in the second quadrant and vertical axis for Dixon and Lineweaver-Burk plots respectively, the inhibition type is competitive."}, {"generated": ["Lineweaver-Burk", "Dixon"], "gold": [], "text": "When the intersection is in the second quadrant and vertical axis for Dixon and Lineweaver-Burk plots respectively, the inhibition type is competitive."}, {"generated": ["UGT1A6"], "gold": [], "text": "For example, 120-fold variability of UGT1A6 expression in human liver might result in 13-fold variablity in serotonin glucuronidation [24]."}, {"generated": ["Du et al."], "gold": [], "text": "The previous study performed by Du et al."}, {"generated": ["celastrol"], "gold": ["celastrol (Cela)"], "text": "Inhibition kinetic analysis of celastrol (Cela) towards UGT2B7-catalyzed 4-MU glucuronidation."}, {"generated": ["Korean red ginseng extract (RGE)"], "gold": ["ginseng", "red ginseng extract (RGE)"], "text": "In case of ginseng interactions, it was reported that no herb\u2013drug interaction between single oral dose of Korean red ginseng extract (RGE) (0.5\u20132.0 g/kg) and the probe substrates for five cytochrome P450 (CYP) enzymes (i.e., CYP1A2, 2C9, 2C19, 2D6, 3A) in mouse [12]."}, {"generated": ["ginsenosides", "valsartan", "RGE"], "gold": ["ginsenosides", "RGE"], "text": "The results suggest that valsartan could be used as a model drug for investigating OATP (in human) or Oatp (in rats)-mediated herb\u2013drug interaction between valsartan and RGE or ginsenosides."}, {"generated": ["tri-glycosylated PPD-type ginsenosides (Rb1, Rb2, and Rc)"], "gold": ["Rb1", "Rb2", "Rc", "tri-glycosylated PPD-type ginsenosides"], "text": "The plasma concentration was ranged from 7.8 \u03bcM to 34.1 \u03bcM but unbound fraction of tri-glycosylated PPD-type ginsenosides (Rb1, Rb2, and Rc) was very low (0.1\u20130.2% in rat plasma, 0.4\u20130.5% in rat liver; Figure 9B)."}, {"generated": ["red ginseng extract"], "gold": ["ginsenosides", "Rb2", "PPT", "PPD", "Rb1", "red ginseng extract (RGE)", "Rd", "Rc"], "text": "Plasma concentration-time profiles of the ginsenosides (A) Rb1, (B) Rb2, (C) Rc, (D) Rd, (E) PPD, and (F) PPT in the rat plasma after 1-week repeated administration of red ginseng extract (RGE)."}, {"generated": ["valsartan"], "gold": ["Rc"], "text": "AUC: area under the plasma concentration-time curve from 0 to 48 h C Pharmacokinetic parameters of valsartan and Rc following intravenous injection of valsartan at a dose of 1 mg/kg in rats."}, {"generated": ["malondialdehyde", "superoxide dismutase", "catalase", "glutathione peroxidase"], "gold": [], "text": "Oxidative stress is dramatically increased in PCOS patients, when oxidant/antioxidant status is measured by circulating serum markers, including catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), and malondialdehyde (MDA) [3]."}, {"generated": ["malondialdehyde", "superoxide dismutase", "catalase", "glutathione peroxidase"], "gold": [], "text": "Oxidative stress is dramatically increased in PCOS patients, when oxidant/antioxidant status is measured by circulating serum markers, including catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), and malondialdehyde (MDA) [3]."}, {"generated": ["malondialdehyde", "superoxide dismutase", "catalase", "glutathione peroxidase"], "gold": [], "text": "Oxidative stress is dramatically increased in PCOS patients, when oxidant/antioxidant status is measured by circulating serum markers, including catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), and malondialdehyde (MDA) [3]."}, {"generated": ["malondialdehyde", "superoxide dismutase", "catalase", "glutathione peroxidase"], "gold": [], "text": "Oxidative stress is dramatically increased in PCOS patients, when oxidant/antioxidant status is measured by circulating serum markers, including catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), and malondialdehyde (MDA) [3]."}, {"generated": ["antioxidant", "polyphenolic"], "gold": ["polyphenolic"], "text": "Therefore, use of an herbal agent with antioxidant and polyphenolic properties without significant side effects helps to treat PCOS as a disease of antioxidant deficiency [13]."}, {"generated": ["insulin", "blood glucose"], "gold": [], "text": "Furthermore, it decreases insulin and blood glucose markedly [17]."}, {"generated": ["insulin", "blood glucose"], "gold": [], "text": "Furthermore, it decreases insulin and blood glucose markedly [17]."}, {"generated": ["Citrus Sinensis"], "gold": ["terpenoids", "polymethoxylated flavonoids (PMF)", "linalool", "hesperidin", "Citrus Sinensis (L.) Osbeck from Rutaceae family", "phenolic", "limonene"], "text": "Citrus Sinensis (L.) Osbeck from Rutaceae family mainly contains hesperidin, polymethoxylated flavonoids (PMF), and terpenoids (limonene and linalool), and these phenolic bioactive compounds indicate considerable cytoprotective effects against OS [18]."}, {"generated": ["Total flavonoids"], "gold": ["flavonoids"], "text": "One mL of methanolic extract (5 mg/mL in acetone-water solution) was mixed with 200 \u00b5L of Folin-Ciocalteau reagent and 1 mL of 2% Na Total flavonoids were determined using the AlCl The herbal mixture powder (120 g) was exposed to hydrodistillation using a Clevenger type apparatus for about 4 h. Then, the obtained dark yellow oil was dried over anhydrous sodium sulfate, measured, and stored in a dark glass at 4 \u00b0C for further analyses."}, {"generated": ["1,1\u2032,3,3\u2032-tetramethoxypropane"], "gold": [], "text": "A 1,1\u2032,3,3\u2032-tetramethoxypropane was used to construct the calibration curve as the standard [32] (reference value: 0.54\u20131.32 pg/mL)."}, {"generated": ["herbal mixture"], "gold": [], "text": "Then, 75 participants were randomly allocated into 3 groups including group 1: CC (n = 25); group 2: herbal mixture (n = 25); and group 3: CC with herbal mixture (n = 25)."}, {"generated": ["insulin", "HOMA-IR", "FBS"], "gold": [], "text": "Moreover, the binary comparison indicated no significant difference in the FBS level (p = 0.212) in group 2, the insulin level (p = 0.842) in group 3, and the HOMA-IR level (p = 0.403) in group 3 compared to group 1."}, {"generated": ["insulin", "HOMA-IR", "FBS"], "gold": [], "text": "Moreover, the binary comparison indicated no significant difference in the FBS level (p = 0.212) in group 2, the insulin level (p = 0.842) in group 3, and the HOMA-IR level (p = 0.403) in group 3 compared to group 1."}, {"generated": ["insulin", "HOMA-IR", "FBS"], "gold": [], "text": "Moreover, the binary comparison indicated no significant difference in the FBS level (p = 0.212) in group 2, the insulin level (p = 0.842) in group 3, and the HOMA-IR level (p = 0.403) in group 3 compared to group 1."}, {"generated": ["EGb 761\u00ae"], "gold": [], "text": "particularly illustrated an increase in the SOD, CAT, and GPx levels, while the MDA level more significantly decreased compared to other groups using only one herb [17]."}, {"generated": ["PCOS"], "gold": [], "text": "We recommend that further research should be undertaken regarding the effects of herbal mixtures on hormonal factors of PCOS women such as sexual hormones in both proliferative and secretory phases, and lipid profile in a longer follow-up."}, {"generated": ["essential oil"], "gold": [], "text": "Volatile compounds identified in the essential oil of herbal mixture."}, {"generated": ["darunavir"], "gold": [], "text": "Thus, at the approved dosage of darunavir-ritonavir, darunavir concentrations at the end of the dosing interval remain well above the concentration needed to inhibit replication of HIV strains (20; V. Sekar, S. Spinosa-Guzman, E. Lefebvre, and R. Hoetelmans, presented at the 16th International AIDS Conference, 2006)."}, {"generated": ["V05895B"], "gold": [], "text": "V05895B; Arkopharma, Madrid, Spain)."}, {"generated": ["CD4+ T-cell"], "gold": [], "text": "The median CD4+ T-cell count was 498 (range, 244 to 962) cells/mm3."}, {"generated": ["botanicals"], "gold": [], "text": "In spite of this, studies of clinical pharmacokinetic interactions between antiretroviral agents and botanicals are scarce in the literature."}, {"generated": ["Ginkgo biloba"], "gold": ["Ginkgo biloba extract"], "text": "Ginkgo biloba extract is a popular herbal remedy used for a variety of disorders."}, {"generated": ["5-OH-OME", "DEX", "DOR", "OME", "MID"], "gold": [], "text": "Precipitation was done the same way without an internal standard for OME, 5-OH-OME, DEX, DOR), and MID assays, respectively."}, {"generated": ["5-OH-OME", "DEX", "DOR", "OME", "MID"], "gold": [], "text": "Precipitation was done the same way without an internal standard for OME, 5-OH-OME, DEX, DOR), and MID assays, respectively."}, {"generated": ["5-OH-OME", "DEX", "DOR", "OME", "MID"], "gold": [], "text": "Precipitation was done the same way without an internal standard for OME, 5-OH-OME, DEX, DOR), and MID assays, respectively."}, {"generated": ["5-OH-OME", "DEX", "DOR", "OME", "MID"], "gold": [], "text": "Precipitation was done the same way without an internal standard for OME, 5-OH-OME, DEX, DOR), and MID assays, respectively."}, {"generated": ["5-OH-OME", "DEX", "DOR", "OME", "MID"], "gold": [], "text": "Precipitation was done the same way without an internal standard for OME, 5-OH-OME, DEX, DOR), and MID assays, respectively."}, {"generated": ["phenotyping metrics"], "gold": [], "text": "Evaluation of phenotyping metrics followed the standard bioequivalence approach, with adjusted margins."}, {"generated": ["CYP2C9", "CYP1A2"], "gold": [], "text": "The metrics used for CYP1A2 and CYP2C9 may be considered as fully validated [28]."}, {"generated": ["CYP2C9", "CYP1A2"], "gold": [], "text": "The metrics used for CYP1A2 and CYP2C9 may be considered as fully validated [28]."}, {"generated": ["CYP2C19"], "gold": [], "text": "does not affect CYP2C19 activity when administered over an 8-day period."}, {"generated": ["CONSORT"], "gold": [], "text": "Based on the two CONSORT statements, the reporting percentage for each of the articles ranged from 36.5% to 61.5% and the mean percentage for all articles was 45.6%."}, {"generated": ["warfarin"], "gold": ["herbal medicines"], "text": "All included studies investigated the PD interactions of warfarin with herbal medicines, but different parameters were used in each study."}, {"generated": ["warfarin"], "gold": ["herb"], "text": "These relevant case reports indicated a potential herb-warfarin interaction, but it was difficult to identify a causal relationship."}, {"generated": ["case reports"], "gold": [], "text": "Some studies pointed out such limitations, that is, that case reports often result in misleading conclusions for multiple reasons [39, 40]."}, {"generated": ["warfarin"], "gold": [], "text": "She had no history of warfarin use, but warfarin was detected in her blood serum analysis."}, {"generated": ["activated partial thromboplastin time", "prothrombin time", "international normalized ratio"], "gold": [], "text": "At the time of admission to ED, she had a prothrombin time (PT) of more than 37 seconds, activated partial thromboplastin time (aPTT) more than 70 seconds, and international normalized ratio (INR) greater than seven."}, {"generated": ["activated partial thromboplastin time", "prothrombin time", "international normalized ratio"], "gold": [], "text": "At the time of admission to ED, she had a prothrombin time (PT) of more than 37 seconds, activated partial thromboplastin time (aPTT) more than 70 seconds, and international normalized ratio (INR) greater than seven."}, {"generated": ["activated partial thromboplastin time", "prothrombin time", "international normalized ratio"], "gold": [], "text": "At the time of admission to ED, she had a prothrombin time (PT) of more than 37 seconds, activated partial thromboplastin time (aPTT) more than 70 seconds, and international normalized ratio (INR) greater than seven."}, {"generated": ["pathologic inhibitors of coagulation", "disseminated intravascular coagulation (DIC)", "vitamin K malabsorption", "super-warfarin", "warfarin"], "gold": [], "text": "Other diagnostic considerations in a patient presenting with coagulopathy of unknown origin include warfarin or super-warfarin exposure, disseminated intravascular coagulation (DIC), vitamin K malabsorption, and pathologic inhibitors of coagulation (6)."}, {"generated": ["pathologic inhibitors of coagulation", "disseminated intravascular coagulation (DIC)", "vitamin K malabsorption", "super-warfarin", "warfarin"], "gold": [], "text": "Other diagnostic considerations in a patient presenting with coagulopathy of unknown origin include warfarin or super-warfarin exposure, disseminated intravascular coagulation (DIC), vitamin K malabsorption, and pathologic inhibitors of coagulation (6)."}, {"generated": ["pathologic inhibitors of coagulation", "disseminated intravascular coagulation (DIC)", "vitamin K malabsorption", "super-warfarin", "warfarin"], "gold": [], "text": "Other diagnostic considerations in a patient presenting with coagulopathy of unknown origin include warfarin or super-warfarin exposure, disseminated intravascular coagulation (DIC), vitamin K malabsorption, and pathologic inhibitors of coagulation (6)."}, {"generated": ["pathologic inhibitors of coagulation", "disseminated intravascular coagulation (DIC)", "vitamin K malabsorption", "super-warfarin", "warfarin"], "gold": [], "text": "Other diagnostic considerations in a patient presenting with coagulopathy of unknown origin include warfarin or super-warfarin exposure, disseminated intravascular coagulation (DIC), vitamin K malabsorption, and pathologic inhibitors of coagulation (6)."}, {"generated": ["pathologic inhibitors of coagulation", "disseminated intravascular coagulation (DIC)", "vitamin K malabsorption", "super-warfarin", "warfarin"], "gold": [], "text": "Other diagnostic considerations in a patient presenting with coagulopathy of unknown origin include warfarin or super-warfarin exposure, disseminated intravascular coagulation (DIC), vitamin K malabsorption, and pathologic inhibitors of coagulation (6)."}, {"generated": ["WSU Institutional Review Board"], "gold": [], "text": "The WSU Institutional Review Board reviewed and approved the study protocol and consent form prior to subject enrollment."}, {"generated": ["SAS"], "gold": [], "text": "The terminal elimination rate constant (\u03bb All statistical analyses were conducted using SAS (v. 9.2; SAS Institute)."}, {"generated": ["raloxifene", "silibinin"], "gold": ["silibinin"], "text": "Alternate study designs, including silibinin predosing and multiple dosing of raloxifene, could provide further insight into interaction potential."}, {"generated": ["CBZ"], "gold": [], "text": "Despite its clinical popularity, CBZ possesses several pharmacokinetic properties which make it prone to interaction with coadministered substances, including drugs, herbal products, and food [7]."}, {"generated": ["CBZ"], "gold": [], "text": "In view of all the constraints of the existing literature, a comprehensive systematic review focusing on CBZ and overcoming the mentioned hurdles is warranted for healthcare professionals to make proper decisions."}, {"generated": ["Cochrane Database of Systematic Reviews"], "gold": [], "text": "2012), Cochrane Database of Systematic Reviews (2005\u2013Dec."}, {"generated": ["EGb 761\u00ae"], "gold": [], "text": "2012)."}, {"generated": ["honey"], "gold": [], "text": "Although honey was shown to decrease the oral bioavailability of CBZ in rabbits, it had no effect on the pharmacokinetic parameters of CBZ in human [63\u201365]."}, {"generated": ["folinic acid", "nicotinamide"], "gold": [], "text": "As regards the dietary supplement-CBZ interactions, folinic acid did not alter the plasma level of CBZ in rats [61] while nicotinamide increased CBZ plasma level and decreased its clearance in two children with epilepsy [70]."}, {"generated": ["folinic acid", "nicotinamide"], "gold": [], "text": "As regards the dietary supplement-CBZ interactions, folinic acid did not alter the plasma level of CBZ in rats [61] while nicotinamide increased CBZ plasma level and decreased its clearance in two children with epilepsy [70]."}, {"generated": ["antiepileptic therapy"], "gold": [], "text": "Patients on antiepileptic therapy are usually on a long-term basis."}, {"generated": ["alcohol"], "gold": [], "text": "Caution should also be paid for beverage containing alcohol."}, {"generated": ["EGb 761\u00ae"], "gold": [], "text": "Composition of individual herbs in the included herbal formulae."}, {"generated": ["herbal medicines"], "gold": [], "text": "Fifty percent of the informants used herbal medicines alongside their prescription drugs."}, {"generated": ["Table 1"], "gold": [], "text": "A summary of the background characteristics of the interviewed patients is given in Table 1."}, {"generated": ["12 identified plants"], "gold": [], "text": "For all of the 12 identified plants, pharmacological evidence validating their traditional use in diabetes management have been published."}, {"generated": ["Herb"], "gold": [], "text": "Herb\u2013drug interactions strongly challenge the clinical combined application of herbs and drugs."}, {"generated": ["HepaRG cell line"], "gold": [], "text": "HepaRG cell line, derived from a hepatocellular carcinoma, could express a large panel of liver-specific enzymes [5,6,7]."}, {"generated": ["aspirin"], "gold": [], "text": "After administration, aspirin is rapidly hydrolyzed in the body with an elimination half-life of approximatly 15 min [11,12]."}, {"generated": ["BNPP", "PNS"], "gold": ["PNS"], "text": "There was no significant difference between BNPP (68 \u00b5g/mL) and PNS (150 \u00b5g/mL)."}, {"generated": ["Liver drug enzymes"], "gold": [], "text": "Liver drug enzymes are the common sites of drug interaction in human."}, {"generated": ["PON"], "gold": [], "text": "The influence test for PON was conducted by the method of Furlong et al."}, {"generated": ["Trizol"], "gold": [], "text": "Briefly, 2 \u00d7 10 Total RNA was extracted from the cells using the Trizol (CW0581, CWbio, Beijing, China)."}, {"generated": ["PNS", "aspirin"], "gold": ["PNS"], "text": "The present work provides an insight into the mechanism exploration governing HDI between aspirin and PNS."}, {"generated": ["EGb 761\u00ae", "valerian"], "gold": [], "text": "However, there is hardly any data on the pharmacological safety of these two herbal medicines."}, {"generated": ["EGb 761\u00ae", "valerian"], "gold": [], "text": "However, there is hardly any data on the pharmacological safety of these two herbal medicines."}, {"generated": ["cytochrome P450 enzymes"], "gold": [], "text": "Inhibition of cytochrome P450 enzymes (CYPs) was quantified by commercial kits and inhibition of drug transporters by use of fluorescent probe substrates."}, {"generated": ["St. John\u2019s Wort"], "gold": ["John\u2019s Wort"], "text": "PXR activating drugs (e.g., rifampicin) or herbal preparations (e.g., St. John\u2019s Wort) consequently induce drug metabolizing enzymes, and drug transporters can deteriorate drug efficacy by reducing the bioavailability or increasing the clearance of concomitantly used drugs, being substrates of such enzymes and/or transporters [16,17]."}, {"generated": ["pheophorbide A"], "gold": [], "text": "BCRP inhibition was tested by flow cytometry using pheophorbide A as a specific BCRP substrate in MDCKII-BCRP cells compared to the parental cell line MDCKII as described previously [24]."}, {"generated": ["cyclosporine A", "rifampicin"], "gold": [], "text": "Results for the positive controls rifampicin and cyclosporine A were published previously [25]."}, {"generated": ["cyclosporine A", "rifampicin"], "gold": [], "text": "Results for the positive controls rifampicin and cyclosporine A were published previously [25]."}, {"generated": ["GeneElute Mammalian Total RNA Miniprep Kit", "RevertAid\u2122 H Minus First Strand cDNA Synthesis Kit"], "gold": [], "text": "RNA was isolated using the GeneElute Mammalian Total RNA Miniprep Kit and cDNA was synthesized with the RevertAid\u2122 H Minus First Strand cDNA Synthesis Kit according to the manufacturers\u2019 instructions."}, {"generated": ["GeneElute Mammalian Total RNA Miniprep Kit", "RevertAid\u2122 H Minus First Strand cDNA Synthesis Kit"], "gold": [], "text": "RNA was isolated using the GeneElute Mammalian Total RNA Miniprep Kit and cDNA was synthesized with the RevertAid\u2122 H Minus First Strand cDNA Synthesis Kit according to the manufacturers\u2019 instructions."}, {"generated": ["reporter gene"], "gold": [], "text": "Results of the reporter gene assays."}, {"generated": ["CYP2J2"], "gold": [], "text": "Expression of CYP2J2 mRNA was quantified by RT-PCR and results normalized to \u03b22mg and to t = 0."}, {"generated": ["Korean Pharmaceutical Codex"], "gold": [], "text": "It has been officially listed in the Korean Pharmaceutical Codex for a long time and an aqueous suspension has recently been developed for convenient administration [1]."}, {"generated": ["Bupleuri Radix", "Paeoniae Radix", "Atractylodis Rhizoma Alba", "Dioscoreae Rhizoma", "Poria Sclerotium", "Bovis Calculus", "Saposhnikoviae Radix", "Cinnamomi cortex", "Ginseng Radix", "Liriopis Tuber", "Armeniacae Semen", "Angelicae Gigantis Radix", "Platycodonis Radix", "Cnidii Rhizoma", "Massa Medicata Fermentata", "Borneolum", "Glycyrrhizae Radix et Rhizoma", "Scutellariae Radix", "Antelopis Cornu", "Glycine Semen Germinatum"], "gold": ["Ginseng", "Zingiberis", "Liriopis", "Angelicae Gigantis", "Dioscoreae", "Atractylodis", "woohwangchengonsimwon suspension", "Poria Sclerotium", "borneol", "Cnidii", "Platycodonis", "Bupleuri", "Scutellariae", "Paeoniae", "Civet", "Armeniacae", "Massa Medicata Fermentata", "Borneolum", "Ampelopsis", "Glycyrrhizae", "isoborneol", "Typhae", "Saposhnikoviae", "Cinnamomi"], "text": "Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol."}, {"generated": ["Bupleuri Radix", "Paeoniae Radix", "Atractylodis Rhizoma Alba", "Dioscoreae Rhizoma", "Poria Sclerotium", "Bovis Calculus", "Saposhnikoviae Radix", "Cinnamomi cortex", "Ginseng Radix", "Liriopis Tuber", "Armeniacae Semen", "Angelicae Gigantis Radix", "Platycodonis Radix", "Cnidii Rhizoma", "Massa Medicata Fermentata", "Borneolum", "Glycyrrhizae Radix et Rhizoma", "Scutellariae Radix", "Antelopis Cornu", "Glycine Semen Germinatum"], "gold": ["Ginseng", "Zingiberis", "Liriopis", "Angelicae Gigantis", "Dioscoreae", "Atractylodis", "woohwangchengonsimwon suspension", "Poria Sclerotium", "borneol", "Cnidii", "Platycodonis", "Bupleuri", "Scutellariae", "Paeoniae", "Civet", "Armeniacae", "Massa Medicata Fermentata", "Borneolum", "Ampelopsis", "Glycyrrhizae", "isoborneol", "Typhae", "Saposhnikoviae", "Cinnamomi"], "text": "Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol."}, {"generated": ["Bupleuri Radix", "Paeoniae Radix", "Atractylodis Rhizoma Alba", "Dioscoreae Rhizoma", "Poria Sclerotium", "Bovis Calculus", "Saposhnikoviae Radix", "Cinnamomi cortex", "Ginseng Radix", "Liriopis Tuber", "Armeniacae Semen", "Angelicae Gigantis Radix", "Platycodonis Radix", "Cnidii Rhizoma", "Massa Medicata Fermentata", "Borneolum", "Glycyrrhizae Radix et Rhizoma", "Scutellariae Radix", "Antelopis Cornu", "Glycine Semen Germinatum"], "gold": ["Ginseng", "Zingiberis", "Liriopis", "Angelicae Gigantis", "Dioscoreae", "Atractylodis", "woohwangchengonsimwon suspension", "Poria Sclerotium", "borneol", "Cnidii", "Platycodonis", "Bupleuri", "Scutellariae", "Paeoniae", "Civet", "Armeniacae", "Massa Medicata Fermentata", "Borneolum", "Ampelopsis", "Glycyrrhizae", "isoborneol", "Typhae", "Saposhnikoviae", "Cinnamomi"], "text": "Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol."}, {"generated": ["Bupleuri Radix", "Paeoniae Radix", "Atractylodis Rhizoma Alba", "Dioscoreae Rhizoma", "Poria Sclerotium", "Bovis Calculus", "Saposhnikoviae Radix", "Cinnamomi cortex", "Ginseng Radix", "Liriopis Tuber", "Armeniacae Semen", "Angelicae Gigantis Radix", "Platycodonis Radix", "Cnidii Rhizoma", "Massa Medicata Fermentata", "Borneolum", "Glycyrrhizae Radix et Rhizoma", "Scutellariae Radix", "Antelopis Cornu", "Glycine Semen Germinatum"], "gold": ["Ginseng", "Zingiberis", "Liriopis", "Angelicae Gigantis", "Dioscoreae", "Atractylodis", "woohwangchengonsimwon suspension", "Poria Sclerotium", "borneol", "Cnidii", "Platycodonis", "Bupleuri", "Scutellariae", "Paeoniae", "Civet", "Armeniacae", "Massa Medicata Fermentata", "Borneolum", "Ampelopsis", "Glycyrrhizae", "isoborneol", "Typhae", "Saposhnikoviae", "Cinnamomi"], "text": "Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol."}, {"generated": ["Bupleuri Radix", "Paeoniae Radix", "Atractylodis Rhizoma Alba", "Dioscoreae Rhizoma", "Poria Sclerotium", "Bovis Calculus", "Saposhnikoviae Radix", "Cinnamomi cortex", "Ginseng Radix", "Liriopis Tuber", "Armeniacae Semen", "Angelicae Gigantis Radix", "Platycodonis Radix", "Cnidii Rhizoma", "Massa Medicata Fermentata", "Borneolum", "Glycyrrhizae Radix et Rhizoma", "Scutellariae Radix", "Antelopis Cornu", "Glycine Semen Germinatum"], "gold": ["Ginseng", "Zingiberis", "Liriopis", "Angelicae Gigantis", "Dioscoreae", "Atractylodis", "woohwangchengonsimwon suspension", "Poria Sclerotium", "borneol", "Cnidii", "Platycodonis", "Bupleuri", "Scutellariae", "Paeoniae", "Civet", "Armeniacae", "Massa Medicata Fermentata", "Borneolum", "Ampelopsis", "Glycyrrhizae", "isoborneol", "Typhae", "Saposhnikoviae", "Cinnamomi"], "text": "Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol."}, {"generated": ["Bupleuri Radix", "Paeoniae Radix", "Atractylodis Rhizoma Alba", "Dioscoreae Rhizoma", "Poria Sclerotium", "Bovis Calculus", "Saposhnikoviae Radix", "Cinnamomi cortex", "Ginseng Radix", "Liriopis Tuber", "Armeniacae Semen", "Angelicae Gigantis Radix", "Platycodonis Radix", "Cnidii Rhizoma", "Massa Medicata Fermentata", "Borneolum", "Glycyrrhizae Radix et Rhizoma", "Scutellariae Radix", "Antelopis Cornu", "Glycine Semen Germinatum"], "gold": ["Ginseng", "Zingiberis", "Liriopis", "Angelicae Gigantis", "Dioscoreae", "Atractylodis", "woohwangchengonsimwon suspension", "Poria Sclerotium", "borneol", "Cnidii", "Platycodonis", "Bupleuri", "Scutellariae", "Paeoniae", "Civet", "Armeniacae", "Massa Medicata Fermentata", "Borneolum", "Ampelopsis", "Glycyrrhizae", "isoborneol", "Typhae", "Saposhnikoviae", "Cinnamomi"], "text": "Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol."}, {"generated": ["Bupleuri Radix", "Paeoniae Radix", "Atractylodis Rhizoma Alba", "Dioscoreae Rhizoma", "Poria Sclerotium", "Bovis Calculus", "Saposhnikoviae Radix", "Cinnamomi cortex", "Ginseng Radix", "Liriopis Tuber", "Armeniacae Semen", "Angelicae Gigantis Radix", "Platycodonis Radix", "Cnidii Rhizoma", "Massa Medicata Fermentata", "Borneolum", "Glycyrrhizae Radix et Rhizoma", "Scutellariae Radix", "Antelopis Cornu", "Glycine Semen Germinatum"], "gold": ["Ginseng", "Zingiberis", "Liriopis", "Angelicae Gigantis", "Dioscoreae", "Atractylodis", "woohwangchengonsimwon suspension", "Poria Sclerotium", "borneol", "Cnidii", "Platycodonis", "Bupleuri", "Scutellariae", "Paeoniae", "Civet", "Armeniacae", "Massa Medicata Fermentata", "Borneolum", "Ampelopsis", "Glycyrrhizae", "isoborneol", "Typhae", "Saposhnikoviae", "Cinnamomi"], "text": "Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol."}, {"generated": ["Bupleuri Radix", "Paeoniae Radix", "Atractylodis Rhizoma Alba", "Dioscoreae Rhizoma", "Poria Sclerotium", "Bovis Calculus", "Saposhnikoviae Radix", "Cinnamomi cortex", "Ginseng Radix", "Liriopis Tuber", "Armeniacae Semen", "Angelicae Gigantis Radix", "Platycodonis Radix", "Cnidii Rhizoma", "Massa Medicata Fermentata", "Borneolum", "Glycyrrhizae Radix et Rhizoma", "Scutellariae Radix", "Antelopis Cornu", "Glycine Semen Germinatum"], "gold": ["Ginseng", "Zingiberis", "Liriopis", "Angelicae Gigantis", "Dioscoreae", "Atractylodis", "woohwangchengonsimwon suspension", "Poria Sclerotium", "borneol", "Cnidii", "Platycodonis", "Bupleuri", "Scutellariae", "Paeoniae", "Civet", "Armeniacae", "Massa Medicata Fermentata", "Borneolum", "Ampelopsis", "Glycyrrhizae", "isoborneol", "Typhae", "Saposhnikoviae", "Cinnamomi"], "text": "Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol."}, {"generated": ["Bupleuri Radix", "Paeoniae Radix", "Atractylodis Rhizoma Alba", "Dioscoreae Rhizoma", "Poria Sclerotium", "Bovis Calculus", "Saposhnikoviae Radix", "Cinnamomi cortex", "Ginseng Radix", "Liriopis Tuber", "Armeniacae Semen", "Angelicae Gigantis Radix", "Platycodonis Radix", "Cnidii Rhizoma", "Massa Medicata Fermentata", "Borneolum", "Glycyrrhizae Radix et Rhizoma", "Scutellariae Radix", "Antelopis Cornu", "Glycine Semen Germinatum"], "gold": ["Ginseng", "Zingiberis", "Liriopis", "Angelicae Gigantis", "Dioscoreae", "Atractylodis", "woohwangchengonsimwon suspension", "Poria Sclerotium", "borneol", "Cnidii", "Platycodonis", "Bupleuri", "Scutellariae", "Paeoniae", "Civet", "Armeniacae", "Massa Medicata Fermentata", "Borneolum", "Ampelopsis", "Glycyrrhizae", "isoborneol", "Typhae", "Saposhnikoviae", "Cinnamomi"], "text": "Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol."}, {"generated": ["Bupleuri Radix", "Paeoniae Radix", "Atractylodis Rhizoma Alba", "Dioscoreae Rhizoma", "Poria Sclerotium", "Bovis Calculus", "Saposhnikoviae Radix", "Cinnamomi cortex", "Ginseng Radix", "Liriopis Tuber", "Armeniacae Semen", "Angelicae Gigantis Radix", "Platycodonis Radix", "Cnidii Rhizoma", "Massa Medicata Fermentata", "Borneolum", "Glycyrrhizae Radix et Rhizoma", "Scutellariae Radix", "Antelopis Cornu", "Glycine Semen Germinatum"], "gold": ["Ginseng", "Zingiberis", "Liriopis", "Angelicae Gigantis", "Dioscoreae", "Atractylodis", "woohwangchengonsimwon suspension", "Poria Sclerotium", "borneol", "Cnidii", "Platycodonis", "Bupleuri", "Scutellariae", "Paeoniae", "Civet", "Armeniacae", "Massa Medicata Fermentata", "Borneolum", "Ampelopsis", "Glycyrrhizae", "isoborneol", "Typhae", "Saposhnikoviae", "Cinnamomi"], "text": "Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol."}, {"generated": ["Bupleuri Radix", "Paeoniae Radix", "Atractylodis Rhizoma Alba", "Dioscoreae Rhizoma", "Poria Sclerotium", "Bovis Calculus", "Saposhnikoviae Radix", "Cinnamomi cortex", "Ginseng Radix", "Liriopis Tuber", "Armeniacae Semen", "Angelicae Gigantis Radix", "Platycodonis Radix", "Cnidii Rhizoma", "Massa Medicata Fermentata", "Borneolum", "Glycyrrhizae Radix et Rhizoma", "Scutellariae Radix", "Antelopis Cornu", "Glycine Semen Germinatum"], "gold": ["Ginseng", "Zingiberis", "Liriopis", "Angelicae Gigantis", "Dioscoreae", "Atractylodis", "woohwangchengonsimwon suspension", "Poria Sclerotium", "borneol", "Cnidii", "Platycodonis", "Bupleuri", "Scutellariae", "Paeoniae", "Civet", "Armeniacae", "Massa Medicata Fermentata", "Borneolum", "Ampelopsis", "Glycyrrhizae", "isoborneol", "Typhae", "Saposhnikoviae", "Cinnamomi"], "text": "Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol."}, {"generated": ["Bupleuri Radix", "Paeoniae Radix", "Atractylodis Rhizoma Alba", "Dioscoreae Rhizoma", "Poria Sclerotium", "Bovis Calculus", "Saposhnikoviae Radix", "Cinnamomi cortex", "Ginseng Radix", "Liriopis Tuber", "Armeniacae Semen", "Angelicae Gigantis Radix", "Platycodonis Radix", "Cnidii Rhizoma", "Massa Medicata Fermentata", "Borneolum", "Glycyrrhizae Radix et Rhizoma", "Scutellariae Radix", "Antelopis Cornu", "Glycine Semen Germinatum"], "gold": ["Ginseng", "Zingiberis", "Liriopis", "Angelicae Gigantis", "Dioscoreae", "Atractylodis", "woohwangchengonsimwon suspension", "Poria Sclerotium", "borneol", "Cnidii", "Platycodonis", "Bupleuri", "Scutellariae", "Paeoniae", "Civet", "Armeniacae", "Massa Medicata Fermentata", "Borneolum", "Ampelopsis", "Glycyrrhizae", "isoborneol", "Typhae", "Saposhnikoviae", "Cinnamomi"], "text": "Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol."}, {"generated": ["Bupleuri Radix", "Paeoniae Radix", "Atractylodis Rhizoma Alba", "Dioscoreae Rhizoma", "Poria Sclerotium", "Bovis Calculus", "Saposhnikoviae Radix", "Cinnamomi cortex", "Ginseng Radix", "Liriopis Tuber", "Armeniacae Semen", "Angelicae Gigantis Radix", "Platycodonis Radix", "Cnidii Rhizoma", "Massa Medicata Fermentata", "Borneolum", "Glycyrrhizae Radix et Rhizoma", "Scutellariae Radix", "Antelopis Cornu", "Glycine Semen Germinatum"], "gold": ["Ginseng", "Zingiberis", "Liriopis", "Angelicae Gigantis", "Dioscoreae", "Atractylodis", "woohwangchengonsimwon suspension", "Poria Sclerotium", "borneol", "Cnidii", "Platycodonis", "Bupleuri", "Scutellariae", "Paeoniae", "Civet", "Armeniacae", "Massa Medicata Fermentata", "Borneolum", "Ampelopsis", "Glycyrrhizae", "isoborneol", "Typhae", "Saposhnikoviae", "Cinnamomi"], "text": "Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol."}, {"generated": ["Bupleuri Radix", "Paeoniae Radix", "Atractylodis Rhizoma Alba", "Dioscoreae Rhizoma", "Poria Sclerotium", "Bovis Calculus", "Saposhnikoviae Radix", "Cinnamomi cortex", "Ginseng Radix", "Liriopis Tuber", "Armeniacae Semen", "Angelicae Gigantis Radix", "Platycodonis Radix", "Cnidii Rhizoma", "Massa Medicata Fermentata", "Borneolum", "Glycyrrhizae Radix et Rhizoma", "Scutellariae Radix", "Antelopis Cornu", "Glycine Semen Germinatum"], "gold": ["Ginseng", "Zingiberis", "Liriopis", "Angelicae Gigantis", "Dioscoreae", "Atractylodis", "woohwangchengonsimwon suspension", "Poria Sclerotium", "borneol", "Cnidii", "Platycodonis", "Bupleuri", "Scutellariae", "Paeoniae", "Civet", "Armeniacae", "Massa Medicata Fermentata", "Borneolum", "Ampelopsis", "Glycyrrhizae", "isoborneol", "Typhae", "Saposhnikoviae", "Cinnamomi"], "text": "Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol."}, {"generated": ["Bupleuri Radix", "Paeoniae Radix", "Atractylodis Rhizoma Alba", "Dioscoreae Rhizoma", "Poria Sclerotium", "Bovis Calculus", "Saposhnikoviae Radix", "Cinnamomi cortex", "Ginseng Radix", "Liriopis Tuber", "Armeniacae Semen", "Angelicae Gigantis Radix", "Platycodonis Radix", "Cnidii Rhizoma", "Massa Medicata Fermentata", "Borneolum", "Glycyrrhizae Radix et Rhizoma", "Scutellariae Radix", "Antelopis Cornu", "Glycine Semen Germinatum"], "gold": ["Ginseng", "Zingiberis", "Liriopis", "Angelicae Gigantis", "Dioscoreae", "Atractylodis", "woohwangchengonsimwon suspension", "Poria Sclerotium", "borneol", "Cnidii", "Platycodonis", "Bupleuri", "Scutellariae", "Paeoniae", "Civet", "Armeniacae", "Massa Medicata Fermentata", "Borneolum", "Ampelopsis", "Glycyrrhizae", "isoborneol", "Typhae", "Saposhnikoviae", "Cinnamomi"], "text": "Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol."}, {"generated": ["Bupleuri Radix", "Paeoniae Radix", "Atractylodis Rhizoma Alba", "Dioscoreae Rhizoma", "Poria Sclerotium", "Bovis Calculus", "Saposhnikoviae Radix", "Cinnamomi cortex", "Ginseng Radix", "Liriopis Tuber", "Armeniacae Semen", "Angelicae Gigantis Radix", "Platycodonis Radix", "Cnidii Rhizoma", "Massa Medicata Fermentata", "Borneolum", "Glycyrrhizae Radix et Rhizoma", "Scutellariae Radix", "Antelopis Cornu", "Glycine Semen Germinatum"], "gold": ["Ginseng", "Zingiberis", "Liriopis", "Angelicae Gigantis", "Dioscoreae", "Atractylodis", "woohwangchengonsimwon suspension", "Poria Sclerotium", "borneol", "Cnidii", "Platycodonis", "Bupleuri", "Scutellariae", "Paeoniae", "Civet", "Armeniacae", "Massa Medicata Fermentata", "Borneolum", "Ampelopsis", "Glycyrrhizae", "isoborneol", "Typhae", "Saposhnikoviae", "Cinnamomi"], "text": "Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol."}, {"generated": ["Bupleuri Radix", "Paeoniae Radix", "Atractylodis Rhizoma Alba", "Dioscoreae Rhizoma", "Poria Sclerotium", "Bovis Calculus", "Saposhnikoviae Radix", "Cinnamomi cortex", "Ginseng Radix", "Liriopis Tuber", "Armeniacae Semen", "Angelicae Gigantis Radix", "Platycodonis Radix", "Cnidii Rhizoma", "Massa Medicata Fermentata", "Borneolum", "Glycyrrhizae Radix et Rhizoma", "Scutellariae Radix", "Antelopis Cornu", "Glycine Semen Germinatum"], "gold": ["Ginseng", "Zingiberis", "Liriopis", "Angelicae Gigantis", "Dioscoreae", "Atractylodis", "woohwangchengonsimwon suspension", "Poria Sclerotium", "borneol", "Cnidii", "Platycodonis", "Bupleuri", "Scutellariae", "Paeoniae", "Civet", "Armeniacae", "Massa Medicata Fermentata", "Borneolum", "Ampelopsis", "Glycyrrhizae", "isoborneol", "Typhae", "Saposhnikoviae", "Cinnamomi"], "text": "Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol."}, {"generated": ["prescription medications"], "gold": [], "text": "Subjects were also asked to abstain from taking prescription and over the counter medications for 2 weeks before and during the study period."}, {"generated": ["CYP2B6"], "gold": [], "text": "CYP2B6 genotyping  CYP2B6 genotyping was performed by pyrosequencing of polymerase chain reaction (PCR) products as described previously [13]."}, {"generated": ["TurboIonSpray"], "gold": [], "text": "The TurboIonSpray interface was operated in positive ion mode at 5500 V and 500\u00b0C."}, {"generated": ["4-hydroxybupropion", "bupropion"], "gold": [], "text": "Geometric means were calculated for the AUC(0,\u221e), Cmax and so on of bupropion and 4-hydroxybupropion."}, {"generated": ["4-hydroxybupropion", "bupropion"], "gold": [], "text": "Geometric means were calculated for the AUC(0,\u221e), Cmax and so on of bupropion and 4-hydroxybupropion."}, {"generated": ["GMRs"], "gold": [], "text": "Geometric mean ratios (GMRs) with 90% confidence intervals (CIs) were calculated after log transformation of within-subject data."}, {"generated": ["tyrosine kinases"], "gold": [], "text": "The overexpression or somatic mutations of tyrosine kinases are dysregulated in various malignancies [3]."}, {"generated": ["drug-metabolizing enzymes", "drug transporters"], "gold": [], "text": "Inhibition and/or induction of drug-metabolizing enzymes (DME) and or drug transporters mediated by herbs is the most typical mechanism of herb-drug interactions, which in turn alters the pharmacokinetic disposition of the drug [24,25]."}, {"generated": ["drug-metabolizing enzymes", "drug transporters"], "gold": [], "text": "Inhibition and/or induction of drug-metabolizing enzymes (DME) and or drug transporters mediated by herbs is the most typical mechanism of herb-drug interactions, which in turn alters the pharmacokinetic disposition of the drug [24,25]."}, {"generated": ["DAS", "APG"], "gold": ["APG"], "text": "The purpose of the current study was to determine whether or not APG has a pharmacokinetic interaction with DAS, and if so, how they would interact."}, {"generated": ["DAS 25"], "gold": [], "text": "The radical alteration in the pharmacokinetic parameters of DAS 25 mg/kg P.O."}, {"generated": ["DAS"], "gold": [], "text": "Group I and II were orally administered with normal saline for 7 days and Group II was orally administered DAS (25 mg/kg) on the 7th day."}, {"generated": ["APG\u2013DAS"], "gold": ["APG"], "text": "Further thorough in vivo studies of the APG\u2013DAS interaction in humans are warranted to support these findings."}, {"generated": ["M.A.A."], "gold": [], "text": "and M.A.A."}, {"generated": ["K.M.A."], "gold": [], "text": "; supervision, K.M.A."}, {"generated": ["DAS", "APG"], "gold": ["APG"], "text": "Hepatic (A) and intestinal (B) BCRP/ABCG2 protein expression in rats after DAS administration with or without APG pretreatment."}, {"generated": ["phytochemical"], "gold": [], "text": "Phytochemical-mediated modulation of cytochrome P-450 (CYP) activity may underlie many herb-drug interactions."}, {"generated": ["CYP"], "gold": [], "text": "If so, herb-mediated changes in CYP activity may take on greater clinical relevance in this population."}, {"generated": ["botanical supplements"], "gold": [], "text": "Concomitant ingestion of botanical supplements with prescription medications, therefore, should be strongly discouraged in the elderly."}, {"generated": ["isokinetic knee extensions"], "gold": [], "text": "In the main test session, subjects performed 5 isokinetic knee extensions of the leg at an angular velocity of 60 degrees/second, and subjects recovered passively for 2 min between sets of measurements [26,27]."}, {"generated": ["isokinetic dynamometer"], "gold": [], "text": "The subject\u2019s knee joint center, measured using the femoral epicondyles as a joint center reference, was aligned with the axis of the isokinetic dynamometer."}, {"generated": ["lactate"], "gold": [], "text": "Resting lactate level was measured at baseline and after 12 weeks, and results are presented in Figure 2."}, {"generated": ["lactate"], "gold": [], "text": "have shown the association between high lactate production and reduced oxidative metabolism [47]."}, {"generated": ["St. John's wort"], "gold": ["St. John's wort (SJW)"], "text": "The first clinically relevant reports of preparations of St. John's wort (SJW), a herbal medicine with anti\u2010depressant effects, interacting with other drugs, altering their bioavailability and efficacy, were published about 20 years ago."}, {"generated": ["pregnane\u2010X\u2010receptor"], "gold": [], "text": "These interactions were caused by pregnane\u2010X\u2010receptor (PXR) activation."}, {"generated": ["SJW extract"], "gold": ["low\u2010hyperforin SJW extract"], "text": "This statement was provided even before another comprehensive pharmacokinetic interaction study was published, where no clinically relevant interactions were found for seven test drugs in concomitant application with a low\u2010hyperforin SJW extract (Zahner et al., 2019)."}, {"generated": ["medicinal mushrooms"], "gold": [], "text": "If the control group also received medicinal mushrooms, there should be significant dosage differences of the mushrooms in the treatment group."}, {"generated": ["medicinal mushrooms"], "gold": [], "text": "Reduce T cell apoptosis and caspase 3 activity through downregulating Bax expression in T cells [170] Increase in efficacy and survival [20], better symptomatic relief [20] increase in T cells count (CD4, CD4/CD8) [20] Better symptomatic relief [141] and increase appetite [144] Less reduction in WBC (CD3+, CD4+ T cells, NK cells) [141, 144], platelets [144] Pharmacodynamic interactions between medicinal mushrooms and cytotoxic drugs in preclinical studies Increase in tumor inhibition effect [83, 84, 98] and survival time [63] Less decrease in WBC [83, 84, 145], platelets [83] and other bone marrow cells [84] Greater recovery rate from intestinal damage caused by 5-FU [173] Increase in survival [67], cytotoxicity and inhibit metastasis [111] Reduce immunosuppression (reduce the decrease in phagocytic activity, antibody production [111], delayed hypersensitivity [111, 112]) Increase in tumor inhibition and apoptotic rate (dose-related or time-dependent) [98\u2013103], similar effect at lower dose of 5-FU [105] Induce cell cycle arrest at different phases [99, 101], increase caspase 3 and 8 expression and activity [100]."}, {"generated": ["Warburg-related proteins"], "gold": [], "text": "Notably, a recent study found that such synergistic effect may be due to the inhibition of tumor metabolism via down-regulating Warburg-related proteins and restoration of the gut dysbiosis induced by paclitaxel [97]."}, {"generated": ["EGb 761\u00ae"], "gold": [], "text": "a."}, {"generated": ["medicinal mushrooms"], "gold": [], "text": "In summary, the aforementioned outcomes suggest that medicinal mushrooms have great potential to ameliorate the adverse effects of chemotherapeutic drugs in clinical settings."}, {"generated": ["Table S4"], "gold": [], "text": "Table S4."}, {"generated": ["estrogen receptor"], "gold": [], "text": "Approximately 70\u201380% of all breast tumors are estrogen receptor (ER) positive [2], and hormonal therapy plays therefore an important role in the therapy of early stage and metastatic ER-positive breast cancer."}, {"generated": ["Viscum album"], "gold": ["Viscum album extracts (VAE)"], "text": "Clinical studies have reported on the benefits of Viscum album extracts (VAE) not only in breast cancer patients but also for other types of cancer [10\u201313]."}, {"generated": ["total mistletoe lectin", "Iscador Qu"], "gold": ["mistletoe lectin", "Malus domestica", "VAEM", "Iscador Qu"], "text": "5\u2009mg (VAEM, host tree Malus domestica, Lot 7054/0, total mistletoe lectin concentration 306\u2009ng/mL), and Iscador Qu spec."}, {"generated": ["dextrorphan-d", "4-hydroxy-N-desmethyltamoxifen hydrochloride", "\u03b2-estradiol"], "gold": [], "text": "(E/Z)-endoxifen hydrochloride (4-hydroxy-N-desmethyltamoxifen hydrochloride), \u03b2-estradiol (E2) and dextrorphan-d Pooled human liver microsomes (HLMs, 50 donors, mixed gender) were purchased from Bioreclamation IVT (Baltimore, USA)."}, {"generated": ["dextrorphan-d", "4-hydroxy-N-desmethyltamoxifen hydrochloride", "\u03b2-estradiol"], "gold": [], "text": "(E/Z)-endoxifen hydrochloride (4-hydroxy-N-desmethyltamoxifen hydrochloride), \u03b2-estradiol (E2) and dextrorphan-d Pooled human liver microsomes (HLMs, 50 donors, mixed gender) were purchased from Bioreclamation IVT (Baltimore, USA)."}, {"generated": ["dextrorphan-d", "4-hydroxy-N-desmethyltamoxifen hydrochloride", "\u03b2-estradiol"], "gold": [], "text": "(E/Z)-endoxifen hydrochloride (4-hydroxy-N-desmethyltamoxifen hydrochloride), \u03b2-estradiol (E2) and dextrorphan-d Pooled human liver microsomes (HLMs, 50 donors, mixed gender) were purchased from Bioreclamation IVT (Baltimore, USA)."}, {"generated": ["VAEM", "endoxifen"], "gold": ["VAEM"], "text": "Significances are given relative to the VAEM untreated values (*p\u00a0<\u20090.05, **p\u00a0<\u20090.01, ***p\u00a0<\u20090.001) VAEM, as well as endoxifen, showed a concentration-dependent inhibition of proliferation (Fig."}, {"generated": ["enzyme phenotypes"], "gold": [], "text": "Based on genotype combinations encoding for varying enzyme phenotypes, patients have been classified as poor, intermediate, extensive, or ultra-rapid metabolizers [32, 33]."}, {"generated": ["CYP2D6"], "gold": [], "text": "The metabolic activity of CYP2D6 was suggested to be associated with the long-term outcomes in breast cancer, although the studies are inconsistent [35]."}, {"generated": ["CYP2D6"], "gold": [], "text": "The significant inter-individual variability of CYP2D6 activity due to genetic polymorphisms was mitigated by the use of pooled microsomes from 50 donors [41]."}, {"generated": ["Figure S2"], "gold": [], "text": "(PDF 36 kb) Figure S2."}, {"generated": ["Dextromethorphan", "Quinidine"], "gold": [], "text": "Dextromethorphan in vitro inhibition profiles of CYP2D6 by reference inhibitor: Quinidine (0.1-1-2-5-10-100 \u03bcM)."}, {"generated": ["Dextromethorphan", "Quinidine"], "gold": [], "text": "Dextromethorphan in vitro inhibition profiles of CYP2D6 by reference inhibitor: Quinidine (0.1-1-2-5-10-100 \u03bcM)."}, {"generated": ["2-4-dibromoacetophenone"], "gold": [], "text": "For derivatization of plasma captopril, a plasma sample (180\u2009\u00b5L) was first mixed with 20\u2009\u00b5L of 520\u2009ppm 2-4-dibromoacetophenone stock solution and 20\u2009\u00b5L of 5% ammonia solution, vortexed for 30 seconds, and incubated at room temperature for 30\u2009min."}, {"generated": ["captopril"], "gold": [], "text": "daily for two weeks at morning and a single captopril dose (4.5\u2009mg/200\u2009g BW; p.o.)"}, {"generated": ["saline solution"], "gold": [], "text": "The loss of body fluid was compensated by administrating 1.0\u2009mL saline solution (p.o.)"}, {"generated": ["captopril"], "gold": [], "text": "The within-run accuracy and precision of captopril analysis ranged from 1.56% to 14.38% (Table 3)."}, {"generated": ["selectivity testing"], "gold": [], "text": "In selectivity testing, six rats plasma was used."}, {"generated": ["2-4-dibromoacetophenone"], "gold": [], "text": "In this experiment, we used 2-4-dibromoacetophenone as a derivatization agent to prevent the sulfhydryl group in captopril from binding to plasma sulfhydryl groups."}, {"generated": ["Ammonia"], "gold": [], "text": "Ammonia was used during derivatization since the reaction is optimal at basic pH."}, {"generated": ["formic acid"], "gold": [], "text": "The reaction was then stopped by adding formic acid [17]."}, {"generated": ["EGb 761\u00ae"], "gold": [], "text": "2016)."}, {"generated": ["Agilent 1290 series liquid chromatography system"], "gold": [], "text": "The analysis was performed on an Agilent 1290 series liquid chromatography system (Agilent Technologies, Palo Alto, CA, USA)."}, {"generated": ["EGb 761\u00ae"], "gold": [], "text": "(n\u00a0=\u00a06)."}, {"generated": ["Eugenia jambolana"], "gold": ["Eugenia jambolana (EJ)"], "text": "Eugenia jambolana (EJ) is an Indian traditional herb widely used for the treatment of diabetes mellitus."}, {"generated": ["SITA"], "gold": [], "text": "Despite low levels of SITA, the combination demonstrated a significant reduction in blood glucose level when compared with individual drug and individual extract administered groups during pharmacodynamic study."}, {"generated": ["extract"], "gold": [], "text": "After seven days, the extract was filtered and the filtrate was stored in refrigerator until next processing."}, {"generated": ["filtrate"], "gold": [], "text": "It was filtered and the filtrate obtained in this step was mixed with the previous filtrate."}, {"generated": ["Glucose"], "gold": [], "text": "Glucose level was determined using GOD-POD Erba diagnostic kits."}, {"generated": ["EGb 761\u00ae"], "gold": [], "text": "3a and b)."}, {"generated": ["SITA", "PRM"], "gold": [], "text": "Mass chromatograms of SITA and PRM (Peak for SITA at 0.642min, PRM at 0.482\u202fmin)."}, {"generated": ["SITA", "PRM"], "gold": [], "text": "Mass chromatograms of SITA and PRM (Peak for SITA at 0.642min, PRM at 0.482\u202fmin)."}, {"generated": ["EGb 761\u00ae"], "gold": [], "text": "*significantly different from normal group, # significantly different from diabetic control group at p\u00a0<\u00a00.001."}, {"generated": ["EJE + SITA", "EJE"], "gold": ["EJE\u202f", "EJE"], "text": "Treatment with EJE and EJE\u202f+\u202fSITA significantly (p\u202f<\u202f0.001) reduced the elevated levels of BUN (Fig."}, {"generated": ["EGb 761\u00ae"], "gold": [], "text": "9, Table\u00a02)."}, {"generated": ["EGb 761\u00ae"], "gold": [], "text": "*significantly different from normal group, # significantly different from diabetic control group at p\u00a0<\u00a00.001."}, {"generated": ["Officinarum"], "gold": ["A.\u00a0Officinarum"], "text": "A.\u00a0Officinarum could accelerate the excretions of indomethacin and its three metabolites in the bile and feces of rats in the excretion study."}, {"generated": ["M-AOE"], "gold": [], "text": "And other experiments were divided into 2 groups: model group and M-AOE group, with six rats in each group."}, {"generated": ["bile"], "gold": [], "text": "The bile was collected during 0\u20131\u00a0h, 1\u20132\u00a0h, 2\u20133\u00a0h, 3\u20134\u00a0h, 4\u20135\u00a0h, 5\u20136\u00a0h and 6\u20137\u00a0h after dosing."}, {"generated": ["indomethacin"], "gold": [], "text": "In our study, the changing trends in the plasma concentration-time curves of indomethacin in S-AOE and M-AOE groups were similar to those in model group shown in Fig."}, {"generated": ["EGb 761\u00ae"], "gold": [], "text": "1)."}, {"generated": ["wine"], "gold": [], "text": "[7] previously showed that administration of 375 ml wine did not result in thrombin times (TTs) outside the therapeutic range, which suggested that a moderate intake of alcohol occasionally may be acceptable during anticoagulant therapy."}, {"generated": ["warfarin"], "gold": [], "text": "Due to public concern regarding the risk of bleeding during treatment with warfarin, as well as the uneasy relationship between allopathic doctors and their patients, no more than 10% of patients with atrial fibrillation take warfarin in China [5]."}, {"generated": ["delphinidin-3-sambubioside", "cyanidin-3-sambubioside", "Anthocyanins"], "gold": ["HS", "Anthocyanins, particularly delphinidin-3-sambubioside and cyanidin-3-sambubioside"], "text": "Anthocyanins, particularly delphinidin-3-sambubioside and cyanidin-3-sambubioside, are generally believed to be the active constituents responsible for the antihypertensive, antioxidant, and hypocholesterolemic effects of HS, possibly because they are found in high relative quantities in aqueous extracts [8, 11, 13, 16]."}, {"generated": ["delphinidin-3-sambubioside", "cyanidin-3-sambubioside", "Anthocyanins"], "gold": ["HS", "Anthocyanins, particularly delphinidin-3-sambubioside and cyanidin-3-sambubioside"], "text": "Anthocyanins, particularly delphinidin-3-sambubioside and cyanidin-3-sambubioside, are generally believed to be the active constituents responsible for the antihypertensive, antioxidant, and hypocholesterolemic effects of HS, possibly because they are found in high relative quantities in aqueous extracts [8, 11, 13, 16]."}, {"generated": ["delphinidin-3-sambubioside", "cyanidin-3-sambubioside", "Anthocyanins"], "gold": ["HS", "Anthocyanins, particularly delphinidin-3-sambubioside and cyanidin-3-sambubioside"], "text": "Anthocyanins, particularly delphinidin-3-sambubioside and cyanidin-3-sambubioside, are generally believed to be the active constituents responsible for the antihypertensive, antioxidant, and hypocholesterolemic effects of HS, possibly because they are found in high relative quantities in aqueous extracts [8, 11, 13, 16]."}, {"generated": ["HS varieties"], "gold": ["HS"], "text": "The HS varieties with deeper red calyxes exhibited greater antioxidant activity as compared to lighter red or white varieties [44, 45]."}, {"generated": ["7.2"], "gold": [], "text": "7.2."}, {"generated": ["cholesterol"], "gold": [], "text": "Table 5  Cholesterol RCT interventions and effects of cholesterol RCT interventions on total cholesterol, HDL-C, LDL-C, and triglycerides."}, {"generated": ["RCT"], "gold": [], "text": "More specifically, most studies did not make clear the type of RCT being conducted and in many cases there were study design problems."}, {"generated": ["Schisandra"], "gold": ["Schisandra lignans"], "text": "Interaction between imatinib and Schisandra lignans was unlikely to be of clinical importance."}, {"generated": ["EGb 761\u00ae"], "gold": [], "text": "Go to: 2."}, {"generated": ["EGb 761\u00ae"], "gold": [], "text": "2.1.2."}, {"generated": ["CYP2C8"], "gold": [], "text": "An extensive in vitro study showed that recombinant CYP2C8 enzyme (supersomes) was less sensitive than human liver microsomes (HLM) to identify potential mechanism\u2010based inhibitors and was characterised by a high lot\u2010to\u2010lot variability."}, {"generated": ["NADPH"], "gold": [], "text": "The reaction was initiated by the addition of NADPH and terminated by placing the tubes on a cooling block (Selleckchem, Houston, TX, USA)."}, {"generated": ["noncompetitive", "competitive", "mixed-inhibition"], "gold": [], "text": "The competitive, noncompetitive and mixed\u2010inhibition models (Equations 1\u20133, respectively) were considered."}, {"generated": ["noncompetitive", "competitive", "mixed-inhibition"], "gold": [], "text": "The competitive, noncompetitive and mixed\u2010inhibition models (Equations 1\u20133, respectively) were considered."}, {"generated": ["noncompetitive", "competitive", "mixed-inhibition"], "gold": [], "text": "The competitive, noncompetitive and mixed\u2010inhibition models (Equations 1\u20133, respectively) were considered."}, {"generated": ["substrates"], "gold": [], "text": "Theoretically, the discrimination between competitive and noncompetitive inhibitions is not critical when concentrations of substrates are much lower than their K m values, which is often the case in the clinical setting."}, {"generated": ["Partition coefficient"], "gold": [], "text": "8 Partition coefficients (log P) of neutral compounds are generally the most influential parameter dictating the extent of distribution to different tissues."}, {"generated": ["MBI"], "gold": [], "text": "MBI, mechanism\u2010based inhibition Go to: 4."}, {"generated": ["Schisandra"], "gold": ["Schisandra lignans"], "text": "by carbamazepine and phenytoin, 72 the predominant outcome from a chronic exposure to Schisandra lignans is a CYP3A inhibition and not induction."}, {"generated": ["Schisandra"], "gold": ["Schisandra lignans"], "text": "Another limitation of the current study is the reliance on the assumption that Schisandra lignans are solely responsible for the interactions with CYP substrates."}, {"generated": ["S. sphenanthera"], "gold": ["S. sphenanthera extract"], "text": "Constituents of S. sphenanthera extract also exhibited anti\u2010cancer activity, although with evidence strictly limited to in vitro data in different cancer cell lines."}, {"generated": ["TM", "VKOR", "CYP"], "gold": [], "text": "Microsomes incubation, Real Time-Polymerase Chain Reaction and Western blot was applied respectively to study the activity, mRNA expression and protein expression of CYP, VKOR and TM."}, {"generated": ["TM", "VKOR", "CYP"], "gold": [], "text": "Microsomes incubation, Real Time-Polymerase Chain Reaction and Western blot was applied respectively to study the activity, mRNA expression and protein expression of CYP, VKOR and TM."}, {"generated": ["TM", "VKOR", "CYP"], "gold": [], "text": "Microsomes incubation, Real Time-Polymerase Chain Reaction and Western blot was applied respectively to study the activity, mRNA expression and protein expression of CYP, VKOR and TM."}, {"generated": ["raw herbs"], "gold": [], "text": "The raw herbs were morphologically authenticated by an in-house herbalist and chemically by the thin layer chromatography in accordance with the Chinese Pharmacopoeia 2005 [36]."}, {"generated": ["vehicle control group"], "gold": [], "text": "Compared with the vehicle control group, there was a significant increase of 420\u00a0% (P\u00a0<\u00a00.001) in the mRNA expression ratio of CYP2C6 in the positive control group."}, {"generated": ["Warfarin", "Gegen", "Danshen"], "gold": ["Gegen", "Danshen"], "text": "Danshen and Gegen elicit their effects by improving microcirculation and inhibiting platelet aggregation [24, 32], whereas warfarin exerts its anticoagulant effect by inhibiting the activity of VKOR and inducing TM."}, {"generated": ["DFG-warfarin"], "gold": ["DFG"], "text": "The results of our previous study showed that the administration of a DFG-warfarin combination led to a reduction in the warfarin plasma concentration and PT time of rats [23, 32]."}, {"generated": ["isoforms"], "gold": [], "text": "Although these isoforms are expressed in several different species, a high degree of similarity in their gene sequences between rats and human may not automatically result in similar levels of catalytic specificity and activity."}, {"generated": ["warfarin"], "gold": [], "text": "Algorithms that integrate the relevant genetic and physical factors into comprehensive, individualized predictive models were used to predict warfarin dose [54]."}, {"generated": ["Beikang Ge", "Zhen Zhang", "Zhu Zu", "Danshen"], "gold": ["salvianolic acid B", "Gegen", "Danshen"], "text": "liver cytochrome P450 vitamin K epoxide reductase vitamin K vitamin K thrombomodulin Danshen\u2013Gegen Formula salvianolic acid B phenobarbital beta-naphthoflavone cyclophosphamide enzyme-linked immunosorbent assay Beikang Ge and Zhen Zhang contributed equally to this work BKG, ZZh and ZZu conceived and designed the study."}, {"generated": ["Beikang Ge", "Zhen Zhang", "Zhu Zu", "Danshen"], "gold": ["salvianolic acid B", "Gegen", "Danshen"], "text": "liver cytochrome P450 vitamin K epoxide reductase vitamin K vitamin K thrombomodulin Danshen\u2013Gegen Formula salvianolic acid B phenobarbital beta-naphthoflavone cyclophosphamide enzyme-linked immunosorbent assay Beikang Ge and Zhen Zhang contributed equally to this work BKG, ZZh and ZZu conceived and designed the study."}, {"generated": ["Beikang Ge", "Zhen Zhang", "Zhu Zu", "Danshen"], "gold": ["salvianolic acid B", "Gegen", "Danshen"], "text": "liver cytochrome P450 vitamin K epoxide reductase vitamin K vitamin K thrombomodulin Danshen\u2013Gegen Formula salvianolic acid B phenobarbital beta-naphthoflavone cyclophosphamide enzyme-linked immunosorbent assay Beikang Ge and Zhen Zhang contributed equally to this work BKG, ZZh and ZZu conceived and designed the study."}, {"generated": ["EGb 761\u00ae"], "gold": [], "text": "Sample preparation was based on the publication by (Beer et al."}, {"generated": ["chemotherapy"], "gold": [], "text": "The 48 (80%) women who had received adjuvant chemotherapy were a mean of 37\u2009months (range 4\u2013113) from completion of chemotherapy."}, {"generated": ["isoenzymes"], "gold": [], "text": "These isoenzymes are responsible for the metabolism of over 70% of prescription and over\u2010the\u2010counter medications (Rendic & Guengerich, 2014)."}, {"generated": ["tropical medicinal herbs"], "gold": [], "text": "Little is known of the effect of most tropical medicinal herbs on the metabolic capacity of CYP isoenzymes."}, {"generated": ["mixture"], "gold": [], "text": "Each mixture was filtered, concentrated, and freeze\u2010dried."}, {"generated": ["CYP isoenzymes"], "gold": [], "text": "Positive controls (see Supporting Information data, Table S1), CYP isoenzymes inhibited, and concentration used in the N\u2010in\u2010one assay are as reported in the validated methods (Turpeinen et\u00a0al., 2005; Tolonen et\u00a0al., 2007; Showande et\u00a0al., 2013)."}, {"generated": ["aqueous extract"], "gold": [], "text": "Fifty percent inhibitory concentration (IC   where A\u00a0=\u00a0log of concentration of aqueous extract of herb in the incubations."}, {"generated": ["in vitro herb\u2013drug interactions"], "gold": [], "text": "In vitro herb\u2013drug interactions studies are mostly conducted for commonly used herbs to evaluate and predict potentially significant in vivo herb\u2013drug interactions and to help design appropriate in vivo herb\u2013drug interaction studies (Fasinu, Bouic, & Rosenkranz, 2012; Awortwe, Bouic, Masimirembwa, & Rosenkranz, 2013)."}, {"generated": ["EGb 761\u00ae"], "gold": [], "text": "(2000)."}, {"generated": ["polyherbal formulation"], "gold": [], "text": "Ltd., Varanasi, India) is a patented polyherbal formulation developed to manage menopause symptoms that can be taken along with other allopathic medicines."}, {"generated": ["ammonium acetate"], "gold": [], "text": "34860-2.5L-R) and ammonium acetate (catalog No."}, {"generated": ["EGb 761\u00ae"], "gold": [], "text": "The following formula determines the half-maximal inhibitory concentration (IC SRM Medical College Hospital and Research Centre and SRM Institute of Science and Technology, Kattankulathur ethics committees approved the protocol (approval No."}, {"generated": ["human chorionic gonadotropin"], "gold": [], "text": "Female volunteers were excluded if they were pregnant (positive test for serum human chorionic gonadotropin at screening or check-in), breastfeeding, or planning to conceive a child within 30 days of treatment cessation."}, {"generated": ["drug containers"], "gold": [], "text": "Double-blinded treatments were allocated using sequentially numbered drug containers."}, {"generated": ["simvastatin", "simvastatin hydroxy acid", "lovastatin"], "gold": [], "text": "The mean (SD) plasma concentrations of simvastatin, its metabolite simvastatin hydroxy acid, and internal standard lovastatin are shown in Figure\u00a04."}, {"generated": ["simvastatin", "simvastatin hydroxy acid", "lovastatin"], "gold": [], "text": "The mean (SD) plasma concentrations of simvastatin, its metabolite simvastatin hydroxy acid, and internal standard lovastatin are shown in Figure\u00a04."}, {"generated": ["simvastatin", "simvastatin hydroxy acid", "lovastatin"], "gold": [], "text": "The mean (SD) plasma concentrations of simvastatin, its metabolite simvastatin hydroxy acid, and internal standard lovastatin are shown in Figure\u00a04."}, {"generated": ["simvastatin"], "gold": [], "text": "(B) Plasma obtained from the volunteer received single oral dose of 40 mg simvastatin."}, {"generated": ["herbal medicines"], "gold": [], "text": "Herb-drug interactions incidence was predicted to increase due to herbal medicines' worldwide popularity with the development of several herbal formulations with improved bioavailability."}, {"generated": ["several herbal supplementations"], "gold": ["Herbal Supplementations"], "text": "Case Report: Fatigue and Bleeding in a Polymedicated Patient Using Several Herbal Supplementations, Detected with g-Nomic\u00ae Software Abel Saldarreaga Marin, 1 Marc Cendros, 2 Carlos J Ciudad, 3 and Ana Sabater 2 Author information Article notes Copyright and License information PMC Disclaimer Go to: Abstract  This was a case report of severe fatigue and bleeding in a 65-year-old man with ischemic heart disease who was wearing a stent and taking multiple medications for hypertension and diabetes."}, {"generated": ["echinacea"], "gold": ["echinacea alkamide tetraene"], "text": "Trough plasma concentrations of the major echinacea alkamide tetraene ranged from 1 to 23 ng ml\u22121, and the Cmax was found to range from 13 to 65 ng ml\u22121."}, {"generated": ["warfarin"], "gold": [], "text": "Interestingly, this effect on the pharmacokinetics of (S)-warfarin was not associated with a significant effect on warfarin pharmacodynamics."}, {"generated": ["previous studies"], "gold": [], "text": "The reason for the discrepancy with previous studies remains unclear."}, {"generated": ["Jamaican prescription drug users"], "gold": [], "text": "A survey of cancer patients attending the oncology and urology clinics at the University Hospital of the West Indies in Kingston, and two earlier surveys of Jamaican prescription drug users identified high levels of herb-drug use (80% [4] 80% [5] and 81% [6], respectively), while awareness of such herb-drug use amongst health care professionals was low across all four surveys (13% [5], 15% [4], 18% [6] and 19% [3], respectively)."}, {"generated": ["Ginkgo biloba", "Panax ginseng", "Allium sativum", "Hypericum perforatum"], "gold": ["St. John\u2019s wort (Hypericum perforatum)", "Panax ginseng", "garlic (Allium sativum)", "Ginkgo biloba"], "text": "Clinical studies of some of the most commonly researched plants include garlic (Allium sativum), St. John\u2019s wort (Hypericum perforatum), Panax ginseng, and Ginkgo biloba [9]."}, {"generated": ["Ginkgo biloba", "Panax ginseng", "Allium sativum", "Hypericum perforatum"], "gold": ["St. John\u2019s wort (Hypericum perforatum)", "Panax ginseng", "garlic (Allium sativum)", "Ginkgo biloba"], "text": "Clinical studies of some of the most commonly researched plants include garlic (Allium sativum), St. John\u2019s wort (Hypericum perforatum), Panax ginseng, and Ginkgo biloba [9]."}, {"generated": ["CYP1A2"], "gold": [], "text": "Key phytochemicals were individually assessed for their impact on CYP1A2 activity."}, {"generated": ["CYP assays"], "gold": [], "text": "The IC It was not possible to determine the IC In vitro CYP assays offer an accurate, and relatively inexpensive, first stage assessment tool for gauging the potential for herb-drug interactions."}, {"generated": ["filter paper"], "gold": [], "text": "The resulting liquor was suction-filtered through type 1 Whatman filter paper and stored in a sealed darkened glass container."}, {"generated": ["LC-MS"], "gold": [], "text": "High resolution LC-MS was conducted using a Waters LCT Time of Flight Mass Spectrometer (Waters Micromass Ltd., Wilmslow, UK), with a Waters Alliance 2690 HPLC and Mass Lynx V4.1 software using similar HPLC conditions to those described above."}, {"generated": ["2,2-diphenyl-1-picrylhydrazyl (DPPH)"], "gold": [], "text": "100 \u00b5L of various concentrations of the extracts, and the ascorbic acid control, in methanol, were added to 100 \u00b5L of a 0.02% (w/v) stock solution of the free radical 2,2-diphenyl-1-picrylhydrazyl (DPPH) in methanol."}, {"generated": ["Disease"], "gold": [], "text": "Worse than the Disease?"}, {"generated": ["extract"], "gold": [], "text": "In our patient, the rash was refractory to glucocorticoids and only resolved once her exposure to the extract ceased, although antihistamines were helpful to reduce pruritis."}, {"generated": ["OS"], "gold": ["Wen Bing formulas"], "text": "To explore more, we would like to investigate the interactions between OS and selected single herbs from these Wen Bing formulas."}, {"generated": ["Radix Scutellariae"], "gold": ["Radix Scutellariae extract (RS)"], "text": "A commercially available, standardized and purified Radix Scutellariae extract (RS) was obtained from Shanghai U-sea Biotech Co., Ltd. (Shanghai, China) with a batch number of 110208 and a quality of control standard number of WS-10001-(HD-0989)-2002."}, {"generated": ["Albuterol"], "gold": [], "text": "Albuterol (as internal standard) was purchased from Sigma-Aldrich Chem."}, {"generated": ["thiazolyl blue tetrazolium bromide", "Hygromycin B", "glycyl-sarcosine"], "gold": [], "text": "Hygromycin B, glycyl-sarcosine (Gly-Sar) and thiazolyl blue tetrazolium bromide (MTT) were purchased from Sigma-Aldrich Chem."}, {"generated": ["thiazolyl blue tetrazolium bromide", "Hygromycin B", "glycyl-sarcosine"], "gold": [], "text": "Hygromycin B, glycyl-sarcosine (Gly-Sar) and thiazolyl blue tetrazolium bromide (MTT) were purchased from Sigma-Aldrich Chem."}, {"generated": ["thiazolyl blue tetrazolium bromide", "Hygromycin B", "glycyl-sarcosine"], "gold": [], "text": "Hygromycin B, glycyl-sarcosine (Gly-Sar) and thiazolyl blue tetrazolium bromide (MTT) were purchased from Sigma-Aldrich Chem."}, {"generated": ["dichlorvos"], "gold": [], "text": "The reaction was terminated by adding 5\u202f\u03bcL of 8\u202fmg/mL dichlorvos and then mixed with 600\u202f\u03bcL PBS."}, {"generated": ["OS"], "gold": [], "text": "The incubation system for rat plasma contains 1\u202f\u03bcg/mL of OS and 10% rat plasma since the super-fast reaction rate of 100% rat plasma resulted in no discrimination for nearly all the studied herb/herbal components."}, {"generated": ["OSA"], "gold": [], "text": "The formation rate of OSA could be significantly suppressed by all the herb/herbal components."}, {"generated": ["RLM", "hCE1"], "gold": [], "text": "Results from RLM and hCE1 showed a similar trend for the ten marker components (Figs."}, {"generated": ["RLM", "hCE1"], "gold": [], "text": "Results from RLM and hCE1 showed a similar trend for the ten marker components (Figs."}, {"generated": ["anti-influenza herbs", "herbal components"], "gold": [], "text": "S4, the P The above in-vitro experiments suggested that there should be some potential HDI between OS and these anti-influenza herbs/herbal components during absorption and metabolism."}, {"generated": ["anti-influenza herbs", "herbal components"], "gold": [], "text": "S4, the P The above in-vitro experiments suggested that there should be some potential HDI between OS and these anti-influenza herbs/herbal components during absorption and metabolism."}, {"generated": ["EGb 761\u00ae"], "gold": [], "text": "S8)."}, {"generated": ["influenza viruses"], "gold": [], "text": "In our current study, a screening platform based on microsomes, enzymes, cells and influenza viruses have for the first time been developed and utilized to screen potential interaction between OS and anti-influenza herb/herbal components."}, {"generated": ["OS"], "gold": [], "text": "The metabolic inhibition studies performed in rat plasma suggested that all the herbal extracts (500\u202f\u03bcg/mL) and all the herbal components (100\u202f\u03bcg/mL) could inhibit the hydrolysis of OS in rat plasma, but the % inhibition rate varied between herbs/herbal components."}, {"generated": ["hydrolase"], "gold": [], "text": "The hydrolase activities in rat plasma may be originated from more than one kind of enzymes (not only hCE1) and the inhibition activities of these herbal components to each kind of hydrolysis enzymes are different."}, {"generated": ["herb/herbal component"], "gold": [], "text": "After such a normalization, the absolute z-score of an herb/herbal component effect on OS would be proportional to its level of HDI relevancy with OS."}, {"generated": ["natural products"], "gold": [], "text": "30%\u201370% of clinical breast cancer patients use natural products, which may increase the likelihood of drug interactions."}, {"generated": ["Phellodendron bark", "dried orange peel", "Anemarrhena"], "gold": ["Phellodendron bark (Phellodendron amurense Rupr.", "dried orange peel (Citrus aurantium L.)", "Anemarrhena (Anemarrhena asphodeloides Bunge)"], "text": "), dried orange peel (Citrus aurantium L.), Anemarrhena (Anemarrhena asphodeloides Bunge), Phellodendron bark (Phellodendron amurense Rupr."}, {"generated": ["Phellodendron bark", "dried orange peel", "Anemarrhena"], "gold": ["Phellodendron bark (Phellodendron amurense Rupr.", "dried orange peel (Citrus aurantium L.)", "Anemarrhena (Anemarrhena asphodeloides Bunge)"], "text": "), dried orange peel (Citrus aurantium L.), Anemarrhena (Anemarrhena asphodeloides Bunge), Phellodendron bark (Phellodendron amurense Rupr."}, {"generated": ["Phellodendron bark", "dried orange peel", "Anemarrhena"], "gold": ["Phellodendron bark (Phellodendron amurense Rupr.", "dried orange peel (Citrus aurantium L.)", "Anemarrhena (Anemarrhena asphodeloides Bunge)"], "text": "), dried orange peel (Citrus aurantium L.), Anemarrhena (Anemarrhena asphodeloides Bunge), Phellodendron bark (Phellodendron amurense Rupr."}, {"generated": ["Lilyturf", "Ginger", "Licorice"], "gold": ["Ginger (Zingiber officinale Roscoe)", "Lilyturf (Ophiopogon japonicus (Thunb.)", "Licorice (Glycyrrhiza glabra L.)"], "text": "), Licorice (Glycyrrhiza glabra L.), Ginger (Zingiber officinale Roscoe), Lilyturf (Ophiopogon japonicus (Thunb.)"}, {"generated": ["Lilyturf", "Ginger", "Licorice"], "gold": ["Ginger (Zingiber officinale Roscoe)", "Lilyturf (Ophiopogon japonicus (Thunb.)", "Licorice (Glycyrrhiza glabra L.)"], "text": "), Licorice (Glycyrrhiza glabra L.), Ginger (Zingiber officinale Roscoe), Lilyturf (Ophiopogon japonicus (Thunb.)"}, {"generated": ["Lilyturf", "Ginger", "Licorice"], "gold": ["Ginger (Zingiber officinale Roscoe)", "Lilyturf (Ophiopogon japonicus (Thunb.)", "Licorice (Glycyrrhiza glabra L.)"], "text": "), Licorice (Glycyrrhiza glabra L.), Ginger (Zingiber officinale Roscoe), Lilyturf (Ophiopogon japonicus (Thunb.)"}, {"generated": ["anti-cancer drugs"], "gold": [], "text": "The key mechanisms of action of anti-cancer drugs involve apoptosis, autophagy, and cell cycle arrest (Chen and Karantza-Wadsworth, 2009; Wang et el., 2011; Kon et al., 2013)."}, {"generated": ["HES", "PIP", "BV", "TAM"], "gold": ["HES", "PIP", "BV"], "text": "A recent study has shown that the combined use of HES, PIP, and BV with TAM showed an enhanced anti-proliferative effect on MCF7 and T47D and can significantly increase cell apoptosis (Khamis et al., 2018)."}, {"generated": ["TAM"], "gold": [], "text": "When combined with TAM, it exhibits a significant synergistic inhibitory effect on MCF-7 and T-47D cell growth (Cho et al., 2010)."}, {"generated": ["Vitex negundo"], "gold": ["10 Evn-50", "Vitex negundo L."], "text": "In a study involving TAM-resistant cell line MCF-7 tam-R, while 10 Evn-50 is an ethyl acetate extract of Vitex negundo L. When used in combination with TAM to treat TAM-resistant MCF-7/TAM-R cells, it significantly reduces cell viability, inhibits cell growth, induces apoptosis, and reverses TAM resistance of MCF-7/TAM-R cells (Hu et al., 2012)."}, {"generated": ["Jaeumkanghwa"], "gold": ["Jaeumkanghwa soup (JEKHT)"], "text": "Jaeumkanghwa soup (JEKHT) is a compound composed of 12 traditional herbs (Jung et al., 2010)."}, {"generated": ["Jiawei Xiaoyao San"], "gold": ["Jiawei Xiaoyao San (JWXYS)"], "text": "Jiawei Xiaoyao San (JWXYS) is a very common Chinese herbal formula used by the Chinese for thousands of years (Chen et al., 2014)."}, {"generated": ["protective effect"], "gold": [], "text": "The protective effect is dose-dependent (Rahate and Rajasekaran, 2015)."}, {"generated": ["protein expression levels"], "gold": [], "text": "Studies have shown that just the monitoring of protein expression levels is insufficient in understanding transcription activity in vitro (Gord\u00e2n et al., 2009)."}, {"generated": ["Don (P. capitatum)"], "gold": ["ex D. Don (P. capitatum)"], "text": "ex D. Don (P. capitatum), a Chinese herbal plant, is often used alone or in combination with antibacterial agents to treat urinary tract infections, pyelonephritis, and prostatitis in China (Chinese Pharmacopoeia Commission, 2010; Liao et al., 2011)."}, {"generated": ["CIP"], "gold": [], "text": "Approximately 60% of CIP is excreted in unchanged form into the urine (Vance-Bryan et al., 1990)."}, {"generated": ["CIP"], "gold": [], "text": "CIP is a known substrate of the ATP-binding cassette transporters, which have been implicated in its intestinal secretion, biliary excretion and secretion into breast milk (Vance-Bryan et al., 1990; Merino et al., 2006; Ando et al., 2007; Mulgaonkar et al., 2012)."}, {"generated": ["gradient elution program"], "gold": [], "text": "The gradient elution program was as follows: 0\u20138.5\u00a0min, 97% A; 8.7\u201311\u00a0min, 60% A; 11.5\u201313.5\u00a0min, 10% A; 14\u201315\u00a0min, 97% A."}, {"generated": ["CIP", "GA", "PCA"], "gold": ["GA", "PCA"], "text": "The supernate was utilized for the quantification of GA, PCA, and CIP."}, {"generated": ["ofloxacin"], "gold": [], "text": "The precursor-product ion transitions of CIP and ofloxacin (internal standard) were 332.1\u2192288.1 and 362.2\u2192318.1, respectively."}, {"generated": ["CIP", "PCE"], "gold": ["GA", "PCE", "PCA"], "text": "After co-administration of CIP and PCE, the PK changes of GA and PCA are displayed in Figures 3, 4, respectively."}, {"generated": ["ciprofloxacin", "gallic acid"], "gold": ["gallic acid (GA)", "PCE", "PCA"], "text": "CIP significantly increased the K  Tissue distribution profiles of gallic acid (GA) after oral administration of PCE in the absence (A) and presence (B) of ciprofloxacin, as well as the tissue to plasma distribution coefficients [K  The tissue distribution curves of PCA in the absence and| presence of CIP are shown in Figures 8A,B, respectively."}, {"generated": ["ciprofloxacin", "gallic acid"], "gold": ["gallic acid (GA)", "PCE", "PCA"], "text": "CIP significantly increased the K  Tissue distribution profiles of gallic acid (GA) after oral administration of PCE in the absence (A) and presence (B) of ciprofloxacin, as well as the tissue to plasma distribution coefficients [K  The tissue distribution curves of PCA in the absence and| presence of CIP are shown in Figures 8A,B, respectively."}, {"generated": ["CIP"], "gold": [], "text": "Since the liver metabolism (approximately 10%) and biliary excretion (approximately 1%) of the drug is relatively low (Vance-Bryan et al., 1990), the reduced circulating CIP in humans was mainly attributed to the change of CIP across the renal and intestinal epithelia."}, {"generated": ["PLC", "YM"], "gold": ["YM"], "text": "However, the total AUC for CHO was lower in YM than PLC (13.3 vs. 15.00, p < 0.001)."}, {"generated": ["Total Energy Expenditure"], "gold": ["YM"], "text": "Total Energy Expenditure (TEE) was neither significantly affected by the treatment (YM vs. PLC) nor the exercise time (Figure 3)."}, {"generated": ["quinic acid", "triterpenic saponins", "mono-caffeolquinic acid", "chlorogenic acids", "dihydrocaffeolquinic acid", "caffeic acid"], "gold": ["caffeine"], "text": "The metabolic effects include adrengenic effects and stimulated central nervous system associated with caffeine, anti-lipolytic, and hypocholesterolemic properties in chlorogenic acids (mono- and di-caffeolquinic acids) hydroxycinnamic acids (caffeic acid, quinic acid) and triterpenic saponins, and other minerals and vitamins [5]."}, {"generated": ["quinic acid", "triterpenic saponins", "mono-caffeolquinic acid", "chlorogenic acids", "dihydrocaffeolquinic acid", "caffeic acid"], "gold": ["caffeine"], "text": "The metabolic effects include adrengenic effects and stimulated central nervous system associated with caffeine, anti-lipolytic, and hypocholesterolemic properties in chlorogenic acids (mono- and di-caffeolquinic acids) hydroxycinnamic acids (caffeic acid, quinic acid) and triterpenic saponins, and other minerals and vitamins [5]."}, {"generated": ["quinic acid", "triterpenic saponins", "mono-caffeolquinic acid", "chlorogenic acids", "dihydrocaffeolquinic acid", "caffeic acid"], "gold": ["caffeine"], "text": "The metabolic effects include adrengenic effects and stimulated central nervous system associated with caffeine, anti-lipolytic, and hypocholesterolemic properties in chlorogenic acids (mono- and di-caffeolquinic acids) hydroxycinnamic acids (caffeic acid, quinic acid) and triterpenic saponins, and other minerals and vitamins [5]."}, {"generated": ["quinic acid", "triterpenic saponins", "mono-caffeolquinic acid", "chlorogenic acids", "dihydrocaffeolquinic acid", "caffeic acid"], "gold": ["caffeine"], "text": "The metabolic effects include adrengenic effects and stimulated central nervous system associated with caffeine, anti-lipolytic, and hypocholesterolemic properties in chlorogenic acids (mono- and di-caffeolquinic acids) hydroxycinnamic acids (caffeic acid, quinic acid) and triterpenic saponins, and other minerals and vitamins [5]."}, {"generated": ["quinic acid", "triterpenic saponins", "mono-caffeolquinic acid", "chlorogenic acids", "dihydrocaffeolquinic acid", "caffeic acid"], "gold": ["caffeine"], "text": "The metabolic effects include adrengenic effects and stimulated central nervous system associated with caffeine, anti-lipolytic, and hypocholesterolemic properties in chlorogenic acids (mono- and di-caffeolquinic acids) hydroxycinnamic acids (caffeic acid, quinic acid) and triterpenic saponins, and other minerals and vitamins [5]."}, {"generated": ["quinic acid", "triterpenic saponins", "mono-caffeolquinic acid", "chlorogenic acids", "dihydrocaffeolquinic acid", "caffeic acid"], "gold": ["caffeine"], "text": "The metabolic effects include adrengenic effects and stimulated central nervous system associated with caffeine, anti-lipolytic, and hypocholesterolemic properties in chlorogenic acids (mono- and di-caffeolquinic acids) hydroxycinnamic acids (caffeic acid, quinic acid) and triterpenic saponins, and other minerals and vitamins [5]."}, {"generated": ["YM capsules"], "gold": ["YM"], "text": "However, further research is required to assess active ingredients of YM capsules and analyze their bioavailability following ingestion."}, {"generated": ["fat and weight-loss supplementation"], "gold": [], "text": "Favorable psychomotor effects on mood state and satiety are often expected outcomes of fat and weight-loss supplementation protocols."}, {"generated": ["OCT1", "OAT3", "OATP1B1", "OAT1", "OATP1B3", "OCT2"], "gold": [], "text": "[ HEK293 cells transiently overexpressing OAT1, OAT3, OCT1, OCT2, OATP1B1, and OATP1B3 transporters were purchased from Corning-Gentest (Tewksbury, MA, USA)."}, {"generated": ["OCT1", "OAT3", "OATP1B1", "OAT1", "OATP1B3", "OCT2"], "gold": [], "text": "[ HEK293 cells transiently overexpressing OAT1, OAT3, OCT1, OCT2, OATP1B1, and OATP1B3 transporters were purchased from Corning-Gentest (Tewksbury, MA, USA)."}, {"generated": ["OCT1", "OAT3", "OATP1B1", "OAT1", "OATP1B3", "OCT2"], "gold": [], "text": "[ HEK293 cells transiently overexpressing OAT1, OAT3, OCT1, OCT2, OATP1B1, and OATP1B3 transporters were purchased from Corning-Gentest (Tewksbury, MA, USA)."}, {"generated": ["OCT1", "OAT3", "OATP1B1", "OAT1", "OATP1B3", "OCT2"], "gold": [], "text": "[ HEK293 cells transiently overexpressing OAT1, OAT3, OCT1, OCT2, OATP1B1, and OATP1B3 transporters were purchased from Corning-Gentest (Tewksbury, MA, USA)."}, {"generated": ["OCT1", "OAT3", "OATP1B1", "OAT1", "OATP1B3", "OCT2"], "gold": [], "text": "[ HEK293 cells transiently overexpressing OAT1, OAT3, OCT1, OCT2, OATP1B1, and OATP1B3 transporters were purchased from Corning-Gentest (Tewksbury, MA, USA)."}, {"generated": ["OCT1", "OAT3", "OATP1B1", "OAT1", "OATP1B3", "OCT2"], "gold": [], "text": "[ HEK293 cells transiently overexpressing OAT1, OAT3, OCT1, OCT2, OATP1B1, and OATP1B3 transporters were purchased from Corning-Gentest (Tewksbury, MA, USA)."}, {"generated": ["Mass Hunter software"], "gold": [], "text": "Mass Hunter software (Agilent Technologies) was used for LC-MS/MS system control and data processing."}, {"generated": ["herbal co-medication"], "gold": [], "text": "showed that the practice of herbal co-medication with prescription drugs cut across various patient demographics, with 38% of respondents reporting concomitant herbal use [6]."}, {"generated": ["echinacea", "kratom", "St. John\u2019s wort", "hydroxycut", "piperine", "celery", "rhodiola", "moringa", "valerian", "terminalia/commiphora ayurvedic mixture", "ginkgo", "ginseng", "kava"], "gold": ["echinacea", "kratom", "terminalia/commiphora ayurvedic", "St. John\u2019s wort", "hydroxycut", "piperine", "celery", "rhodiola", "moringa", "valerian", "ginkgo", "ginseng", "kava"], "text": "These are celery, echinacea, ginkgo, ginseng, hydroxycut, kava, kratom, moringa, piperine, rhodiola, St. John\u2019s wort, terminalia/commiphora ayurvedic mixture and valerian."}, {"generated": ["HDI"], "gold": [], "text": "Anecdotal pieces of evidence like this not only highlight the reality and severity of the consequences of HDIs, they underscore the importance of further studies to guide clinical decisions."}, {"generated": ["oral administration"], "gold": [], "text": "This is important because the vast majority of herbal products are orally administered."}, {"generated": ["dietary supplements"], "gold": [], "text": "This is because many marketed herbal products are made of mixtures of different herbal species and/or dietary supplements whose biological disposition in humans is poorly understood."}, {"generated": ["P-gp", "CYP3A4"], "gold": [], "text": "CYP3A4 and P-gp are richly expressed in the human small intestinal enterocytes."}, {"generated": ["P-gp", "CYP3A4"], "gold": [], "text": "CYP3A4 and P-gp are richly expressed in the human small intestinal enterocytes."}, {"generated": ["echinacea", "kratom", "St. John\u2019s wort", "hydroxycut", "piperine", "celery", "rhodiola", "moringa", "valerian", "terminalia/commiphora ayurvedic mixture", "ginkgo", "ginseng", "kava"], "gold": ["echinacea", "kratom", "St. John\u2019s wort", "piperine", "celery", "rhodiola", "moringa", "valerian", "terminalia/commiphora ayurvedic mixture", "ginkgo", "ginseng", "kava"], "text": "This review identified 13 herbal products - celery, echinacea, ginkgo, ginseng, hydroxycut, kava, kratom, moringa, piperine, rhodiola, St. John\u2019s wort, terminalia/commiphora ayurvedic mixture and valerian \u2013 all of which have shown interactions with specific neuropsychiatric drugs."}, {"generated": ["medicinal herbs"], "gold": [], "text": "Medicinal herbs are rich sources of natural bioactive compounds that could interact with drugs."}, {"generated": ["Sirolimus"], "gold": [], "text": "Sirolimus displays a synergistic action with calcineurin inhibitors and a distinctive mechanism of action from calcineurin inhibitors, which are indispensable immunosuppressive agents in kidney transplantation."}, {"generated": ["drugs"], "gold": [], "text": "This is especially important for drugs with a narrow therapeutic window."}, {"generated": ["sirolimus", "tacrolimus"], "gold": [], "text": "The patient received tacrolimus-based immunosuppression until April 2016, and then the treatment was switched from tacrolimus to sirolimus due to evident tremors."}, {"generated": ["sirolimus", "tacrolimus"], "gold": [], "text": "The patient received tacrolimus-based immunosuppression until April 2016, and then the treatment was switched from tacrolimus to sirolimus due to evident tremors."}, {"generated": ["Sirolimus"], "gold": [], "text": "Sirolimus is an immunosuppressive drug used to prevent graft rejection."}, {"generated": ["sirolimus"], "gold": [], "text": "Previous studies have shown the interactions between sirolimus and drugs that affect the activities of metabolizing enzymes and transporter proteins."}, {"generated": ["parsley"], "gold": [], "text": "In this patient, we reported the possible effect of parsley juice on the level of sirolimus."}, {"generated": ["Zuccaria"], "gold": [], "text": "et Zucc.)"}, {"generated": ["Maxim extract"], "gold": ["Maxim"], "text": "Maxim extract are available from the authors."}, {"generated": ["Bilia and C\u00e9u Costas"], "gold": [], "text": "A more detailed description of the regulatory environment in Europe, as well as its practical effects, can be found in the Bilia and C\u00e9u Costas review [13]."}, {"generated": ["analgetic drugs"], "gold": [], "text": "Though non-pharmacological treatments are the main therapy for these patients, application of analgetic drugs is common, often over years."}, {"generated": ["plants"], "gold": [], "text": "Thus, two studies from Canada and the USA were screened to find plants that patients might use."}, {"generated": ["hepatotoxic herbs"], "gold": [], "text": "Many potentially hepatotoxic herbs are not studied extensively enough to determine a safe daily dose."}, {"generated": ["opioids"], "gold": [], "text": "Short-term use of opioids for patients who cannot reach pain relief otherwise may occur, e.g., to bridge the time until surgical intervention."}, {"generated": ["leaf powder"], "gold": [], "text": "Another patient experienced liver injury after taking 500 mg leaf powder every 2\u20133 days as a laxative [117]."}, {"generated": ["food supplements"], "gold": [], "text": "There are only food supplements available, with insufficiently defined product quality."}, {"generated": ["thrombin"], "gold": [], "text": "There are in vitro experiments confirming thrombin inhibition [172]."}, {"generated": ["HILI"], "gold": [], "text": "HILI could occur more frequently in these groups because of the combination of risk factors."}, {"generated": ["CYP"], "gold": [], "text": "They favor CYP, as the patient could be unusually susceptible due to the individual genotype [207]."}, {"generated": ["ASA"], "gold": [], "text": "With MTX doses between 7.5 and 15 mg weekly, this effect is moderate (AUC +28% with ASA, less for the others), and there is inter-individual variability."}, {"generated": ["plants"], "gold": [], "text": "It is important to make patients aware of the fact that plants can cause adverse effects and are not safe in every situation by being \u201cnatural\u201d."}, {"generated": ["Valerian"], "gold": ["HMP"], "text": "Valerian, for example, is marketed in Germany, mainly as HMP, and, thus, possibly a great proportion of consumption was not included in the survey by Garcia-Alvarez [7]."}, {"generated": ["Publisher\u2019s Note"], "gold": [], "text": "Publisher\u2019s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations."}, {"generated": ["Herb"], "gold": [], "text": "Herb\u2013drug interactions (HDI) may affect clinical safety and efficacy via additive/synergistic or antagonistic interactions among the herbal components and drug molecules."}, {"generated": ["HDI"], "gold": [], "text": "When these herbs and drugs are used together, pharmacodynamic HDI (either additive/synergistic) may occur."}, {"generated": ["sulfur compounds"], "gold": ["allyl thiosulfinates"], "text": "It is composed of a large number of sulfur compounds, with suspected bioactive compounds called allyl thiosulfinates (mainly allicin) [65]."}, {"generated": ["diabetic treatment"], "gold": [], "text": "This herb has been in use for diabetic treatment for almost two millennia [72]."}, {"generated": ["gymnema tea"], "gold": ["gymnema"], "text": "These findings suggest further research in individuals with diabetes is required to determine the effect of the combination of gymnema tea and metformin on blood sugar levels."}, {"generated": ["no interaction"], "gold": [], "text": "no interaction [98]."}, {"generated": ["DEX"], "gold": [], "text": "The O-demethylation of DEX to dextrorphan (DOR) is predominantly mediated by CYP2D6 (Barnhart, 1980; Schadel et al., 1995)."}, {"generated": ["DEX"], "gold": [], "text": "So, DEX has been used as a common probe for both CYP3A and CYP2D6 activities (Spanakis et al., 2009; Yu and Haining, 2001), as well as in vivo in several studies (Ducharme et al., 1996; Funck-Brentano et al., 2005; Jones et al., 1996)."}, {"generated": ["betaxolol", "codeine"], "gold": [], "text": "The internal standards codeine and betaxolol were of USP reference standard."}, {"generated": ["betaxolol", "codeine"], "gold": [], "text": "The internal standards codeine and betaxolol were of USP reference standard."}, {"generated": ["HPLC grade solvents", "General-purpose reagents"], "gold": [], "text": "General-purpose reagents (GPR) were used for extraction processes, while HPLC grade solvents were used for HPLC determinations."}, {"generated": ["HPLC grade solvents", "General-purpose reagents"], "gold": [], "text": "General-purpose reagents (GPR) were used for extraction processes, while HPLC grade solvents were used for HPLC determinations."}, {"generated": ["Zorbax SB-CN"], "gold": [], "text": "Urine samples were eluted on a Zorbax SB-CN column (5\u00a0\u03bcm, 250\u00a0\u00d7\u00a04.6\u00a0mm)."}, {"generated": ["Asafetida resin"], "gold": [], "text": "In the in vitro study, Asafetida resin alcoholic extract inhibited the formation of DOR from DEX in a concentration dependent manner (Fig."}, {"generated": ["activation"], "gold": [], "text": "The activation was highest at 25\u00a0\u03bcg/ml concentration."}, {"generated": ["abemaciclib"], "gold": [], "text": "These may favor the occurrence of abemaciclib-related diarrhea, causing dose reductions and poor adherence and eventually negatively influencing patients' outcomes and quality of life."}], "FN": [{"generated": ["medicinal cannabis"], "gold": ["cannabis"], "text": "This case report highlights the complexity associated with medicinal cannabis and the health risks associated with its use."}, {"generated": ["Faangum", "Sasanemasa/Sesemasa", "Lifui", "Akoko"], "gold": ["Sasanemasa/Sesemasa", "Esisimansa", "Akoko", "Faangum", "Lifui"], "text": "Local names for this shrub include Faangum in Cameroon, Sasanemasa/Sesemasa or Esisimansa in Ghana, Lifui in Togo, and Akoko in Nigeria."}, {"generated": ["Danshen"], "gold": ["Danshen components"], "text": "For the most part these latter two transporter families and the OATs have fairly distinct substrate interactions; however, the possibility that they also may contribute to the overall clinical pharmacokinetic profile of Danshen components in vivo needs to be considered until investigated directly."}, {"generated": ["Polygonum capitatum"], "gold": ["Relinqing\u00ae granule", "Polygonum capitatum"], "text": "For patients with urinary system infection, Relinqing\u00ae granule from Polygonum capitatum is usually combined with LVFX."}, {"generated": ["KF"], "gold": ["the extract and constituents of KF"], "text": "Furthermore, the extract and constituents of KF have been shown to possess anticancer, antioxidant, anti-osteoporosis, and anti-inflammatory properties (Nadia et al., 2012; Fathilah et al., 2013)."}, {"generated": ["digoxin"], "gold": ["non-essential amino acids"], "text": "Radio labeled digoxin [ Parental and transfected MDCK-II cells were grown in DMEM supplemented with 10% FBS, 1% non-essential amino acids, 1%  The assay for reversible inhibition was conducted in a total volume of 200 \u03bcL in 96-well microplates."}, {"generated": ["KF"], "gold": ["KF", "alkyl phenols and triterpene glycosides (saponins)"], "text": "The two major classes of compounds isolated from the roots of KF are alkyl phenols and triterpene glycosides (saponins) as reported earlier (Ali and Khan, 2011)."}, {"generated": ["L. pumila"], "gold": ["the extract of L. pumila and the constituents", "calcein-AM"], "text": "IC Next, we determined the inhibition of P-gp by the extract of L. pumila and the constituents by using the two widely used probes calcein-AM and digoxin (Rautio et al., 2006)."}, {"generated": ["L. pumila"], "gold": ["the extract of L. pumila and the constituents", "calcein-AM"], "text": "IC Next, we determined the inhibition of P-gp by the extract of L. pumila and the constituents by using the two widely used probes calcein-AM and digoxin (Rautio et al., 2006)."}, {"generated": ["ASP"], "gold": ["polyphenols", "ASP"], "text": "GRT containing higher levels of polyphenols, in particular ASP (12.78% compared to 0.36%), demonstrated a more potent inhibition of CYP3A4 activity than FRE with IC CYP2C9 plays a role in the oxidation of xenobiotic and endogenous compounds and is responsible for the metabolism of 15%\u201320% of drugs undergoing phase I metabolism [52,53]."}, {"generated": ["E. purpurea"], "gold": ["alkylamide", "DTAI", "E. purpurea"], "text": "For example, alkylamide content is known to vary considerably across different parts of E. purpurea plants [20], and DTAI are more abundant in roots than in leaves."}, {"generated": ["E. purpurea"], "gold": ["alkylamide", "DTAI", "E. purpurea"], "text": "For example, alkylamide content is known to vary considerably across different parts of E. purpurea plants [20], and DTAI are more abundant in roots than in leaves."}, {"generated": ["E. purpurea"], "gold": ["alkylamides", "E. purpurea"], "text": "In LS180 cells, our group has shown significant induction of CYP3A4 by isolated alkylamides and E. purpurea extracts using a gene reporter assay, which is a reliable method to assess the CYP3A4 induction potential of compounds [23]."}, {"generated": ["IS"], "gold": ["EGC", "EC", "ECG"], "text": "The monitored M/Z values of the parent and product ions under the positive electrospray mode of ECG, EGC, EC, and internal standard (IS) injected into MS through the Atlantis T3 (4.6\u00d750 mm \u00d73 \u00b5m) C18 (Waters) column were 443.10 \u2192 123.00, 307.20 \u2192 151.00, 291.20 \u2192 139.00, and 199.00 \u2192 127.03, respectively."}, {"generated": ["IS"], "gold": ["EGC", "EC", "ECG"], "text": "The monitored M/Z values of the parent and product ions under the positive electrospray mode of ECG, EGC, EC, and internal standard (IS) injected into MS through the Atlantis T3 (4.6\u00d750 mm \u00d73 \u00b5m) C18 (Waters) column were 443.10 \u2192 123.00, 307.20 \u2192 151.00, 291.20 \u2192 139.00, and 199.00 \u2192 127.03, respectively."}, {"generated": ["IS"], "gold": ["EGC", "EC", "ECG"], "text": "The monitored M/Z values of the parent and product ions under the positive electrospray mode of ECG, EGC, EC, and internal standard (IS) injected into MS through the Atlantis T3 (4.6\u00d750 mm \u00d73 \u00b5m) C18 (Waters) column were 443.10 \u2192 123.00, 307.20 \u2192 151.00, 291.20 \u2192 139.00, and 199.00 \u2192 127.03, respectively."}, {"generated": ["GTC"], "gold": ["EC", "ECG", "EGC", "EGCG", "GTC"], "text": "Compared to the single administration of digoxin (Day 1), the concomitant administration of digoxin and GTC was associated with a significant reduction in systemic exposure of digoxin (Day 15): AUC The concentration\u2013time profiles of EC, EGC, ECG, and EGCG and the pharmacokinetics parameters are presented in Figure 4 and Table 3."}, {"generated": ["GTC"], "gold": ["EC", "ECG", "EGC", "EGCG", "GTC"], "text": "Compared to the single administration of digoxin (Day 1), the concomitant administration of digoxin and GTC was associated with a significant reduction in systemic exposure of digoxin (Day 15): AUC The concentration\u2013time profiles of EC, EGC, ECG, and EGCG and the pharmacokinetics parameters are presented in Figure 4 and Table 3."}, {"generated": ["GTC"], "gold": ["EC", "ECG", "EGC", "EGCG", "GTC"], "text": "Compared to the single administration of digoxin (Day 1), the concomitant administration of digoxin and GTC was associated with a significant reduction in systemic exposure of digoxin (Day 15): AUC The concentration\u2013time profiles of EC, EGC, ECG, and EGCG and the pharmacokinetics parameters are presented in Figure 4 and Table 3."}, {"generated": ["GTC"], "gold": ["EC", "ECG", "EGC", "EGCG", "GTC"], "text": "Compared to the single administration of digoxin (Day 1), the concomitant administration of digoxin and GTC was associated with a significant reduction in systemic exposure of digoxin (Day 15): AUC The concentration\u2013time profiles of EC, EGC, ECG, and EGCG and the pharmacokinetics parameters are presented in Figure 4 and Table 3."}, {"generated": ["ginsenosides"], "gold": ["ginsenosides", "RGE"], "text": "After RGE was orally administered to rats at single or multiple doses for 1 or 2 weeks, the plasma concentrations of ginsenosides were also monitored."}, {"generated": ["Mrp2 substrate drug"], "gold": ["RGE"], "text": "Next, we investigated the effects of RGE on the biliary excretion of Mrp2 substrate drug in rats."}, {"generated": ["Rh1", "Re", "Rg3"], "gold": ["ginsenosides", "Rh1", "Re", "RGE", "Rg3"], "text": "However, other ginsenosides, such as Rg3, Re, and Rh1, were not detected in rat plasma despite their high content in RGE (Table 1 and Table 2)."}, {"generated": ["Rh1", "Re", "Rg3"], "gold": ["ginsenosides", "Rh1", "Re", "RGE", "Rg3"], "text": "However, other ginsenosides, such as Rg3, Re, and Rh1, were not detected in rat plasma despite their high content in RGE (Table 1 and Table 2)."}, {"generated": ["RGE"], "gold": ["ginsenosides", "RGE"], "text": "Contents of ginsenosides in RGE."}, {"generated": [], "gold": ["Ginkgo biloba L. (Yinxing)", "Carica papaya (Mugua)", "citronellal", "Tapinanthus sessilifolius", "Vernonia amygdalina (Biantaobanjiuju)", "Conioselinum anthriscoides \u201cChuanxiong\u201d (Chuanxiong)"], "text": "In vivo, digoxin was administered intravenously to control rats and citronellal pretreated experimental rats, and in vitro, the transcellular transport of   Single TCM: Single TCM formulations that are capable of inhibiting or downregulating P-gP include Conioselinum anthriscoides \u201cChuanxiong\u201d (Chuanxiong), Vernonia amygdalina (Biantaobanjiuju), Tapinanthus sessilifolius, Carica papaya (Mugua) and Ginkgo biloba L. (Yinxing)."}, {"generated": [], "gold": ["Ginkgo biloba L. (Yinxing)", "Carica papaya (Mugua)", "citronellal", "Tapinanthus sessilifolius", "Vernonia amygdalina (Biantaobanjiuju)", "Conioselinum anthriscoides \u201cChuanxiong\u201d (Chuanxiong)"], "text": "In vivo, digoxin was administered intravenously to control rats and citronellal pretreated experimental rats, and in vitro, the transcellular transport of   Single TCM: Single TCM formulations that are capable of inhibiting or downregulating P-gP include Conioselinum anthriscoides \u201cChuanxiong\u201d (Chuanxiong), Vernonia amygdalina (Biantaobanjiuju), Tapinanthus sessilifolius, Carica papaya (Mugua) and Ginkgo biloba L. (Yinxing)."}, {"generated": [], "gold": ["Ginkgo biloba L. (Yinxing)", "Carica papaya (Mugua)", "citronellal", "Tapinanthus sessilifolius", "Vernonia amygdalina (Biantaobanjiuju)", "Conioselinum anthriscoides \u201cChuanxiong\u201d (Chuanxiong)"], "text": "In vivo, digoxin was administered intravenously to control rats and citronellal pretreated experimental rats, and in vitro, the transcellular transport of   Single TCM: Single TCM formulations that are capable of inhibiting or downregulating P-gP include Conioselinum anthriscoides \u201cChuanxiong\u201d (Chuanxiong), Vernonia amygdalina (Biantaobanjiuju), Tapinanthus sessilifolius, Carica papaya (Mugua) and Ginkgo biloba L. (Yinxing)."}, {"generated": [], "gold": ["Ginkgo biloba L. (Yinxing)", "Carica papaya (Mugua)", "citronellal", "Tapinanthus sessilifolius", "Vernonia amygdalina (Biantaobanjiuju)", "Conioselinum anthriscoides \u201cChuanxiong\u201d (Chuanxiong)"], "text": "In vivo, digoxin was administered intravenously to control rats and citronellal pretreated experimental rats, and in vitro, the transcellular transport of   Single TCM: Single TCM formulations that are capable of inhibiting or downregulating P-gP include Conioselinum anthriscoides \u201cChuanxiong\u201d (Chuanxiong), Vernonia amygdalina (Biantaobanjiuju), Tapinanthus sessilifolius, Carica papaya (Mugua) and Ginkgo biloba L. (Yinxing)."}, {"generated": [], "gold": ["Ginkgo biloba L. (Yinxing)", "Carica papaya (Mugua)", "citronellal", "Tapinanthus sessilifolius", "Vernonia amygdalina (Biantaobanjiuju)", "Conioselinum anthriscoides \u201cChuanxiong\u201d (Chuanxiong)"], "text": "In vivo, digoxin was administered intravenously to control rats and citronellal pretreated experimental rats, and in vitro, the transcellular transport of   Single TCM: Single TCM formulations that are capable of inhibiting or downregulating P-gP include Conioselinum anthriscoides \u201cChuanxiong\u201d (Chuanxiong), Vernonia amygdalina (Biantaobanjiuju), Tapinanthus sessilifolius, Carica papaya (Mugua) and Ginkgo biloba L. (Yinxing)."}, {"generated": [], "gold": ["Ginkgo biloba L. (Yinxing)", "Carica papaya (Mugua)", "citronellal", "Tapinanthus sessilifolius", "Vernonia amygdalina (Biantaobanjiuju)", "Conioselinum anthriscoides \u201cChuanxiong\u201d (Chuanxiong)"], "text": "In vivo, digoxin was administered intravenously to control rats and citronellal pretreated experimental rats, and in vitro, the transcellular transport of   Single TCM: Single TCM formulations that are capable of inhibiting or downregulating P-gP include Conioselinum anthriscoides \u201cChuanxiong\u201d (Chuanxiong), Vernonia amygdalina (Biantaobanjiuju), Tapinanthus sessilifolius, Carica papaya (Mugua) and Ginkgo biloba L. (Yinxing)."}, {"generated": ["C. pinnatifida Bunge (Shanzha)"], "gold": ["flavonoid glycoside", "flavane polymers", "C. pinnatifida Bunge (Shanzha)"], "text": "used the duration of QRS interval prolongation, ventricular precontraction, ventricular tachycardia, and ventricular fibrillation as markers of arrhythmia to study the effects of C. pinnatifida Bunge (Shanzha) extract on digoxin-induced arrhythmias, and the results showed that the ventricular arrhythmias in the digoxin-induced experimental group of rats all decreased after the administration of C. pinnatifida Bunge (Shanzha) extract, indicating that the flavonoid glycoside and flavane polymers in C. pinnatifida Bunge (Shanzha) extract can antagonize digoxin-induced arrhythmias (Li and Huang, 2016), which may be related to their ability to dilate blood vessels, lower blood pressure, slow down the heart rhythm, and improve the cardiovascular system (Zhang et al., 2021)."}, {"generated": ["C. pinnatifida Bunge (Shanzha)"], "gold": ["flavonoid glycoside", "flavane polymers", "C. pinnatifida Bunge (Shanzha)"], "text": "used the duration of QRS interval prolongation, ventricular precontraction, ventricular tachycardia, and ventricular fibrillation as markers of arrhythmia to study the effects of C. pinnatifida Bunge (Shanzha) extract on digoxin-induced arrhythmias, and the results showed that the ventricular arrhythmias in the digoxin-induced experimental group of rats all decreased after the administration of C. pinnatifida Bunge (Shanzha) extract, indicating that the flavonoid glycoside and flavane polymers in C. pinnatifida Bunge (Shanzha) extract can antagonize digoxin-induced arrhythmias (Li and Huang, 2016), which may be related to their ability to dilate blood vessels, lower blood pressure, slow down the heart rhythm, and improve the cardiovascular system (Zhang et al., 2021)."}, {"generated": ["C. asiatica"], "gold": ["C. asiatica Plant"], "text": "C. asiatica Plant Material and Preparation of CAW-R61J."}, {"generated": ["CAW-R61F", "CAW-R61H"], "gold": ["dried CA for CAW-R61F", "dried CA for CAW-R61H"], "text": "Aliquots of the two filtrates were shipped to Oregon Health & Science University (OHSU, Portland, OR), where they were frozen and lyophilized, yielding 21.4% from dried CA for CAW-R61F (extraction lot 1) and 23.9% from dried CA for CAW-R61H (extraction lot 2)."}, {"generated": ["CAW-R61F", "CAW-R61H"], "gold": ["dried CA for CAW-R61F", "dried CA for CAW-R61H"], "text": "Aliquots of the two filtrates were shipped to Oregon Health & Science University (OHSU, Portland, OR), where they were frozen and lyophilized, yielding 21.4% from dried CA for CAW-R61F (extraction lot 1) and 23.9% from dried CA for CAW-R61H (extraction lot 2)."}, {"generated": ["DMSO"], "gold": ["CAW-R61J"], "text": "DMSO was added to the CAW-R61J dosing solutions to 0.1% (v/v) such that all treatment conditions contained 0.1% DMSO."}, {"generated": ["CAW-R61J"], "gold": ["the centelloid content of CAW-R61J"], "text": "Based on the centelloid content of CAW-R61J, we expect similar plasma concentrations for these compounds in our clinical studies using this extract."}, {"generated": ["CA derivatives"], "gold": ["CA"], "text": "It will also be important to examine possible interactions of CA derivatives with phase II drug-metabolizing enzymes."}, {"generated": ["Epicatechin", "Catechin", "Caffeic acid", "Chlorogenic acid", "p-Coumaric acid"], "gold": ["Epicatechin", "Catechin", "phenolic compounds", "Caffeic acid", "Chlorogenic acid", "p-Coumaric acid"], "text": "Note: values are expressed as mg\u00b7kg Structures of the phenolic compounds identified and quantified from crude herbal extracts (1) Caffeic acid; (2) Catechin; (3) Chlorogenic acid; (4) Epicatechin; (5) p-Coumaric acid."}, {"generated": ["AAP"], "gold": ["GGT"], "text": "AAP at 1000 once a day or 1000 mg \u00d7 4 times a day was administered in the presence or absence of GGT (7680 mg) daily."}, {"generated": ["garlic"], "gold": ["garlic", "allyl sulfide"], "text": "[42] The difference in extent of inhibition between the two age groups hints at either an age-related diminution in CYP2E1 responsivity or a dissimilarity in allyl sulfide content between the garlic supplements."}, {"generated": ["ginkgo"], "gold": ["ginkgolides"], "text": "This interaction appears attributable to the inhibition of platelet activating factor by various ginkgolides."}, {"generated": ["Panax ginseng"], "gold": ["Panax ginseng", "G. biloba"], "text": "Like G. biloba, Panax ginseng appears to have little effect on the activities of the specific CYP isoforms investigated in this study."}, {"generated": ["G. kola"], "gold": ["phenols", "benxophenones", "kolaviron", "saponins", "xanthones", "alkaloids", "biflavonoid complex", "G. kola", "tannins"], "text": "[4] Studies on phytochemical analysis of G. kola seeds [6\u201311] reveal benxophenones, xanthones, alkaloids, phenols, tannins and saponins, kolaviron a biflavonoid complex, and metallic ions such as aluminum, magnesium, calcium and copper as major chemical components of G. kola."}, {"generated": ["G. kola"], "gold": ["phenols", "benxophenones", "kolaviron", "saponins", "xanthones", "alkaloids", "biflavonoid complex", "G. kola", "tannins"], "text": "[4] Studies on phytochemical analysis of G. kola seeds [6\u201311] reveal benxophenones, xanthones, alkaloids, phenols, tannins and saponins, kolaviron a biflavonoid complex, and metallic ions such as aluminum, magnesium, calcium and copper as major chemical components of G. kola."}, {"generated": ["G. kola"], "gold": ["phenols", "benxophenones", "kolaviron", "saponins", "xanthones", "alkaloids", "biflavonoid complex", "G. kola", "tannins"], "text": "[4] Studies on phytochemical analysis of G. kola seeds [6\u201311] reveal benxophenones, xanthones, alkaloids, phenols, tannins and saponins, kolaviron a biflavonoid complex, and metallic ions such as aluminum, magnesium, calcium and copper as major chemical components of G. kola."}, {"generated": ["G. kola"], "gold": ["phenols", "benxophenones", "kolaviron", "saponins", "xanthones", "alkaloids", "biflavonoid complex", "G. kola", "tannins"], "text": "[4] Studies on phytochemical analysis of G. kola seeds [6\u201311] reveal benxophenones, xanthones, alkaloids, phenols, tannins and saponins, kolaviron a biflavonoid complex, and metallic ions such as aluminum, magnesium, calcium and copper as major chemical components of G. kola."}, {"generated": ["G. kola"], "gold": ["phenols", "benxophenones", "kolaviron", "saponins", "xanthones", "alkaloids", "biflavonoid complex", "G. kola", "tannins"], "text": "[4] Studies on phytochemical analysis of G. kola seeds [6\u201311] reveal benxophenones, xanthones, alkaloids, phenols, tannins and saponins, kolaviron a biflavonoid complex, and metallic ions such as aluminum, magnesium, calcium and copper as major chemical components of G. kola."}, {"generated": ["G. kola"], "gold": ["phenols", "benxophenones", "kolaviron", "saponins", "xanthones", "alkaloids", "biflavonoid complex", "G. kola", "tannins"], "text": "[4] Studies on phytochemical analysis of G. kola seeds [6\u201311] reveal benxophenones, xanthones, alkaloids, phenols, tannins and saponins, kolaviron a biflavonoid complex, and metallic ions such as aluminum, magnesium, calcium and copper as major chemical components of G. kola."}, {"generated": ["G. kola"], "gold": ["phenols", "benxophenones", "kolaviron", "saponins", "xanthones", "alkaloids", "biflavonoid complex", "G. kola", "tannins"], "text": "[4] Studies on phytochemical analysis of G. kola seeds [6\u201311] reveal benxophenones, xanthones, alkaloids, phenols, tannins and saponins, kolaviron a biflavonoid complex, and metallic ions such as aluminum, magnesium, calcium and copper as major chemical components of G. kola."}, {"generated": ["G. kola"], "gold": ["phenols", "benxophenones", "kolaviron", "saponins", "xanthones", "alkaloids", "biflavonoid complex", "G. kola", "tannins"], "text": "[4] Studies on phytochemical analysis of G. kola seeds [6\u201311] reveal benxophenones, xanthones, alkaloids, phenols, tannins and saponins, kolaviron a biflavonoid complex, and metallic ions such as aluminum, magnesium, calcium and copper as major chemical components of G. kola."}, {"generated": ["G. kola"], "gold": ["G. kola", "flavonoids"], "text": "[38]  Although, the exact mechanism responsible for the delayed and decreased absorption of quinine in the presence of G. kola in this current study is not known, it is possible that quinine may have interacted through complex formation with the trace metals or flavonoids usually found in G. kola [6, 11] as evidenced from a significant reduction in the Cmax and tmax of quinine but no significant change in parameters which are indicative of interference with elimination."}, {"generated": ["Sophora frutescens"], "gold": ["S. frutescens"], "text": "In Stage 2 77 additional participants were randomized to either 1,200 mg S. frutescens or placebo."}, {"generated": ["EGb 761", "garlic", "S-warfarin", "R-warfarin"], "gold": ["cranberry", "garlic"], "text": "Table 2  Pharmacokinetic parameters of S-warfarin and R-warfarin  \tMean (95% CI)\tGeometric mean ratio (90% CI)  \tWarfarin only\tWarfarin and cranberry\tWarfarin and garlic\tWarfarin and cranberry/warfarin only\tWarfarin and garlic/warfarin only S-warfarin \u2003tmax (h)\t1.4 (1.1\u20131.6)\t1.9 (1.1\u20132.7)\t1.3 (1.1\u20131.6)\tNA\tNA \u2003Cmax (\u03bcg\u2009mL\u22121)\t1.8 (1.7\u20131.9)\t1.7 (1.5\u20132.0)\t1.9 (1.5\u20132.2)\t0.94 (0.67\u20131.29)\t1.06 (0.77\u20131.47) \u2003t1/2 (h)\t38.6 (35.7\u201341.5)\t34.9 (31.0\u201338.8)\t41.2 (35.1\u201347.3)\t0.94 (0.79\u20131.12)\t0.99 (0.83\u20131.18) \u2003AUC (\u03bcg\u2009mL\u22121\u2009h)\t60.3 (54.5\u201366.1)\t63.0 (57.3\u201368.8)\t65.5 (55.3\u201375.6)\t1.04 (0.94\u20131.67)\t1.06 (0.95\u20131.19) \u2003CL/F (mL\u2009h\u22121)\t213 (193\u2013232)\t204 (183\u2013224)\t202 (175\u2013229)\t0.89 (0.80\u20130.99)\t1.05 (0.94\u20131.17) \u2003Fraction unbound (fu)\t0.010 (0.007\u20130.013)\t0.010 (0.007\u20130.014)\t0.011 (0.008\u20130.014)\t1.00 (0.75\u20131.25)\t1.12 (0.39\u20131.84)  \t \t \t \t \t  R-warfarin \u2003tmax (h)\t1.4 (1.1\u20131.6)\t1.9 (1.1\u20132.7)\t1.8 (0.7\u20132.9)\tNA\tNA \u2003Cmax (\u03bcg\u2009mL\u22121)\t1.8 (1.7\u20132.0)\t1.7 (1.5\u20131.9)\t1.9 (1.5\u20132.2)\t0.90 (0.67\u20131.21)\t1.02 (0.8\u20131.4) \u2003t1/2 (h)\t55.6 (46.2\u201365.0)\t47.7 (41.5\u201353.9)\t52.6 (47.4\u201357.9)\t0.93 (0.80\u20131.08)\t0.98 (0.84\u20131.14) \u2003AUC (\u03bcg\u2009mL\u22121\u2009h)\t108.7 (90.0\u2013127.3)\t105.8 (91.7\u2013119.9)\t105.0 (96.3\u2013113.7)\t1.0 (0.9\u20131.1)\t0.99 (0.87\u20131.13) \u2003CL/F (mL\u2009h\u22121)\t123 (106\u2013140)\t124 (109\u2013139)\t121 (112\u2013131)\t0.87 (0.75\u20130.99)\t0.96 (0.84\u20131.11) \u2003Fraction unbound (fu)\t0.006 (0.004\u20130.007)\t0.005 (0.004\u20130.007)\t0.006 (0.004\u20130.007)\t0.95 (0.72\u20131.18)\t1.04 (0.80\u20131.29) Open in a separate window Abbreviations: AUC, area under the plasma concentration\u2013time curve; CI, confidence interval; CL, clearance; CL/F, apparent clearance; Cmax, maximum concentration; F, bioavailability; NA, not applicable; tmax, time to Cmax."}, {"generated": ["cranberry juice"], "gold": ["cranberry"], "text": "(2007) also investigated the effect of pretreatment with cranberry juice for 5 days on warfarin pharmacokinetics and found no clinically significant change in the AUC of S-warfarin."}, {"generated": ["cranberry juice"], "gold": ["cranberry"], "text": "(2007) concluded that there were no pharmacodynamic interactions between warfarin and cranberry juice, but they employed a low dose of warfarin (10\u2009mg), which made this end point difficult to assess."}, {"generated": ["Valerian"], "gold": ["Valeriana officinalis", "valerian"], "text": "However, they state that warnings that valerian (Valeriana officinalis) may stimulate CYP 3A4."}, {"generated": ["valerian"], "gold": ["valerenic acid", "valerian"], "text": "Daily before going to bed, participants took two tablets, with 500\u2009mg valerian extract each (extraction solvent ethanol 70%, valerenic acid content 5.51\u2009mg/tablet), for 14 subsequent days."}, {"generated": [], "gold": ["valerian"], "text": "A possible pharmacodynamic interaction of valerian preparations with other drugs is supported only by two case reports."}, {"generated": ["herb extract complex", "red ginseng"], "gold": ["herb extract complex (RHC)", "red ginseng"], "text": "This study aims to confirm the safety of red ginseng and herb extract complex (RHC), which are used to relieve menopausal symptoms."}, {"generated": [], "gold": ["isoflavone", "horseradish", "white sorghum", "red shamrock", "pomegranate", "flaxseed", "red ginseng"], "text": "Meanwhile, the exclusion criteria were: 1) women who became menopausal from surgery or chemotherapy; 2) women who underwent hysterectomy; 3) women with a history of endometrial hyperplasia or endometrial, breast, or sex hormone\u2013related cancers; 4) women with uncontrolled hypertension (160/100\u00a0mmHg or higher); 5) women with uncontrolled diabetes mellitus (fasting blood sugar 180\u00a0mg/dL or higher, or cases of starting or changing medication due to diabetes within 3\u00a0mo); 6) uncontrolled thyroid patients; 7) women who have had severe migraines within the last year or who have been diagnosed with thromboembolism, cerebrovascular disease, or serious cardiovascular disease; 8) women with atypical uterine bleeding after 1\u00a0yr of menopause; 9) women who have taken sleep inducers, antidepressants, selective estrogen receptor modulators, antihyperlipidemic drugs, antithrombotic drugs (Aspirin, Warfarin, and Clopidogrel), bisphosphonates, or calcitonin within 4\u00a0wk; 10) women who have taken plant hormones (isoflavone, flaxseed, pomegranate, horseradish, white sorghum, red shamrock, and red ginseng products) in the form of supplements or medicines within 4\u00a0wk; 11) women who have continuously taken functional foods and herbal medicines that could affect bone health, blood lipid lipids (triglyceride and cholesterol), and blood circulation within 4\u00a0wk; 12) women who were administered female hormone formulations within 6\u00a0mo; 13) women with alanine aminotransferase (ALT) or aspartate aminotransferase (AST) levels exceeding 3 times the laboratory's normal upper limit; 14) women with creatinine levels exceeding 2 times the laboratory's normal upper limit; 15) women with a history of drug or alcohol abuse; 16) women who have performed intensive exercises (more than 10\u00a0h) within 3\u00a0mo; 17) women with hypersensitivity to the test drug or its ingredients; 18) women with clinically significant abnormalities based on mammographies or Pap smears (Category 0 or higher than 3 of Breast Imaging Reporting and Data System (BI-RADS)) is confirmed (in the case of BI-RADS Category 0, subject registration is possible after confirming additional test results; in the case of Pap smear, atypical squamous cell of undetermined significance can be registered); 19) women who have participated in other clinical trials within 1\u00a0mo of the start of the current study or who are planning to participate in another clinical trial during the study period; and, 20) in cases where the researchers decided that the subject is unsuitable to participate in this study."}, {"generated": [], "gold": ["isoflavone", "horseradish", "white sorghum", "red shamrock", "pomegranate", "flaxseed", "red ginseng"], "text": "Meanwhile, the exclusion criteria were: 1) women who became menopausal from surgery or chemotherapy; 2) women who underwent hysterectomy; 3) women with a history of endometrial hyperplasia or endometrial, breast, or sex hormone\u2013related cancers; 4) women with uncontrolled hypertension (160/100\u00a0mmHg or higher); 5) women with uncontrolled diabetes mellitus (fasting blood sugar 180\u00a0mg/dL or higher, or cases of starting or changing medication due to diabetes within 3\u00a0mo); 6) uncontrolled thyroid patients; 7) women who have had severe migraines within the last year or who have been diagnosed with thromboembolism, cerebrovascular disease, or serious cardiovascular disease; 8) women with atypical uterine bleeding after 1\u00a0yr of menopause; 9) women who have taken sleep inducers, antidepressants, selective estrogen receptor modulators, antihyperlipidemic drugs, antithrombotic drugs (Aspirin, Warfarin, and Clopidogrel), bisphosphonates, or calcitonin within 4\u00a0wk; 10) women who have taken plant hormones (isoflavone, flaxseed, pomegranate, horseradish, white sorghum, red shamrock, and red ginseng products) in the form of supplements or medicines within 4\u00a0wk; 11) women who have continuously taken functional foods and herbal medicines that could affect bone health, blood lipid lipids (triglyceride and cholesterol), and blood circulation within 4\u00a0wk; 12) women who were administered female hormone formulations within 6\u00a0mo; 13) women with alanine aminotransferase (ALT) or aspartate aminotransferase (AST) levels exceeding 3 times the laboratory's normal upper limit; 14) women with creatinine levels exceeding 2 times the laboratory's normal upper limit; 15) women with a history of drug or alcohol abuse; 16) women who have performed intensive exercises (more than 10\u00a0h) within 3\u00a0mo; 17) women with hypersensitivity to the test drug or its ingredients; 18) women with clinically significant abnormalities based on mammographies or Pap smears (Category 0 or higher than 3 of Breast Imaging Reporting and Data System (BI-RADS)) is confirmed (in the case of BI-RADS Category 0, subject registration is possible after confirming additional test results; in the case of Pap smear, atypical squamous cell of undetermined significance can be registered); 19) women who have participated in other clinical trials within 1\u00a0mo of the start of the current study or who are planning to participate in another clinical trial during the study period; and, 20) in cases where the researchers decided that the subject is unsuitable to participate in this study."}, {"generated": [], "gold": ["isoflavone", "horseradish", "white sorghum", "red shamrock", "pomegranate", "flaxseed", "red ginseng"], "text": "Meanwhile, the exclusion criteria were: 1) women who became menopausal from surgery or chemotherapy; 2) women who underwent hysterectomy; 3) women with a history of endometrial hyperplasia or endometrial, breast, or sex hormone\u2013related cancers; 4) women with uncontrolled hypertension (160/100\u00a0mmHg or higher); 5) women with uncontrolled diabetes mellitus (fasting blood sugar 180\u00a0mg/dL or higher, or cases of starting or changing medication due to diabetes within 3\u00a0mo); 6) uncontrolled thyroid patients; 7) women who have had severe migraines within the last year or who have been diagnosed with thromboembolism, cerebrovascular disease, or serious cardiovascular disease; 8) women with atypical uterine bleeding after 1\u00a0yr of menopause; 9) women who have taken sleep inducers, antidepressants, selective estrogen receptor modulators, antihyperlipidemic drugs, antithrombotic drugs (Aspirin, Warfarin, and Clopidogrel), bisphosphonates, or calcitonin within 4\u00a0wk; 10) women who have taken plant hormones (isoflavone, flaxseed, pomegranate, horseradish, white sorghum, red shamrock, and red ginseng products) in the form of supplements or medicines within 4\u00a0wk; 11) women who have continuously taken functional foods and herbal medicines that could affect bone health, blood lipid lipids (triglyceride and cholesterol), and blood circulation within 4\u00a0wk; 12) women who were administered female hormone formulations within 6\u00a0mo; 13) women with alanine aminotransferase (ALT) or aspartate aminotransferase (AST) levels exceeding 3 times the laboratory's normal upper limit; 14) women with creatinine levels exceeding 2 times the laboratory's normal upper limit; 15) women with a history of drug or alcohol abuse; 16) women who have performed intensive exercises (more than 10\u00a0h) within 3\u00a0mo; 17) women with hypersensitivity to the test drug or its ingredients; 18) women with clinically significant abnormalities based on mammographies or Pap smears (Category 0 or higher than 3 of Breast Imaging Reporting and Data System (BI-RADS)) is confirmed (in the case of BI-RADS Category 0, subject registration is possible after confirming additional test results; in the case of Pap smear, atypical squamous cell of undetermined significance can be registered); 19) women who have participated in other clinical trials within 1\u00a0mo of the start of the current study or who are planning to participate in another clinical trial during the study period; and, 20) in cases where the researchers decided that the subject is unsuitable to participate in this study."}, {"generated": [], "gold": ["isoflavone", "horseradish", "white sorghum", "red shamrock", "pomegranate", "flaxseed", "red ginseng"], "text": "Meanwhile, the exclusion criteria were: 1) women who became menopausal from surgery or chemotherapy; 2) women who underwent hysterectomy; 3) women with a history of endometrial hyperplasia or endometrial, breast, or sex hormone\u2013related cancers; 4) women with uncontrolled hypertension (160/100\u00a0mmHg or higher); 5) women with uncontrolled diabetes mellitus (fasting blood sugar 180\u00a0mg/dL or higher, or cases of starting or changing medication due to diabetes within 3\u00a0mo); 6) uncontrolled thyroid patients; 7) women who have had severe migraines within the last year or who have been diagnosed with thromboembolism, cerebrovascular disease, or serious cardiovascular disease; 8) women with atypical uterine bleeding after 1\u00a0yr of menopause; 9) women who have taken sleep inducers, antidepressants, selective estrogen receptor modulators, antihyperlipidemic drugs, antithrombotic drugs (Aspirin, Warfarin, and Clopidogrel), bisphosphonates, or calcitonin within 4\u00a0wk; 10) women who have taken plant hormones (isoflavone, flaxseed, pomegranate, horseradish, white sorghum, red shamrock, and red ginseng products) in the form of supplements or medicines within 4\u00a0wk; 11) women who have continuously taken functional foods and herbal medicines that could affect bone health, blood lipid lipids (triglyceride and cholesterol), and blood circulation within 4\u00a0wk; 12) women who were administered female hormone formulations within 6\u00a0mo; 13) women with alanine aminotransferase (ALT) or aspartate aminotransferase (AST) levels exceeding 3 times the laboratory's normal upper limit; 14) women with creatinine levels exceeding 2 times the laboratory's normal upper limit; 15) women with a history of drug or alcohol abuse; 16) women who have performed intensive exercises (more than 10\u00a0h) within 3\u00a0mo; 17) women with hypersensitivity to the test drug or its ingredients; 18) women with clinically significant abnormalities based on mammographies or Pap smears (Category 0 or higher than 3 of Breast Imaging Reporting and Data System (BI-RADS)) is confirmed (in the case of BI-RADS Category 0, subject registration is possible after confirming additional test results; in the case of Pap smear, atypical squamous cell of undetermined significance can be registered); 19) women who have participated in other clinical trials within 1\u00a0mo of the start of the current study or who are planning to participate in another clinical trial during the study period; and, 20) in cases where the researchers decided that the subject is unsuitable to participate in this study."}, {"generated": [], "gold": ["isoflavone", "horseradish", "white sorghum", "red shamrock", "pomegranate", "flaxseed", "red ginseng"], "text": "Meanwhile, the exclusion criteria were: 1) women who became menopausal from surgery or chemotherapy; 2) women who underwent hysterectomy; 3) women with a history of endometrial hyperplasia or endometrial, breast, or sex hormone\u2013related cancers; 4) women with uncontrolled hypertension (160/100\u00a0mmHg or higher); 5) women with uncontrolled diabetes mellitus (fasting blood sugar 180\u00a0mg/dL or higher, or cases of starting or changing medication due to diabetes within 3\u00a0mo); 6) uncontrolled thyroid patients; 7) women who have had severe migraines within the last year or who have been diagnosed with thromboembolism, cerebrovascular disease, or serious cardiovascular disease; 8) women with atypical uterine bleeding after 1\u00a0yr of menopause; 9) women who have taken sleep inducers, antidepressants, selective estrogen receptor modulators, antihyperlipidemic drugs, antithrombotic drugs (Aspirin, Warfarin, and Clopidogrel), bisphosphonates, or calcitonin within 4\u00a0wk; 10) women who have taken plant hormones (isoflavone, flaxseed, pomegranate, horseradish, white sorghum, red shamrock, and red ginseng products) in the form of supplements or medicines within 4\u00a0wk; 11) women who have continuously taken functional foods and herbal medicines that could affect bone health, blood lipid lipids (triglyceride and cholesterol), and blood circulation within 4\u00a0wk; 12) women who were administered female hormone formulations within 6\u00a0mo; 13) women with alanine aminotransferase (ALT) or aspartate aminotransferase (AST) levels exceeding 3 times the laboratory's normal upper limit; 14) women with creatinine levels exceeding 2 times the laboratory's normal upper limit; 15) women with a history of drug or alcohol abuse; 16) women who have performed intensive exercises (more than 10\u00a0h) within 3\u00a0mo; 17) women with hypersensitivity to the test drug or its ingredients; 18) women with clinically significant abnormalities based on mammographies or Pap smears (Category 0 or higher than 3 of Breast Imaging Reporting and Data System (BI-RADS)) is confirmed (in the case of BI-RADS Category 0, subject registration is possible after confirming additional test results; in the case of Pap smear, atypical squamous cell of undetermined significance can be registered); 19) women who have participated in other clinical trials within 1\u00a0mo of the start of the current study or who are planning to participate in another clinical trial during the study period; and, 20) in cases where the researchers decided that the subject is unsuitable to participate in this study."}, {"generated": [], "gold": ["isoflavone", "horseradish", "white sorghum", "red shamrock", "pomegranate", "flaxseed", "red ginseng"], "text": "Meanwhile, the exclusion criteria were: 1) women who became menopausal from surgery or chemotherapy; 2) women who underwent hysterectomy; 3) women with a history of endometrial hyperplasia or endometrial, breast, or sex hormone\u2013related cancers; 4) women with uncontrolled hypertension (160/100\u00a0mmHg or higher); 5) women with uncontrolled diabetes mellitus (fasting blood sugar 180\u00a0mg/dL or higher, or cases of starting or changing medication due to diabetes within 3\u00a0mo); 6) uncontrolled thyroid patients; 7) women who have had severe migraines within the last year or who have been diagnosed with thromboembolism, cerebrovascular disease, or serious cardiovascular disease; 8) women with atypical uterine bleeding after 1\u00a0yr of menopause; 9) women who have taken sleep inducers, antidepressants, selective estrogen receptor modulators, antihyperlipidemic drugs, antithrombotic drugs (Aspirin, Warfarin, and Clopidogrel), bisphosphonates, or calcitonin within 4\u00a0wk; 10) women who have taken plant hormones (isoflavone, flaxseed, pomegranate, horseradish, white sorghum, red shamrock, and red ginseng products) in the form of supplements or medicines within 4\u00a0wk; 11) women who have continuously taken functional foods and herbal medicines that could affect bone health, blood lipid lipids (triglyceride and cholesterol), and blood circulation within 4\u00a0wk; 12) women who were administered female hormone formulations within 6\u00a0mo; 13) women with alanine aminotransferase (ALT) or aspartate aminotransferase (AST) levels exceeding 3 times the laboratory's normal upper limit; 14) women with creatinine levels exceeding 2 times the laboratory's normal upper limit; 15) women with a history of drug or alcohol abuse; 16) women who have performed intensive exercises (more than 10\u00a0h) within 3\u00a0mo; 17) women with hypersensitivity to the test drug or its ingredients; 18) women with clinically significant abnormalities based on mammographies or Pap smears (Category 0 or higher than 3 of Breast Imaging Reporting and Data System (BI-RADS)) is confirmed (in the case of BI-RADS Category 0, subject registration is possible after confirming additional test results; in the case of Pap smear, atypical squamous cell of undetermined significance can be registered); 19) women who have participated in other clinical trials within 1\u00a0mo of the start of the current study or who are planning to participate in another clinical trial during the study period; and, 20) in cases where the researchers decided that the subject is unsuitable to participate in this study."}, {"generated": [], "gold": ["isoflavone", "horseradish", "white sorghum", "red shamrock", "pomegranate", "flaxseed", "red ginseng"], "text": "Meanwhile, the exclusion criteria were: 1) women who became menopausal from surgery or chemotherapy; 2) women who underwent hysterectomy; 3) women with a history of endometrial hyperplasia or endometrial, breast, or sex hormone\u2013related cancers; 4) women with uncontrolled hypertension (160/100\u00a0mmHg or higher); 5) women with uncontrolled diabetes mellitus (fasting blood sugar 180\u00a0mg/dL or higher, or cases of starting or changing medication due to diabetes within 3\u00a0mo); 6) uncontrolled thyroid patients; 7) women who have had severe migraines within the last year or who have been diagnosed with thromboembolism, cerebrovascular disease, or serious cardiovascular disease; 8) women with atypical uterine bleeding after 1\u00a0yr of menopause; 9) women who have taken sleep inducers, antidepressants, selective estrogen receptor modulators, antihyperlipidemic drugs, antithrombotic drugs (Aspirin, Warfarin, and Clopidogrel), bisphosphonates, or calcitonin within 4\u00a0wk; 10) women who have taken plant hormones (isoflavone, flaxseed, pomegranate, horseradish, white sorghum, red shamrock, and red ginseng products) in the form of supplements or medicines within 4\u00a0wk; 11) women who have continuously taken functional foods and herbal medicines that could affect bone health, blood lipid lipids (triglyceride and cholesterol), and blood circulation within 4\u00a0wk; 12) women who were administered female hormone formulations within 6\u00a0mo; 13) women with alanine aminotransferase (ALT) or aspartate aminotransferase (AST) levels exceeding 3 times the laboratory's normal upper limit; 14) women with creatinine levels exceeding 2 times the laboratory's normal upper limit; 15) women with a history of drug or alcohol abuse; 16) women who have performed intensive exercises (more than 10\u00a0h) within 3\u00a0mo; 17) women with hypersensitivity to the test drug or its ingredients; 18) women with clinically significant abnormalities based on mammographies or Pap smears (Category 0 or higher than 3 of Breast Imaging Reporting and Data System (BI-RADS)) is confirmed (in the case of BI-RADS Category 0, subject registration is possible after confirming additional test results; in the case of Pap smear, atypical squamous cell of undetermined significance can be registered); 19) women who have participated in other clinical trials within 1\u00a0mo of the start of the current study or who are planning to participate in another clinical trial during the study period; and, 20) in cases where the researchers decided that the subject is unsuitable to participate in this study."}, {"generated": ["celastrol"], "gold": ["celastrol (Cela)"], "text": "Inhibition kinetic analysis of celastrol (Cela) towards UGT2B7-catalyzed 4-MU glucuronidation."}, {"generated": ["Korean red ginseng extract (RGE)"], "gold": ["ginseng", "red ginseng extract (RGE)"], "text": "In case of ginseng interactions, it was reported that no herb\u2013drug interaction between single oral dose of Korean red ginseng extract (RGE) (0.5\u20132.0 g/kg) and the probe substrates for five cytochrome P450 (CYP) enzymes (i.e., CYP1A2, 2C9, 2C19, 2D6, 3A) in mouse [12]."}, {"generated": ["Korean red ginseng extract (RGE)"], "gold": ["ginseng", "red ginseng extract (RGE)"], "text": "In case of ginseng interactions, it was reported that no herb\u2013drug interaction between single oral dose of Korean red ginseng extract (RGE) (0.5\u20132.0 g/kg) and the probe substrates for five cytochrome P450 (CYP) enzymes (i.e., CYP1A2, 2C9, 2C19, 2D6, 3A) in mouse [12]."}, {"generated": ["tri-glycosylated PPD-type ginsenosides (Rb1, Rb2, and Rc)"], "gold": ["Rb1", "Rb2", "Rc", "tri-glycosylated PPD-type ginsenosides"], "text": "The plasma concentration was ranged from 7.8 \u03bcM to 34.1 \u03bcM but unbound fraction of tri-glycosylated PPD-type ginsenosides (Rb1, Rb2, and Rc) was very low (0.1\u20130.2% in rat plasma, 0.4\u20130.5% in rat liver; Figure 9B)."}, {"generated": ["tri-glycosylated PPD-type ginsenosides (Rb1, Rb2, and Rc)"], "gold": ["Rb1", "Rb2", "Rc", "tri-glycosylated PPD-type ginsenosides"], "text": "The plasma concentration was ranged from 7.8 \u03bcM to 34.1 \u03bcM but unbound fraction of tri-glycosylated PPD-type ginsenosides (Rb1, Rb2, and Rc) was very low (0.1\u20130.2% in rat plasma, 0.4\u20130.5% in rat liver; Figure 9B)."}, {"generated": ["tri-glycosylated PPD-type ginsenosides (Rb1, Rb2, and Rc)"], "gold": ["Rb1", "Rb2", "Rc", "tri-glycosylated PPD-type ginsenosides"], "text": "The plasma concentration was ranged from 7.8 \u03bcM to 34.1 \u03bcM but unbound fraction of tri-glycosylated PPD-type ginsenosides (Rb1, Rb2, and Rc) was very low (0.1\u20130.2% in rat plasma, 0.4\u20130.5% in rat liver; Figure 9B)."}, {"generated": ["tri-glycosylated PPD-type ginsenosides (Rb1, Rb2, and Rc)"], "gold": ["Rb1", "Rb2", "Rc", "tri-glycosylated PPD-type ginsenosides"], "text": "The plasma concentration was ranged from 7.8 \u03bcM to 34.1 \u03bcM but unbound fraction of tri-glycosylated PPD-type ginsenosides (Rb1, Rb2, and Rc) was very low (0.1\u20130.2% in rat plasma, 0.4\u20130.5% in rat liver; Figure 9B)."}, {"generated": ["red ginseng extract"], "gold": ["ginsenosides", "Rb2", "PPT", "PPD", "Rb1", "red ginseng extract (RGE)", "Rd", "Rc"], "text": "Plasma concentration-time profiles of the ginsenosides (A) Rb1, (B) Rb2, (C) Rc, (D) Rd, (E) PPD, and (F) PPT in the rat plasma after 1-week repeated administration of red ginseng extract (RGE)."}, {"generated": ["red ginseng extract"], "gold": ["ginsenosides", "Rb2", "PPT", "PPD", "Rb1", "red ginseng extract (RGE)", "Rd", "Rc"], "text": "Plasma concentration-time profiles of the ginsenosides (A) Rb1, (B) Rb2, (C) Rc, (D) Rd, (E) PPD, and (F) PPT in the rat plasma after 1-week repeated administration of red ginseng extract (RGE)."}, {"generated": ["red ginseng extract"], "gold": ["ginsenosides", "Rb2", "PPT", "PPD", "Rb1", "red ginseng extract (RGE)", "Rd", "Rc"], "text": "Plasma concentration-time profiles of the ginsenosides (A) Rb1, (B) Rb2, (C) Rc, (D) Rd, (E) PPD, and (F) PPT in the rat plasma after 1-week repeated administration of red ginseng extract (RGE)."}, {"generated": ["red ginseng extract"], "gold": ["ginsenosides", "Rb2", "PPT", "PPD", "Rb1", "red ginseng extract (RGE)", "Rd", "Rc"], "text": "Plasma concentration-time profiles of the ginsenosides (A) Rb1, (B) Rb2, (C) Rc, (D) Rd, (E) PPD, and (F) PPT in the rat plasma after 1-week repeated administration of red ginseng extract (RGE)."}, {"generated": ["red ginseng extract"], "gold": ["ginsenosides", "Rb2", "PPT", "PPD", "Rb1", "red ginseng extract (RGE)", "Rd", "Rc"], "text": "Plasma concentration-time profiles of the ginsenosides (A) Rb1, (B) Rb2, (C) Rc, (D) Rd, (E) PPD, and (F) PPT in the rat plasma after 1-week repeated administration of red ginseng extract (RGE)."}, {"generated": ["red ginseng extract"], "gold": ["ginsenosides", "Rb2", "PPT", "PPD", "Rb1", "red ginseng extract (RGE)", "Rd", "Rc"], "text": "Plasma concentration-time profiles of the ginsenosides (A) Rb1, (B) Rb2, (C) Rc, (D) Rd, (E) PPD, and (F) PPT in the rat plasma after 1-week repeated administration of red ginseng extract (RGE)."}, {"generated": ["red ginseng extract"], "gold": ["ginsenosides", "Rb2", "PPT", "PPD", "Rb1", "red ginseng extract (RGE)", "Rd", "Rc"], "text": "Plasma concentration-time profiles of the ginsenosides (A) Rb1, (B) Rb2, (C) Rc, (D) Rd, (E) PPD, and (F) PPT in the rat plasma after 1-week repeated administration of red ginseng extract (RGE)."}, {"generated": ["red ginseng extract"], "gold": ["ginsenosides", "Rb2", "PPT", "PPD", "Rb1", "red ginseng extract (RGE)", "Rd", "Rc"], "text": "Plasma concentration-time profiles of the ginsenosides (A) Rb1, (B) Rb2, (C) Rc, (D) Rd, (E) PPD, and (F) PPT in the rat plasma after 1-week repeated administration of red ginseng extract (RGE)."}, {"generated": ["valsartan"], "gold": ["Rc"], "text": "AUC: area under the plasma concentration-time curve from 0 to 48 h C Pharmacokinetic parameters of valsartan and Rc following intravenous injection of valsartan at a dose of 1 mg/kg in rats."}, {"generated": ["Citrus Sinensis"], "gold": ["terpenoids", "polymethoxylated flavonoids (PMF)", "linalool", "hesperidin", "Citrus Sinensis (L.) Osbeck from Rutaceae family", "phenolic", "limonene"], "text": "Citrus Sinensis (L.) Osbeck from Rutaceae family mainly contains hesperidin, polymethoxylated flavonoids (PMF), and terpenoids (limonene and linalool), and these phenolic bioactive compounds indicate considerable cytoprotective effects against OS [18]."}, {"generated": ["Citrus Sinensis"], "gold": ["terpenoids", "polymethoxylated flavonoids (PMF)", "linalool", "hesperidin", "Citrus Sinensis (L.) Osbeck from Rutaceae family", "phenolic", "limonene"], "text": "Citrus Sinensis (L.) Osbeck from Rutaceae family mainly contains hesperidin, polymethoxylated flavonoids (PMF), and terpenoids (limonene and linalool), and these phenolic bioactive compounds indicate considerable cytoprotective effects against OS [18]."}, {"generated": ["Citrus Sinensis"], "gold": ["terpenoids", "polymethoxylated flavonoids (PMF)", "linalool", "hesperidin", "Citrus Sinensis (L.) Osbeck from Rutaceae family", "phenolic", "limonene"], "text": "Citrus Sinensis (L.) Osbeck from Rutaceae family mainly contains hesperidin, polymethoxylated flavonoids (PMF), and terpenoids (limonene and linalool), and these phenolic bioactive compounds indicate considerable cytoprotective effects against OS [18]."}, {"generated": ["Citrus Sinensis"], "gold": ["terpenoids", "polymethoxylated flavonoids (PMF)", "linalool", "hesperidin", "Citrus Sinensis (L.) Osbeck from Rutaceae family", "phenolic", "limonene"], "text": "Citrus Sinensis (L.) Osbeck from Rutaceae family mainly contains hesperidin, polymethoxylated flavonoids (PMF), and terpenoids (limonene and linalool), and these phenolic bioactive compounds indicate considerable cytoprotective effects against OS [18]."}, {"generated": ["Citrus Sinensis"], "gold": ["terpenoids", "polymethoxylated flavonoids (PMF)", "linalool", "hesperidin", "Citrus Sinensis (L.) Osbeck from Rutaceae family", "phenolic", "limonene"], "text": "Citrus Sinensis (L.) Osbeck from Rutaceae family mainly contains hesperidin, polymethoxylated flavonoids (PMF), and terpenoids (limonene and linalool), and these phenolic bioactive compounds indicate considerable cytoprotective effects against OS [18]."}, {"generated": ["Citrus Sinensis"], "gold": ["terpenoids", "polymethoxylated flavonoids (PMF)", "linalool", "hesperidin", "Citrus Sinensis (L.) Osbeck from Rutaceae family", "phenolic", "limonene"], "text": "Citrus Sinensis (L.) Osbeck from Rutaceae family mainly contains hesperidin, polymethoxylated flavonoids (PMF), and terpenoids (limonene and linalool), and these phenolic bioactive compounds indicate considerable cytoprotective effects against OS [18]."}, {"generated": ["Citrus Sinensis"], "gold": ["terpenoids", "polymethoxylated flavonoids (PMF)", "linalool", "hesperidin", "Citrus Sinensis (L.) Osbeck from Rutaceae family", "phenolic", "limonene"], "text": "Citrus Sinensis (L.) Osbeck from Rutaceae family mainly contains hesperidin, polymethoxylated flavonoids (PMF), and terpenoids (limonene and linalool), and these phenolic bioactive compounds indicate considerable cytoprotective effects against OS [18]."}, {"generated": ["Total flavonoids"], "gold": ["flavonoids"], "text": "One mL of methanolic extract (5 mg/mL in acetone-water solution) was mixed with 200 \u00b5L of Folin-Ciocalteau reagent and 1 mL of 2% Na Total flavonoids were determined using the AlCl The herbal mixture powder (120 g) was exposed to hydrodistillation using a Clevenger type apparatus for about 4 h. Then, the obtained dark yellow oil was dried over anhydrous sodium sulfate, measured, and stored in a dark glass at 4 \u00b0C for further analyses."}, {"generated": ["spearmint"], "gold": ["phenolic phytochemicals", "spearmint"], "text": "showed that phenolic phytochemicals of spearmint possessed hypoglycemic, and antioxidant attributes [57]."}, {"generated": ["C. sinensis"], "gold": ["C. sinensis", "Polymethoxylated flavones (PMFs)"], "text": "Polymethoxylated flavones (PMFs) of C. sinensis have hypolipidemic effects, resulting in a significant reduction of insulin tolerance and glucose levels [61]."}, {"generated": ["Ginkgo biloba"], "gold": ["Ginkgo biloba extract"], "text": "Ginkgo biloba extract is a popular herbal remedy used for a variety of disorders."}, {"generated": ["EGb 761\u00ae"], "gold": ["EGb 761\u00ae", "EGb 761\u00ae components"], "text": "A maximum exposure was realized with a 240-mg EGb 761\u00ae daily dose, and exposure duration was sufficient to eventually induce CYPs, as steady state for EGb 761\u00ae components was reached, and 1\u00a0week is typically sufficient to achieve full induction [35]."}, {"generated": [], "gold": ["herbal medicines"], "text": "The aim of this study was to systematically review data regarding pharmacokinetic (PK)-pharmacodynamic (PD) parameters from randomized controlled trials relating to interactions between herbal medicines and warfarin."}, {"generated": [], "gold": ["herbal medicines"], "text": "The aim of this article was to systematically review clinical data, including PK-PD parameters, from randomized controlled trials (RCTs) and to discuss interactions between herbal medicines and warfarin."}, {"generated": [], "gold": ["herbal preparations"], "text": "Extraction and formulation method, composition, and bioanalytical data regarding the herbal preparations from the included RCTs are summarized Table 2."}, {"generated": ["warfarin"], "gold": ["herbal medicines"], "text": "All included studies investigated the PD interactions of warfarin with herbal medicines, but different parameters were used in each study."}, {"generated": ["warfarin"], "gold": ["herb"], "text": "These relevant case reports indicated a potential herb-warfarin interaction, but it was difficult to identify a causal relationship."}, {"generated": ["Silibinin"], "gold": ["herbal product", "silibinin", "Silibinin"], "text": "Silibinin was selected as a model herbal product perpetrator based on well\u2010characterized composition, availability of human pharmacokinetic data, and in vitro inhibitory potency (K Because standard approaches to evaluate herb\u2013drug interactions mediated via inhibition of intestinal glucuronidation in humans have not been described, two different modeling platforms were used to predict the likelihood and magnitude of the silibinin\u2013raloxifene interaction."}, {"generated": [], "gold": ["Herbs"], "text": "Herbs have been used for primary health care for thousands of years before the advent of modern medicines."}, {"generated": ["notoginsenoside R"], "gold": ["notoginsenoside R", "PNS"], "text": "PNS contents were determined as: notoginsenoside R UPLC-MS/MS analysis was conducted on an Ultimate 3000 UPLC system (Thermo Fisher Scientific, Waltham, MA, USA) equipped with an LTQ-Orbitrap Elite mass spectrometer (Thermo Fisher Scientific, Waltham, MA, USA)."}, {"generated": ["St. John\u2019s Wort"], "gold": ["John\u2019s Wort"], "text": "PXR activating drugs (e.g., rifampicin) or herbal preparations (e.g., St. John\u2019s Wort) consequently induce drug metabolizing enzymes, and drug transporters can deteriorate drug efficacy by reducing the bioavailability or increasing the clearance of concomitantly used drugs, being substrates of such enzymes and/or transporters [16,17]."}, {"generated": ["Bupleuri Radix", "Paeoniae Radix", "Atractylodis Rhizoma Alba", "Dioscoreae Rhizoma", "Poria Sclerotium", "Bovis Calculus", "Saposhnikoviae Radix", "Cinnamomi cortex", "Ginseng Radix", "Liriopis Tuber", "Armeniacae Semen", "Angelicae Gigantis Radix", "Platycodonis Radix", "Cnidii Rhizoma", "Massa Medicata Fermentata", "Borneolum", "Glycyrrhizae Radix et Rhizoma", "Scutellariae Radix", "Antelopis Cornu", "Glycine Semen Germinatum"], "gold": ["Ginseng", "Zingiberis", "Liriopis", "Angelicae Gigantis", "Dioscoreae", "Atractylodis", "woohwangchengonsimwon suspension", "Poria Sclerotium", "borneol", "Cnidii", "Platycodonis", "Bupleuri", "Scutellariae", "Paeoniae", "Civet", "Armeniacae", "Massa Medicata Fermentata", "Borneolum", "Ampelopsis", "Glycyrrhizae", "isoborneol", "Typhae", "Saposhnikoviae", "Cinnamomi"], "text": "Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol."}, {"generated": ["Bupleuri Radix", "Paeoniae Radix", "Atractylodis Rhizoma Alba", "Dioscoreae Rhizoma", "Poria Sclerotium", "Bovis Calculus", "Saposhnikoviae Radix", "Cinnamomi cortex", "Ginseng Radix", "Liriopis Tuber", "Armeniacae Semen", "Angelicae Gigantis Radix", "Platycodonis Radix", "Cnidii Rhizoma", "Massa Medicata Fermentata", "Borneolum", "Glycyrrhizae Radix et Rhizoma", "Scutellariae Radix", "Antelopis Cornu", "Glycine Semen Germinatum"], "gold": ["Ginseng", "Zingiberis", "Liriopis", "Angelicae Gigantis", "Dioscoreae", "Atractylodis", "woohwangchengonsimwon suspension", "Poria Sclerotium", "borneol", "Cnidii", "Platycodonis", "Bupleuri", "Scutellariae", "Paeoniae", "Civet", "Armeniacae", "Massa Medicata Fermentata", "Borneolum", "Ampelopsis", "Glycyrrhizae", "isoborneol", "Typhae", "Saposhnikoviae", "Cinnamomi"], "text": "Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol."}, {"generated": ["Bupleuri Radix", "Paeoniae Radix", "Atractylodis Rhizoma Alba", "Dioscoreae Rhizoma", "Poria Sclerotium", "Bovis Calculus", "Saposhnikoviae Radix", "Cinnamomi cortex", "Ginseng Radix", "Liriopis Tuber", "Armeniacae Semen", "Angelicae Gigantis Radix", "Platycodonis Radix", "Cnidii Rhizoma", "Massa Medicata Fermentata", "Borneolum", "Glycyrrhizae Radix et Rhizoma", "Scutellariae Radix", "Antelopis Cornu", "Glycine Semen Germinatum"], "gold": ["Ginseng", "Zingiberis", "Liriopis", "Angelicae Gigantis", "Dioscoreae", "Atractylodis", "woohwangchengonsimwon suspension", "Poria Sclerotium", "borneol", "Cnidii", "Platycodonis", "Bupleuri", "Scutellariae", "Paeoniae", "Civet", "Armeniacae", "Massa Medicata Fermentata", "Borneolum", "Ampelopsis", "Glycyrrhizae", "isoborneol", "Typhae", "Saposhnikoviae", "Cinnamomi"], "text": "Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol."}, {"generated": ["Bupleuri Radix", "Paeoniae Radix", "Atractylodis Rhizoma Alba", "Dioscoreae Rhizoma", "Poria Sclerotium", "Bovis Calculus", "Saposhnikoviae Radix", "Cinnamomi cortex", "Ginseng Radix", "Liriopis Tuber", "Armeniacae Semen", "Angelicae Gigantis Radix", "Platycodonis Radix", "Cnidii Rhizoma", "Massa Medicata Fermentata", "Borneolum", "Glycyrrhizae Radix et Rhizoma", "Scutellariae Radix", "Antelopis Cornu", "Glycine Semen Germinatum"], "gold": ["Ginseng", "Zingiberis", "Liriopis", "Angelicae Gigantis", "Dioscoreae", "Atractylodis", "woohwangchengonsimwon suspension", "Poria Sclerotium", "borneol", "Cnidii", "Platycodonis", "Bupleuri", "Scutellariae", "Paeoniae", "Civet", "Armeniacae", "Massa Medicata Fermentata", "Borneolum", "Ampelopsis", "Glycyrrhizae", "isoborneol", "Typhae", "Saposhnikoviae", "Cinnamomi"], "text": "Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol."}, {"generated": ["Bupleuri Radix", "Paeoniae Radix", "Atractylodis Rhizoma Alba", "Dioscoreae Rhizoma", "Poria Sclerotium", "Bovis Calculus", "Saposhnikoviae Radix", "Cinnamomi cortex", "Ginseng Radix", "Liriopis Tuber", "Armeniacae Semen", "Angelicae Gigantis Radix", "Platycodonis Radix", "Cnidii Rhizoma", "Massa Medicata Fermentata", "Borneolum", "Glycyrrhizae Radix et Rhizoma", "Scutellariae Radix", "Antelopis Cornu", "Glycine Semen Germinatum"], "gold": ["Ginseng", "Zingiberis", "Liriopis", "Angelicae Gigantis", "Dioscoreae", "Atractylodis", "woohwangchengonsimwon suspension", "Poria Sclerotium", "borneol", "Cnidii", "Platycodonis", "Bupleuri", "Scutellariae", "Paeoniae", "Civet", "Armeniacae", "Massa Medicata Fermentata", "Borneolum", "Ampelopsis", "Glycyrrhizae", "isoborneol", "Typhae", "Saposhnikoviae", "Cinnamomi"], "text": "Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol."}, {"generated": ["Bupleuri Radix", "Paeoniae Radix", "Atractylodis Rhizoma Alba", "Dioscoreae Rhizoma", "Poria Sclerotium", "Bovis Calculus", "Saposhnikoviae Radix", "Cinnamomi cortex", "Ginseng Radix", "Liriopis Tuber", "Armeniacae Semen", "Angelicae Gigantis Radix", "Platycodonis Radix", "Cnidii Rhizoma", "Massa Medicata Fermentata", "Borneolum", "Glycyrrhizae Radix et Rhizoma", "Scutellariae Radix", "Antelopis Cornu", "Glycine Semen Germinatum"], "gold": ["Ginseng", "Zingiberis", "Liriopis", "Angelicae Gigantis", "Dioscoreae", "Atractylodis", "woohwangchengonsimwon suspension", "Poria Sclerotium", "borneol", "Cnidii", "Platycodonis", "Bupleuri", "Scutellariae", "Paeoniae", "Civet", "Armeniacae", "Massa Medicata Fermentata", "Borneolum", "Ampelopsis", "Glycyrrhizae", "isoborneol", "Typhae", "Saposhnikoviae", "Cinnamomi"], "text": "Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol."}, {"generated": ["Bupleuri Radix", "Paeoniae Radix", "Atractylodis Rhizoma Alba", "Dioscoreae Rhizoma", "Poria Sclerotium", "Bovis Calculus", "Saposhnikoviae Radix", "Cinnamomi cortex", "Ginseng Radix", "Liriopis Tuber", "Armeniacae Semen", "Angelicae Gigantis Radix", "Platycodonis Radix", "Cnidii Rhizoma", "Massa Medicata Fermentata", "Borneolum", "Glycyrrhizae Radix et Rhizoma", "Scutellariae Radix", "Antelopis Cornu", "Glycine Semen Germinatum"], "gold": ["Ginseng", "Zingiberis", "Liriopis", "Angelicae Gigantis", "Dioscoreae", "Atractylodis", "woohwangchengonsimwon suspension", "Poria Sclerotium", "borneol", "Cnidii", "Platycodonis", "Bupleuri", "Scutellariae", "Paeoniae", "Civet", "Armeniacae", "Massa Medicata Fermentata", "Borneolum", "Ampelopsis", "Glycyrrhizae", "isoborneol", "Typhae", "Saposhnikoviae", "Cinnamomi"], "text": "Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol."}, {"generated": ["Bupleuri Radix", "Paeoniae Radix", "Atractylodis Rhizoma Alba", "Dioscoreae Rhizoma", "Poria Sclerotium", "Bovis Calculus", "Saposhnikoviae Radix", "Cinnamomi cortex", "Ginseng Radix", "Liriopis Tuber", "Armeniacae Semen", "Angelicae Gigantis Radix", "Platycodonis Radix", "Cnidii Rhizoma", "Massa Medicata Fermentata", "Borneolum", "Glycyrrhizae Radix et Rhizoma", "Scutellariae Radix", "Antelopis Cornu", "Glycine Semen Germinatum"], "gold": ["Ginseng", "Zingiberis", "Liriopis", "Angelicae Gigantis", "Dioscoreae", "Atractylodis", "woohwangchengonsimwon suspension", "Poria Sclerotium", "borneol", "Cnidii", "Platycodonis", "Bupleuri", "Scutellariae", "Paeoniae", "Civet", "Armeniacae", "Massa Medicata Fermentata", "Borneolum", "Ampelopsis", "Glycyrrhizae", "isoborneol", "Typhae", "Saposhnikoviae", "Cinnamomi"], "text": "Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol."}, {"generated": ["Bupleuri Radix", "Paeoniae Radix", "Atractylodis Rhizoma Alba", "Dioscoreae Rhizoma", "Poria Sclerotium", "Bovis Calculus", "Saposhnikoviae Radix", "Cinnamomi cortex", "Ginseng Radix", "Liriopis Tuber", "Armeniacae Semen", "Angelicae Gigantis Radix", "Platycodonis Radix", "Cnidii Rhizoma", "Massa Medicata Fermentata", "Borneolum", "Glycyrrhizae Radix et Rhizoma", "Scutellariae Radix", "Antelopis Cornu", "Glycine Semen Germinatum"], "gold": ["Ginseng", "Zingiberis", "Liriopis", "Angelicae Gigantis", "Dioscoreae", "Atractylodis", "woohwangchengonsimwon suspension", "Poria Sclerotium", "borneol", "Cnidii", "Platycodonis", "Bupleuri", "Scutellariae", "Paeoniae", "Civet", "Armeniacae", "Massa Medicata Fermentata", "Borneolum", "Ampelopsis", "Glycyrrhizae", "isoborneol", "Typhae", "Saposhnikoviae", "Cinnamomi"], "text": "Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol."}, {"generated": ["Bupleuri Radix", "Paeoniae Radix", "Atractylodis Rhizoma Alba", "Dioscoreae Rhizoma", "Poria Sclerotium", "Bovis Calculus", "Saposhnikoviae Radix", "Cinnamomi cortex", "Ginseng Radix", "Liriopis Tuber", "Armeniacae Semen", "Angelicae Gigantis Radix", "Platycodonis Radix", "Cnidii Rhizoma", "Massa Medicata Fermentata", "Borneolum", "Glycyrrhizae Radix et Rhizoma", "Scutellariae Radix", "Antelopis Cornu", "Glycine Semen Germinatum"], "gold": ["Ginseng", "Zingiberis", "Liriopis", "Angelicae Gigantis", "Dioscoreae", "Atractylodis", "woohwangchengonsimwon suspension", "Poria Sclerotium", "borneol", "Cnidii", "Platycodonis", "Bupleuri", "Scutellariae", "Paeoniae", "Civet", "Armeniacae", "Massa Medicata Fermentata", "Borneolum", "Ampelopsis", "Glycyrrhizae", "isoborneol", "Typhae", "Saposhnikoviae", "Cinnamomi"], "text": "Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol."}, {"generated": ["Bupleuri Radix", "Paeoniae Radix", "Atractylodis Rhizoma Alba", "Dioscoreae Rhizoma", "Poria Sclerotium", "Bovis Calculus", "Saposhnikoviae Radix", "Cinnamomi cortex", "Ginseng Radix", "Liriopis Tuber", "Armeniacae Semen", "Angelicae Gigantis Radix", "Platycodonis Radix", "Cnidii Rhizoma", "Massa Medicata Fermentata", "Borneolum", "Glycyrrhizae Radix et Rhizoma", "Scutellariae Radix", "Antelopis Cornu", "Glycine Semen Germinatum"], "gold": ["Ginseng", "Zingiberis", "Liriopis", "Angelicae Gigantis", "Dioscoreae", "Atractylodis", "woohwangchengonsimwon suspension", "Poria Sclerotium", "borneol", "Cnidii", "Platycodonis", "Bupleuri", "Scutellariae", "Paeoniae", "Civet", "Armeniacae", "Massa Medicata Fermentata", "Borneolum", "Ampelopsis", "Glycyrrhizae", "isoborneol", "Typhae", "Saposhnikoviae", "Cinnamomi"], "text": "Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol."}, {"generated": ["Bupleuri Radix", "Paeoniae Radix", "Atractylodis Rhizoma Alba", "Dioscoreae Rhizoma", "Poria Sclerotium", "Bovis Calculus", "Saposhnikoviae Radix", "Cinnamomi cortex", "Ginseng Radix", "Liriopis Tuber", "Armeniacae Semen", "Angelicae Gigantis Radix", "Platycodonis Radix", "Cnidii Rhizoma", "Massa Medicata Fermentata", "Borneolum", "Glycyrrhizae Radix et Rhizoma", "Scutellariae Radix", "Antelopis Cornu", "Glycine Semen Germinatum"], "gold": ["Ginseng", "Zingiberis", "Liriopis", "Angelicae Gigantis", "Dioscoreae", "Atractylodis", "woohwangchengonsimwon suspension", "Poria Sclerotium", "borneol", "Cnidii", "Platycodonis", "Bupleuri", "Scutellariae", "Paeoniae", "Civet", "Armeniacae", "Massa Medicata Fermentata", "Borneolum", "Ampelopsis", "Glycyrrhizae", "isoborneol", "Typhae", "Saposhnikoviae", "Cinnamomi"], "text": "Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol."}, {"generated": ["Bupleuri Radix", "Paeoniae Radix", "Atractylodis Rhizoma Alba", "Dioscoreae Rhizoma", "Poria Sclerotium", "Bovis Calculus", "Saposhnikoviae Radix", "Cinnamomi cortex", "Ginseng Radix", "Liriopis Tuber", "Armeniacae Semen", "Angelicae Gigantis Radix", "Platycodonis Radix", "Cnidii Rhizoma", "Massa Medicata Fermentata", "Borneolum", "Glycyrrhizae Radix et Rhizoma", "Scutellariae Radix", "Antelopis Cornu", "Glycine Semen Germinatum"], "gold": ["Ginseng", "Zingiberis", "Liriopis", "Angelicae Gigantis", "Dioscoreae", "Atractylodis", "woohwangchengonsimwon suspension", "Poria Sclerotium", "borneol", "Cnidii", "Platycodonis", "Bupleuri", "Scutellariae", "Paeoniae", "Civet", "Armeniacae", "Massa Medicata Fermentata", "Borneolum", "Ampelopsis", "Glycyrrhizae", "isoborneol", "Typhae", "Saposhnikoviae", "Cinnamomi"], "text": "Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol."}, {"generated": ["Bupleuri Radix", "Paeoniae Radix", "Atractylodis Rhizoma Alba", "Dioscoreae Rhizoma", "Poria Sclerotium", "Bovis Calculus", "Saposhnikoviae Radix", "Cinnamomi cortex", "Ginseng Radix", "Liriopis Tuber", "Armeniacae Semen", "Angelicae Gigantis Radix", "Platycodonis Radix", "Cnidii Rhizoma", "Massa Medicata Fermentata", "Borneolum", "Glycyrrhizae Radix et Rhizoma", "Scutellariae Radix", "Antelopis Cornu", "Glycine Semen Germinatum"], "gold": ["Ginseng", "Zingiberis", "Liriopis", "Angelicae Gigantis", "Dioscoreae", "Atractylodis", "woohwangchengonsimwon suspension", "Poria Sclerotium", "borneol", "Cnidii", "Platycodonis", "Bupleuri", "Scutellariae", "Paeoniae", "Civet", "Armeniacae", "Massa Medicata Fermentata", "Borneolum", "Ampelopsis", "Glycyrrhizae", "isoborneol", "Typhae", "Saposhnikoviae", "Cinnamomi"], "text": "Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol."}, {"generated": ["Bupleuri Radix", "Paeoniae Radix", "Atractylodis Rhizoma Alba", "Dioscoreae Rhizoma", "Poria Sclerotium", "Bovis Calculus", "Saposhnikoviae Radix", "Cinnamomi cortex", "Ginseng Radix", "Liriopis Tuber", "Armeniacae Semen", "Angelicae Gigantis Radix", "Platycodonis Radix", "Cnidii Rhizoma", "Massa Medicata Fermentata", "Borneolum", "Glycyrrhizae Radix et Rhizoma", "Scutellariae Radix", "Antelopis Cornu", "Glycine Semen Germinatum"], "gold": ["Ginseng", "Zingiberis", "Liriopis", "Angelicae Gigantis", "Dioscoreae", "Atractylodis", "woohwangchengonsimwon suspension", "Poria Sclerotium", "borneol", "Cnidii", "Platycodonis", "Bupleuri", "Scutellariae", "Paeoniae", "Civet", "Armeniacae", "Massa Medicata Fermentata", "Borneolum", "Ampelopsis", "Glycyrrhizae", "isoborneol", "Typhae", "Saposhnikoviae", "Cinnamomi"], "text": "Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol."}, {"generated": ["Bupleuri Radix", "Paeoniae Radix", "Atractylodis Rhizoma Alba", "Dioscoreae Rhizoma", "Poria Sclerotium", "Bovis Calculus", "Saposhnikoviae Radix", "Cinnamomi cortex", "Ginseng Radix", "Liriopis Tuber", "Armeniacae Semen", "Angelicae Gigantis Radix", "Platycodonis Radix", "Cnidii Rhizoma", "Massa Medicata Fermentata", "Borneolum", "Glycyrrhizae Radix et Rhizoma", "Scutellariae Radix", "Antelopis Cornu", "Glycine Semen Germinatum"], "gold": ["Ginseng", "Zingiberis", "Liriopis", "Angelicae Gigantis", "Dioscoreae", "Atractylodis", "woohwangchengonsimwon suspension", "Poria Sclerotium", "borneol", "Cnidii", "Platycodonis", "Bupleuri", "Scutellariae", "Paeoniae", "Civet", "Armeniacae", "Massa Medicata Fermentata", "Borneolum", "Ampelopsis", "Glycyrrhizae", "isoborneol", "Typhae", "Saposhnikoviae", "Cinnamomi"], "text": "Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol."}, {"generated": ["Bupleuri Radix", "Paeoniae Radix", "Atractylodis Rhizoma Alba", "Dioscoreae Rhizoma", "Poria Sclerotium", "Bovis Calculus", "Saposhnikoviae Radix", "Cinnamomi cortex", "Ginseng Radix", "Liriopis Tuber", "Armeniacae Semen", "Angelicae Gigantis Radix", "Platycodonis Radix", "Cnidii Rhizoma", "Massa Medicata Fermentata", "Borneolum", "Glycyrrhizae Radix et Rhizoma", "Scutellariae Radix", "Antelopis Cornu", "Glycine Semen Germinatum"], "gold": ["Ginseng", "Zingiberis", "Liriopis", "Angelicae Gigantis", "Dioscoreae", "Atractylodis", "woohwangchengonsimwon suspension", "Poria Sclerotium", "borneol", "Cnidii", "Platycodonis", "Bupleuri", "Scutellariae", "Paeoniae", "Civet", "Armeniacae", "Massa Medicata Fermentata", "Borneolum", "Ampelopsis", "Glycyrrhizae", "isoborneol", "Typhae", "Saposhnikoviae", "Cinnamomi"], "text": "Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol."}, {"generated": ["Bupleuri Radix", "Paeoniae Radix", "Atractylodis Rhizoma Alba", "Dioscoreae Rhizoma", "Poria Sclerotium", "Bovis Calculus", "Saposhnikoviae Radix", "Cinnamomi cortex", "Ginseng Radix", "Liriopis Tuber", "Armeniacae Semen", "Angelicae Gigantis Radix", "Platycodonis Radix", "Cnidii Rhizoma", "Massa Medicata Fermentata", "Borneolum", "Glycyrrhizae Radix et Rhizoma", "Scutellariae Radix", "Antelopis Cornu", "Glycine Semen Germinatum"], "gold": ["Ginseng", "Zingiberis", "Liriopis", "Angelicae Gigantis", "Dioscoreae", "Atractylodis", "woohwangchengonsimwon suspension", "Poria Sclerotium", "borneol", "Cnidii", "Platycodonis", "Bupleuri", "Scutellariae", "Paeoniae", "Civet", "Armeniacae", "Massa Medicata Fermentata", "Borneolum", "Ampelopsis", "Glycyrrhizae", "isoborneol", "Typhae", "Saposhnikoviae", "Cinnamomi"], "text": "Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol."}, {"generated": ["Bupleuri Radix", "Paeoniae Radix", "Atractylodis Rhizoma Alba", "Dioscoreae Rhizoma", "Poria Sclerotium", "Bovis Calculus", "Saposhnikoviae Radix", "Cinnamomi cortex", "Ginseng Radix", "Liriopis Tuber", "Armeniacae Semen", "Angelicae Gigantis Radix", "Platycodonis Radix", "Cnidii Rhizoma", "Massa Medicata Fermentata", "Borneolum", "Glycyrrhizae Radix et Rhizoma", "Scutellariae Radix", "Antelopis Cornu", "Glycine Semen Germinatum"], "gold": ["Ginseng", "Zingiberis", "Liriopis", "Angelicae Gigantis", "Dioscoreae", "Atractylodis", "woohwangchengonsimwon suspension", "Poria Sclerotium", "borneol", "Cnidii", "Platycodonis", "Bupleuri", "Scutellariae", "Paeoniae", "Civet", "Armeniacae", "Massa Medicata Fermentata", "Borneolum", "Ampelopsis", "Glycyrrhizae", "isoborneol", "Typhae", "Saposhnikoviae", "Cinnamomi"], "text": "Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol."}, {"generated": ["Bupleuri Radix", "Paeoniae Radix", "Atractylodis Rhizoma Alba", "Dioscoreae Rhizoma", "Poria Sclerotium", "Bovis Calculus", "Saposhnikoviae Radix", "Cinnamomi cortex", "Ginseng Radix", "Liriopis Tuber", "Armeniacae Semen", "Angelicae Gigantis Radix", "Platycodonis Radix", "Cnidii Rhizoma", "Massa Medicata Fermentata", "Borneolum", "Glycyrrhizae Radix et Rhizoma", "Scutellariae Radix", "Antelopis Cornu", "Glycine Semen Germinatum"], "gold": ["Ginseng", "Zingiberis", "Liriopis", "Angelicae Gigantis", "Dioscoreae", "Atractylodis", "woohwangchengonsimwon suspension", "Poria Sclerotium", "borneol", "Cnidii", "Platycodonis", "Bupleuri", "Scutellariae", "Paeoniae", "Civet", "Armeniacae", "Massa Medicata Fermentata", "Borneolum", "Ampelopsis", "Glycyrrhizae", "isoborneol", "Typhae", "Saposhnikoviae", "Cinnamomi"], "text": "Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol."}, {"generated": ["Bupleuri Radix", "Paeoniae Radix", "Atractylodis Rhizoma Alba", "Dioscoreae Rhizoma", "Poria Sclerotium", "Bovis Calculus", "Saposhnikoviae Radix", "Cinnamomi cortex", "Ginseng Radix", "Liriopis Tuber", "Armeniacae Semen", "Angelicae Gigantis Radix", "Platycodonis Radix", "Cnidii Rhizoma", "Massa Medicata Fermentata", "Borneolum", "Glycyrrhizae Radix et Rhizoma", "Scutellariae Radix", "Antelopis Cornu", "Glycine Semen Germinatum"], "gold": ["Ginseng", "Zingiberis", "Liriopis", "Angelicae Gigantis", "Dioscoreae", "Atractylodis", "woohwangchengonsimwon suspension", "Poria Sclerotium", "borneol", "Cnidii", "Platycodonis", "Bupleuri", "Scutellariae", "Paeoniae", "Civet", "Armeniacae", "Massa Medicata Fermentata", "Borneolum", "Ampelopsis", "Glycyrrhizae", "isoborneol", "Typhae", "Saposhnikoviae", "Cinnamomi"], "text": "Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol."}, {"generated": ["APG\u2013DAS"], "gold": ["APG"], "text": "Further thorough in vivo studies of the APG\u2013DAS interaction in humans are warranted to support these findings."}, {"generated": ["SC extract"], "gold": ["SC extract", "SC"], "text": "The mean SC extract supplementation and placebo compliance were 97.3% (90.2\u2212100%) in the SC group and 95.8% (86.7\u2013100%) in the placebo group."}, {"generated": ["St. John's wort"], "gold": ["St. John's wort (SJW)"], "text": "The first clinically relevant reports of preparations of St. John's wort (SJW), a herbal medicine with anti\u2010depressant effects, interacting with other drugs, altering their bioavailability and efficacy, were published about 20 years ago."}, {"generated": ["hypericin", "hyperforin", "flavonoids"], "gold": ["hypericin", "hyperforin", "SJW extracts", "flavonoids"], "text": "SJW extracts as well as isolated constituents (hyperforin, hypericin, or flavonoids) have been investigated in vitro and in vivo for their interactions with a variety of potentially relevant targets for depression."}, {"generated": ["hyperforin"], "gold": ["SJW", "hyperforin"], "text": "For OATP2B1, we have recently shown that this transporter is not only inhibited by hyperforin but also transports this constituent of SJW (Sch\u00e4fer, Bock, & Meyer Zu Schwabedissen, 2018), thus influencing the intracellular transactivation of PXR by hyperforin (Sch\u00e4fer et al., 2019)."}, {"generated": ["SJW extract"], "gold": ["low\u2010hyperforin SJW extract"], "text": "This statement was provided even before another comprehensive pharmacokinetic interaction study was published, where no clinically relevant interactions were found for seven test drugs in concomitant application with a low\u2010hyperforin SJW extract (Zahner et al., 2019)."}, {"generated": ["Viscum album"], "gold": ["Viscum album extracts (VAE)"], "text": "Clinical studies have reported on the benefits of Viscum album extracts (VAE) not only in breast cancer patients but also for other types of cancer [10\u201313]."}, {"generated": ["total mistletoe lectin", "Iscador Qu"], "gold": ["mistletoe lectin", "Malus domestica", "VAEM", "Iscador Qu"], "text": "5\u2009mg (VAEM, host tree Malus domestica, Lot 7054/0, total mistletoe lectin concentration 306\u2009ng/mL), and Iscador Qu spec."}, {"generated": ["total mistletoe lectin", "Iscador Qu"], "gold": ["mistletoe lectin", "Malus domestica", "VAEM", "Iscador Qu"], "text": "5\u2009mg (VAEM, host tree Malus domestica, Lot 7054/0, total mistletoe lectin concentration 306\u2009ng/mL), and Iscador Qu spec."}, {"generated": ["total mistletoe lectin", "Iscador Qu"], "gold": ["mistletoe lectin", "Malus domestica", "VAEM", "Iscador Qu"], "text": "5\u2009mg (VAEM, host tree Malus domestica, Lot 7054/0, total mistletoe lectin concentration 306\u2009ng/mL), and Iscador Qu spec."}, {"generated": ["Eugenia jambolana"], "gold": ["Eugenia jambolana (EJ)"], "text": "Eugenia jambolana (EJ) is an Indian traditional herb widely used for the treatment of diabetes mellitus."}, {"generated": ["EJE"], "gold": ["anthocyanins", "EJE", "EJ", "flavonoids"], "text": "(EJ) are considered to be functional foods owing to their anti-diabetic Several research groups studying the protective and therapeutic effect of EJE and have identified presence of various classes of bioactive constituents like anthocyanins, flavonoids Gliptins are a class of oral anti-diabetic agents which act by competitively antagonizing the enzyme dipeptidyl peptidase-4 (DDP-4)."}, {"generated": ["EJE"], "gold": ["anthocyanins", "EJE", "EJ", "flavonoids"], "text": "(EJ) are considered to be functional foods owing to their anti-diabetic Several research groups studying the protective and therapeutic effect of EJE and have identified presence of various classes of bioactive constituents like anthocyanins, flavonoids Gliptins are a class of oral anti-diabetic agents which act by competitively antagonizing the enzyme dipeptidyl peptidase-4 (DDP-4)."}, {"generated": ["EJE"], "gold": ["anthocyanins", "EJE", "EJ", "flavonoids"], "text": "(EJ) are considered to be functional foods owing to their anti-diabetic Several research groups studying the protective and therapeutic effect of EJE and have identified presence of various classes of bioactive constituents like anthocyanins, flavonoids Gliptins are a class of oral anti-diabetic agents which act by competitively antagonizing the enzyme dipeptidyl peptidase-4 (DDP-4)."}, {"generated": ["EJE + SITA", "EJE"], "gold": ["EJE\u202f", "EJE"], "text": "Treatment with EJE and EJE\u202f+\u202fSITA significantly (p\u202f<\u202f0.001) reduced the elevated levels of BUN (Fig."}, {"generated": ["Officinarum"], "gold": ["A.\u00a0Officinarum"], "text": "A.\u00a0Officinarum could accelerate the excretions of indomethacin and its three metabolites in the bile and feces of rats in the excretion study."}, {"generated": ["delphinidin-3-sambubioside", "cyanidin-3-sambubioside", "Anthocyanins"], "gold": ["HS", "Anthocyanins, particularly delphinidin-3-sambubioside and cyanidin-3-sambubioside"], "text": "Anthocyanins, particularly delphinidin-3-sambubioside and cyanidin-3-sambubioside, are generally believed to be the active constituents responsible for the antihypertensive, antioxidant, and hypocholesterolemic effects of HS, possibly because they are found in high relative quantities in aqueous extracts [8, 11, 13, 16]."}, {"generated": ["delphinidin-3-sambubioside", "cyanidin-3-sambubioside", "Anthocyanins"], "gold": ["HS", "Anthocyanins, particularly delphinidin-3-sambubioside and cyanidin-3-sambubioside"], "text": "Anthocyanins, particularly delphinidin-3-sambubioside and cyanidin-3-sambubioside, are generally believed to be the active constituents responsible for the antihypertensive, antioxidant, and hypocholesterolemic effects of HS, possibly because they are found in high relative quantities in aqueous extracts [8, 11, 13, 16]."}, {"generated": ["HS varieties"], "gold": ["HS"], "text": "The HS varieties with deeper red calyxes exhibited greater antioxidant activity as compared to lighter red or white varieties [44, 45]."}, {"generated": [], "gold": ["anthocyanins", "HS extracts"], "text": "Biological Mechanisms  In vitro and in vivo studies focused on mechanism of action have determined several potential mechanisms of the HS extracts that may explain the hypotensive activity, including (1) vasodilation mediated through endothelium-derived relaxant pathways and inhibition of calcium influx [9, 57], (2) ACE inhibition [9] by the stimulation of new vessel formation and a reduction of myocardial mass [52] or anthocyanins competing with the substrate for the active site [58], (3) decrease in blood viscosity through cyclooxygenase inhibitory activity [44], and (4) inhibition of adipocyte differentiation through the modulation of PI3-K/Akt and ERK pathway [59]."}, {"generated": [], "gold": ["anthocyanins", "HS extracts"], "text": "Biological Mechanisms  In vitro and in vivo studies focused on mechanism of action have determined several potential mechanisms of the HS extracts that may explain the hypotensive activity, including (1) vasodilation mediated through endothelium-derived relaxant pathways and inhibition of calcium influx [9, 57], (2) ACE inhibition [9] by the stimulation of new vessel formation and a reduction of myocardial mass [52] or anthocyanins competing with the substrate for the active site [58], (3) decrease in blood viscosity through cyclooxygenase inhibitory activity [44], and (4) inhibition of adipocyte differentiation through the modulation of PI3-K/Akt and ERK pathway [59]."}, {"generated": ["Schisandra"], "gold": ["Schisandra lignans"], "text": "Interaction between imatinib and Schisandra lignans was unlikely to be of clinical importance."}, {"generated": ["Schisandra"], "gold": ["Schisandra lignans"], "text": "by carbamazepine and phenytoin, 72 the predominant outcome from a chronic exposure to Schisandra lignans is a CYP3A inhibition and not induction."}, {"generated": ["Schisandra"], "gold": ["Schisandra lignans"], "text": "Another limitation of the current study is the reliance on the assumption that Schisandra lignans are solely responsible for the interactions with CYP substrates."}, {"generated": ["S. sphenanthera"], "gold": ["S. sphenanthera extract"], "text": "Constituents of S. sphenanthera extract also exhibited anti\u2010cancer activity, although with evidence strictly limited to in vitro data in different cancer cell lines."}, {"generated": ["DFG-warfarin"], "gold": ["DFG"], "text": "The results of our previous study showed that the administration of a DFG-warfarin combination led to a reduction in the warfarin plasma concentration and PT time of rats [23, 32]."}, {"generated": ["Gegen"], "gold": ["Gegen", "DFG"], "text": "Taken together with the results of the current study, it seems clear that these effects could be attributed to the Gegen present in DFG."}, {"generated": ["Danshen"], "gold": ["Gegen", "Danshen"], "text": "Although there were no clinical reports in the literature pertaining to the interactions between Gegen and warfarin, the results of several case reports indicated that Danshen can interact with warfarin in humans [20\u201322]."}, {"generated": ["Danshen"], "gold": ["tanshinone", "Danshen"], "text": "This finding is also supported by Yueng\u2019s study, where the major tanshinone components rather than the aqueous extract of Danshen showed effects on warfarin hydroxylation in vitro and in vivo [58]."}, {"generated": ["SAB"], "gold": ["SAB", "Danshen"], "text": "In our study, although SAB was used as a major component of the Danshen granules, the in vivo effects were very different to those observed in cells because of the poor absorption and bioavailability of SAB."}, {"generated": ["Beikang Ge", "Zhen Zhang", "Zhu Zu", "Danshen"], "gold": ["salvianolic acid B", "Gegen", "Danshen"], "text": "liver cytochrome P450 vitamin K epoxide reductase vitamin K vitamin K thrombomodulin Danshen\u2013Gegen Formula salvianolic acid B phenobarbital beta-naphthoflavone cyclophosphamide enzyme-linked immunosorbent assay Beikang Ge and Zhen Zhang contributed equally to this work BKG, ZZh and ZZu conceived and designed the study."}, {"generated": ["Beikang Ge", "Zhen Zhang", "Zhu Zu", "Danshen"], "gold": ["salvianolic acid B", "Gegen", "Danshen"], "text": "liver cytochrome P450 vitamin K epoxide reductase vitamin K vitamin K thrombomodulin Danshen\u2013Gegen Formula salvianolic acid B phenobarbital beta-naphthoflavone cyclophosphamide enzyme-linked immunosorbent assay Beikang Ge and Zhen Zhang contributed equally to this work BKG, ZZh and ZZu conceived and designed the study."}, {"generated": ["several herbal supplementations"], "gold": ["Herbal Supplementations"], "text": "Case Report: Fatigue and Bleeding in a Polymedicated Patient Using Several Herbal Supplementations, Detected with g-Nomic\u00ae Software Abel Saldarreaga Marin, 1 Marc Cendros, 2 Carlos J Ciudad, 3 and Ana Sabater 2 Author information Article notes Copyright and License information PMC Disclaimer Go to: Abstract  This was a case report of severe fatigue and bleeding in a 65-year-old man with ischemic heart disease who was wearing a stent and taking multiple medications for hypertension and diabetes."}, {"generated": ["echinacea"], "gold": ["echinacea alkamide tetraene"], "text": "Trough plasma concentrations of the major echinacea alkamide tetraene ranged from 1 to 23 ng ml\u22121, and the Cmax was found to range from 13 to 65 ng ml\u22121."}, {"generated": ["Ginkgo biloba", "Panax ginseng", "Allium sativum", "Hypericum perforatum"], "gold": ["St. John\u2019s wort (Hypericum perforatum)", "Panax ginseng", "garlic (Allium sativum)", "Ginkgo biloba"], "text": "Clinical studies of some of the most commonly researched plants include garlic (Allium sativum), St. John\u2019s wort (Hypericum perforatum), Panax ginseng, and Ginkgo biloba [9]."}, {"generated": ["Ginkgo biloba", "Panax ginseng", "Allium sativum", "Hypericum perforatum"], "gold": ["St. John\u2019s wort (Hypericum perforatum)", "Panax ginseng", "garlic (Allium sativum)", "Ginkgo biloba"], "text": "Clinical studies of some of the most commonly researched plants include garlic (Allium sativum), St. John\u2019s wort (Hypericum perforatum), Panax ginseng, and Ginkgo biloba [9]."}, {"generated": ["5\u2032-methoxydehydropodophyllotoxin", "deoxydehydropodophyllotoxin", "cadina-4,10(15)-dien-3-one", "dehydro-b-peltatin methyl ether", "4\u2032-demethyldesoxypodophyllotoxin", "dehydropodophyllotoxin", "\u03b2-Sitosterol"], "gold": ["5\u2032-methoxydehydropodophyllotoxin", "deoxydehydropodophyllotoxin", "cadina-4,10(15)-dien-3-one", "dehydro-b-peltatin methyl ether", "lignans", "4\u2032-demethyldesoxypodophyllotoxin", "dehydropodophyllotoxin", "\u03b2-Sitosterol"], "text": "\u03b2-Sitosterol, cadina-4,10(15)-dien-3-one and a mix of five lignans comprised of dehydropodophyllotoxin, deoxydehydropodophyllotoxin, 4\u2032-demethyldesoxypodophyllotoxin, 5\u2032-methoxydehydropodophyllotoxin, and dehydro-b-peltatin methyl ether were supplied by the Department of Chemistry, University of the West Indies, Mona Campus, Jamaica."}, {"generated": ["OS"], "gold": ["Wen Bing formulas"], "text": "To explore more, we would like to investigate the interactions between OS and selected single herbs from these Wen Bing formulas."}, {"generated": ["Radix Scutellariae"], "gold": ["Radix Scutellariae extract (RS)"], "text": "A commercially available, standardized and purified Radix Scutellariae extract (RS) was obtained from Shanghai U-sea Biotech Co., Ltd. (Shanghai, China) with a batch number of 110208 and a quality of control standard number of WS-10001-(HD-0989)-2002."}, {"generated": ["Radix Isatidis"], "gold": ["Radix Isatidis", "Isatis indigotica Fort"], "text": "Radix Isatidis (Root of Isatis indigotica Fort., Banlangen)."}, {"generated": ["Fructus Arctii"], "gold": ["Fructus Arctii", "Arctium lappa L."], "text": "Fructus Arctii (Fruit of Arctium lappa L., Niubangzi)."}, {"generated": ["Phellodendron bark", "dried orange peel", "Anemarrhena"], "gold": ["Phellodendron bark (Phellodendron amurense Rupr.", "dried orange peel (Citrus aurantium L.)", "Anemarrhena (Anemarrhena asphodeloides Bunge)"], "text": "), dried orange peel (Citrus aurantium L.), Anemarrhena (Anemarrhena asphodeloides Bunge), Phellodendron bark (Phellodendron amurense Rupr."}, {"generated": ["Phellodendron bark", "dried orange peel", "Anemarrhena"], "gold": ["Phellodendron bark (Phellodendron amurense Rupr.", "dried orange peel (Citrus aurantium L.)", "Anemarrhena (Anemarrhena asphodeloides Bunge)"], "text": "), dried orange peel (Citrus aurantium L.), Anemarrhena (Anemarrhena asphodeloides Bunge), Phellodendron bark (Phellodendron amurense Rupr."}, {"generated": ["Phellodendron bark", "dried orange peel", "Anemarrhena"], "gold": ["Phellodendron bark (Phellodendron amurense Rupr.", "dried orange peel (Citrus aurantium L.)", "Anemarrhena (Anemarrhena asphodeloides Bunge)"], "text": "), dried orange peel (Citrus aurantium L.), Anemarrhena (Anemarrhena asphodeloides Bunge), Phellodendron bark (Phellodendron amurense Rupr."}, {"generated": ["Lilyturf", "Ginger", "Licorice"], "gold": ["Ginger (Zingiber officinale Roscoe)", "Lilyturf (Ophiopogon japonicus (Thunb.)", "Licorice (Glycyrrhiza glabra L.)"], "text": "), Licorice (Glycyrrhiza glabra L.), Ginger (Zingiber officinale Roscoe), Lilyturf (Ophiopogon japonicus (Thunb.)"}, {"generated": ["Lilyturf", "Ginger", "Licorice"], "gold": ["Ginger (Zingiber officinale Roscoe)", "Lilyturf (Ophiopogon japonicus (Thunb.)", "Licorice (Glycyrrhiza glabra L.)"], "text": "), Licorice (Glycyrrhiza glabra L.), Ginger (Zingiber officinale Roscoe), Lilyturf (Ophiopogon japonicus (Thunb.)"}, {"generated": ["Lilyturf", "Ginger", "Licorice"], "gold": ["Ginger (Zingiber officinale Roscoe)", "Lilyturf (Ophiopogon japonicus (Thunb.)", "Licorice (Glycyrrhiza glabra L.)"], "text": "), Licorice (Glycyrrhiza glabra L.), Ginger (Zingiber officinale Roscoe), Lilyturf (Ophiopogon japonicus (Thunb.)"}, {"generated": ["Vitex negundo"], "gold": ["10 Evn-50", "Vitex negundo L."], "text": "In a study involving TAM-resistant cell line MCF-7 tam-R, while 10 Evn-50 is an ethyl acetate extract of Vitex negundo L. When used in combination with TAM to treat TAM-resistant MCF-7/TAM-R cells, it significantly reduces cell viability, inhibits cell growth, induces apoptosis, and reverses TAM resistance of MCF-7/TAM-R cells (Hu et al., 2012)."}, {"generated": ["Vitex negundo"], "gold": ["10 Evn-50", "Vitex negundo L."], "text": "In a study involving TAM-resistant cell line MCF-7 tam-R, while 10 Evn-50 is an ethyl acetate extract of Vitex negundo L. When used in combination with TAM to treat TAM-resistant MCF-7/TAM-R cells, it significantly reduces cell viability, inhibits cell growth, induces apoptosis, and reverses TAM resistance of MCF-7/TAM-R cells (Hu et al., 2012)."}, {"generated": ["Jaeumkanghwa"], "gold": ["Jaeumkanghwa soup (JEKHT)"], "text": "Jaeumkanghwa soup (JEKHT) is a compound composed of 12 traditional herbs (Jung et al., 2010)."}, {"generated": ["Jiawei Xiaoyao San"], "gold": ["Jiawei Xiaoyao San (JWXYS)"], "text": "Jiawei Xiaoyao San (JWXYS) is a very common Chinese herbal formula used by the Chinese for thousands of years (Chen et al., 2014)."}, {"generated": ["Don (P. capitatum)"], "gold": ["ex D. Don (P. capitatum)"], "text": "ex D. Don (P. capitatum), a Chinese herbal plant, is often used alone or in combination with antibacterial agents to treat urinary tract infections, pyelonephritis, and prostatitis in China (Chinese Pharmacopoeia Commission, 2010; Liao et al., 2011)."}, {"generated": ["GA", "PCA"], "gold": ["GA", "PCE", "PCA"], "text": "Consequently, GA and PCA were chosen as PCE tracer components in the pharmacokinetic- and tissue distribution-based HDIs studies."}, {"generated": ["CIP", "PCE"], "gold": ["GA", "PCE", "PCA"], "text": "After co-administration of CIP and PCE, the PK changes of GA and PCA are displayed in Figures 3, 4, respectively."}, {"generated": ["CIP", "PCE"], "gold": ["GA", "PCE", "PCA"], "text": "After co-administration of CIP and PCE, the PK changes of GA and PCA are displayed in Figures 3, 4, respectively."}, {"generated": ["ciprofloxacin", "gallic acid"], "gold": ["gallic acid (GA)", "PCE", "PCA"], "text": "CIP significantly increased the K  Tissue distribution profiles of gallic acid (GA) after oral administration of PCE in the absence (A) and presence (B) of ciprofloxacin, as well as the tissue to plasma distribution coefficients [K  The tissue distribution curves of PCA in the absence and| presence of CIP are shown in Figures 8A,B, respectively."}, {"generated": ["ciprofloxacin", "gallic acid"], "gold": ["gallic acid (GA)", "PCE", "PCA"], "text": "CIP significantly increased the K  Tissue distribution profiles of gallic acid (GA) after oral administration of PCE in the absence (A) and presence (B) of ciprofloxacin, as well as the tissue to plasma distribution coefficients [K  The tissue distribution curves of PCA in the absence and| presence of CIP are shown in Figures 8A,B, respectively."}, {"generated": ["ciprofloxacin", "gallic acid"], "gold": ["gallic acid (GA)", "PCE", "PCA"], "text": "CIP significantly increased the K  Tissue distribution profiles of gallic acid (GA) after oral administration of PCE in the absence (A) and presence (B) of ciprofloxacin, as well as the tissue to plasma distribution coefficients [K  The tissue distribution curves of PCA in the absence and| presence of CIP are shown in Figures 8A,B, respectively."}, {"generated": ["Total Energy Expenditure"], "gold": ["YM"], "text": "Total Energy Expenditure (TEE) was neither significantly affected by the treatment (YM vs. PLC) nor the exercise time (Figure 3)."}, {"generated": ["quinic acid", "triterpenic saponins", "mono-caffeolquinic acid", "chlorogenic acids", "dihydrocaffeolquinic acid", "caffeic acid"], "gold": ["caffeine"], "text": "The metabolic effects include adrengenic effects and stimulated central nervous system associated with caffeine, anti-lipolytic, and hypocholesterolemic properties in chlorogenic acids (mono- and di-caffeolquinic acids) hydroxycinnamic acids (caffeic acid, quinic acid) and triterpenic saponins, and other minerals and vitamins [5]."}, {"generated": ["YM capsules"], "gold": ["YM"], "text": "However, further research is required to assess active ingredients of YM capsules and analyze their bioavailability following ingestion."}, {"generated": ["echinacea", "kratom", "St. John\u2019s wort", "hydroxycut", "piperine", "celery", "rhodiola", "moringa", "valerian", "terminalia/commiphora ayurvedic mixture", "ginkgo", "ginseng", "kava"], "gold": ["echinacea", "kratom", "terminalia/commiphora ayurvedic", "St. John\u2019s wort", "hydroxycut", "piperine", "celery", "rhodiola", "moringa", "valerian", "ginkgo", "ginseng", "kava"], "text": "These are celery, echinacea, ginkgo, ginseng, hydroxycut, kava, kratom, moringa, piperine, rhodiola, St. John\u2019s wort, terminalia/commiphora ayurvedic mixture and valerian."}, {"generated": ["kava"], "gold": ["kava", "kavalactones"], "text": "The pharmacological activities of kava have been attributed to kavalactones, which are concentrated in the rhizomes [96]."}, {"generated": ["Parsley"], "gold": ["Parsley", "Petroselinum crispum"], "text": "Parsley, Petroselinum crispum, is a food, spice, and also a medicinal herb."}, {"generated": ["Maxim extract"], "gold": ["Maxim"], "text": "Maxim extract are available from the authors."}, {"generated": ["Allium sativum"], "gold": ["allicin", "Allium sativum"], "text": "The European pharmacopoeia monographs pulverized dried bulbs of Allium sativum containing at least 0.45% allicin [154]."}, {"generated": ["Valerian"], "gold": ["HMP"], "text": "Valerian, for example, is marketed in Germany, mainly as HMP, and, thus, possibly a great proportion of consumption was not included in the survey by Garcia-Alvarez [7]."}, {"generated": ["sulfur compounds"], "gold": ["allyl thiosulfinates"], "text": "It is composed of a large number of sulfur compounds, with suspected bioactive compounds called allyl thiosulfinates (mainly allicin) [65]."}, {"generated": ["gymnema tea"], "gold": ["gymnema"], "text": "These findings suggest further research in individuals with diabetes is required to determine the effect of the combination of gymnema tea and metformin on blood sugar levels."}]}